id	sid	tid	token	lemma	pos
aji-7	1	1	_	_	PUNCT
aji-7	2	1	_	_	PUNCT
aji-7	3	1	_	_	PUNCT
aji-7	4	1	_	_	PUNCT
aji-7	5	1	_	_	PUNCT
aji-7	6	1	_	_	PUNCT
aji-7	7	1	_	_	PUNCT
aji-7	8	1	_	_	PUNCT
aji-7	9	1	_	_	PUNCT
aji-7	10	1	_	_	PUNCT
aji-7	11	1	_	_	PUNCT
aji-7	12	1	_	_	PUNCT
aji-7	13	1	_	_	PUNCT
aji-7	14	1	_	_	PUNCT
aji-7	15	1	_	_	PUNCT
aji-7	16	1	_	_	PUNCT
aji-7	17	1	_	_	PUNCT
aji-7	18	1	_	_	PUNCT
aji-7	19	1	_	_	PUNCT
aji-7	20	1	_	_	PUNCT
aji-7	21	1	_	_	PUNCT
aji-7	22	1	_	_	PUNCT
aji-7	23	1	_	_	PUNCT
aji-7	24	1	_	_	PUNCT
aji-7	25	1	_	_	PUNCT
aji-7	26	1	_	_	PUNCT
aji-7	27	1	_	_	PUNCT
aji-7	28	1	_	_	PUNCT
aji-7	29	1	_	_	PUNCT
aji-7	30	1	_	_	PUNCT
aji-7	31	1	_	_	PUNCT
aji-7	32	1	_	_	PUNCT
aji-7	33	1	_	_	PUNCT
aji-7	34	1	_	_	PUNCT
aji-7	35	1	_	_	PUNCT
aji-7	36	1	_	_	PUNCT
aji-7	37	1	_	_	PUNCT
aji-7	38	1	_	_	PUNCT
aji-7	39	1	_	_	PUNCT
aji-7	40	1	_	_	PUNCT
aji-7	41	1	_	_	PUNCT
aji-7	42	1	_	_	PUNCT
aji-7	43	1	_	_	PUNCT
aji-7	44	1	_	_	PUNCT
aji-7	45	1	_	_	PUNCT
aji-7	46	1	_	_	PUNCT
aji-7	47	1	_	_	PUNCT
aji-7	48	1	_	_	PUNCT
aji-7	49	1	_	_	PUNCT
aji-7	50	1	_	_	PUNCT
aji-7	51	1	_	_	PUNCT
aji-7	52	1	_	_	PUNCT
aji-7	53	1	_	_	PUNCT
aji-7	54	1	_	_	PUNCT
aji-7	55	1	_	_	PUNCT
aji-7	56	1	_	_	PUNCT
aji-7	57	1	_	_	PUNCT
aji-7	58	1	_	_	PUNCT
aji-7	59	1	_	_	PUNCT
aji-7	60	1	_	_	PUNCT
aji-7	61	1	_	_	PUNCT
aji-7	62	1	_	_	PUNCT
aji-7	63	1	_	_	PUNCT
aji-7	64	1	_	_	PUNCT
aji-7	65	1	_	_	PUNCT
aji-7	66	1	_	_	PUNCT
aji-7	67	1	_	_	PUNCT
aji-7	68	1	_	_	PUNCT
aji-7	69	1	_	_	PUNCT
aji-7	70	1	_	_	PUNCT
aji-7	71	1	_	_	PUNCT
aji-7	72	1	_	_	PUNCT
aji-7	73	1	_	_	PUNCT
aji-7	74	1	_	_	PUNCT
aji-7	75	1	_	_	PUNCT
aji-7	76	1	_	_	PUNCT
aji-7	77	1	_	_	PUNCT
aji-7	78	1	_	_	PUNCT
aji-7	79	1	_	_	PUNCT
aji-7	80	1	_	_	PUNCT
aji-7	81	1	_	_	PUNCT
aji-7	82	1	_	_	PUNCT
aji-7	83	1	_	_	PUNCT
aji-7	84	1	_	_	PUNCT
aji-7	85	1	_	_	PUNCT
aji-7	86	1	_	_	PUNCT
aji-7	87	1	_	_	PUNCT
aji-7	88	1	_	_	PUNCT
aji-7	89	1	_	_	PUNCT
aji-7	90	1	_	_	PUNCT
aji-7	91	1	_	_	PUNCT
aji-7	92	1	_	_	PUNCT
aji-7	93	1	_	_	PUNCT
aji-7	94	1	_	_	PUNCT
aji-7	95	1	_	_	PUNCT
aji-7	96	1	_	_	PUNCT
aji-7	97	1	_	_	PUNCT
aji-7	98	1	_	_	PUNCT
aji-7	99	1	_	_	PUNCT
aji-7	100	1	_	_	PUNCT
aji-7	101	1	_	_	PUNCT
aji-7	102	1	*	*	PUNCT
aji-7	102	2	corresponding	correspond	VERB
aji-7	102	3	author	author	NOUN
aji-7	102	4	:	:	PUNCT
aji-7	102	5	e	e	NOUN
aji-7	102	6	-	-	NOUN
aji-7	102	7	mail	mail	NOUN
aji-7	102	8	:	:	PUNCT
aji-7	102	9	naser_elsawy@ymail.com	naser_elsawy@ymail.com	NOUN
aji-7	102	10	;	;	PUNCT
aji-7	102	11	asian	asian	ADJ
aji-7	102	12	journal	journal	NOUN
aji-7	102	13	of	of	ADP
aji-7	102	14	immunology	immunology	NOUN
aji-7	102	15	2(1	2(1	NUM
aji-7	102	16	):	):	PUNCT
aji-7	102	17	34	34	NUM
aji-7	102	18	-	-	SYM
aji-7	102	19	44	44	NUM
aji-7	102	20	,	,	PUNCT
aji-7	102	21	2019	2019	NUM
aji-7	102	22	;	;	PUNCT
aji-7	102	23	article	article	NOUN
aji-7	102	24	no.aji.53258	no.aji.53258	PROPN
aji-7	102	25	therapeutic	therapeutic	ADJ
aji-7	102	26	potential	potential	NOUN
aji-7	102	27	of	of	ADP
aji-7	102	28	the	the	DET
aji-7	102	29	dual	dual	ADJ
aji-7	102	30	peroxisome	peroxisome	NOUN
aji-7	102	31	proliferator	proliferator	NOUN
aji-7	102	32	activated	activate	VERB
aji-7	102	33	receptor	receptor	NOUN
aji-7	102	34	(	(	PUNCT
aji-7	102	35	ppar)/	ppar)/	PUNCT
aji-7	102	36	agonist	agonist	NOUN
aji-7	102	37	aleglitazar	aleglitazar	NOUN
aji-7	102	38	in	in	ADP
aji-7	102	39	attenuating	attenuate	VERB
aji-7	102	40	tnf	tnf	PROPN
aji-7	102	41	-	-	PUNCT
aji-7	102	42	mediated	mediate	VERB
aji-7	102	43	inflammation	inflammation	NOUN
aji-7	102	44	and	and	CCONJ
aji-7	102	45	insulin	insulin	NOUN
aji-7	102	46	resistance	resistance	NOUN
aji-7	102	47	in	in	ADP
aji-7	102	48	human	human	ADJ
aji-7	102	49	adipocytes	adipocyte	NOUN
aji-7	102	50	:	:	PUNCT
aji-7	102	51	a	a	DET
aji-7	102	52	review	review	NOUN
aji-7	102	53	naser	naser	PROPN
aji-7	102	54	a.	a.	NOUN
aji-7	102	55	elsawy1	elsawy1	PROPN
aji-7	102	56	*	*	SYM
aji-7	102	57	1	1	NUM
aji-7	102	58	department	department	NOUN
aji-7	102	59	of	of	ADP
aji-7	102	60	anatomy	anatomy	PROPN
aji-7	102	61	and	and	CCONJ
aji-7	102	62	embryology	embryology	NOUN
aji-7	102	63	,	,	PUNCT
aji-7	102	64	faculty	faculty	NOUN
aji-7	102	65	of	of	ADP
aji-7	102	66	medicine	medicine	NOUN
aji-7	102	67	,	,	PUNCT
aji-7	102	68	zagazig	zagazig	PROPN
aji-7	102	69	university	university	PROPN
aji-7	102	70	,	,	PUNCT
aji-7	102	71	egypt	egypt	PROPN
aji-7	102	72	.	.	PUNCT
aji-7	103	1	author	author	PROPN
aji-7	103	2	’s	’s	PART
aji-7	103	3	contribution	contribution	NOUN
aji-7	103	4	the	the	DET
aji-7	103	5	sole	sole	ADJ
aji-7	103	6	author	author	NOUN
aji-7	103	7	designed	design	VERB
aji-7	103	8	,	,	PUNCT
aji-7	103	9	analysed	analyse	VERB
aji-7	103	10	,	,	PUNCT
aji-7	103	11	interpreted	interpret	VERB
aji-7	103	12	and	and	CCONJ
aji-7	103	13	prepared	prepare	VERB
aji-7	103	14	the	the	DET
aji-7	103	15	manuscript	manuscript	NOUN
aji-7	103	16	.	.	PUNCT
aji-7	104	1	article	article	NOUN
aji-7	104	2	information	information	PROPN
aji-7	104	3	editor(s	editor(s	PROPN
aji-7	104	4	):	):	PUNCT
aji-7	104	5	(	(	PUNCT
aji-7	104	6	1	1	X
aji-7	104	7	)	)	PUNCT
aji-7	104	8	dr	dr	PROPN
aji-7	104	9	.	.	PROPN
aji-7	104	10	cynthia	cynthia	PROPN
aji-7	104	11	aracely	aracely	ADV
aji-7	104	12	alvizo	alvizo	VERB
aji-7	104	13	báez	báez	NOUN
aji-7	104	14	,	,	PUNCT
aji-7	104	15	professor	professor	NOUN
aji-7	104	16	,	,	PUNCT
aji-7	104	17	laboratory	laboratory	NOUN
aji-7	104	18	immunology	immunology	NOUN
aji-7	104	19	and	and	CCONJ
aji-7	104	20	virology	virology	NOUN
aji-7	104	21	,	,	PUNCT
aji-7	104	22	faculty	faculty	NOUN
aji-7	104	23	of	of	ADP
aji-7	104	24	biological	biological	ADJ
aji-7	104	25	sciences	science	NOUN
aji-7	104	26	,	,	PUNCT
aji-7	104	27	autonomous	autonomous	ADJ
aji-7	104	28	university	university	PROPN
aji-7	104	29	of	of	ADP
aji-7	104	30	nuevo	nuevo	PROPN
aji-7	104	31	leon	leon	PROPN
aji-7	104	32	,	,	PUNCT
aji-7	104	33	mexico	mexico	PROPN
aji-7	104	34	.	.	PUNCT
aji-7	105	1	reviewers	reviewer	NOUN
aji-7	105	2	:	:	PUNCT
aji-7	105	3	(	(	PUNCT
aji-7	105	4	1	1	X
aji-7	105	5	)	)	PUNCT
aji-7	105	6	umezurike	umezurike	PROPN
aji-7	105	7	benedict	benedict	PROPN
aji-7	105	8	chidozie	chidozie	PROPN
aji-7	105	9	,	,	PUNCT
aji-7	105	10	nigeria	nigeria	PROPN
aji-7	105	11	.	.	PUNCT
aji-7	106	1	(	(	PUNCT
aji-7	106	2	2	2	X
aji-7	106	3	)	)	PUNCT
aji-7	106	4	gayatri	gayatri	PROPN
aji-7	106	5	c.	c.	PROPN
aji-7	106	6	gawade	gawade	PROPN
aji-7	106	7	,	,	PUNCT
aji-7	106	8	bharati	bharati	PROPN
aji-7	106	9	vidyapeeth	vidyapeeth	PROPN
aji-7	106	10	dental	dental	PROPN
aji-7	106	11	college	college	NOUN
aji-7	106	12	and	and	CCONJ
aji-7	106	13	hospital	hospital	NOUN
aji-7	106	14	,	,	PUNCT
aji-7	106	15	india	india	PROPN
aji-7	106	16	.	.	PUNCT
aji-7	107	1	complete	complete	ADJ
aji-7	107	2	peer	peer	NOUN
aji-7	107	3	review	review	NOUN
aji-7	107	4	history	history	NOUN
aji-7	107	5	:	:	PUNCT
aji-7	107	6	http://www.sdiarticle4.com/review-history/53258	http://www.sdiarticle4.com/review-history/53258	PROPN
aji-7	107	7	received	receive	VERB
aji-7	107	8	01	01	NUM
aji-7	107	9	october	october	PROPN
aji-7	107	10	2019	2019	NUM
aji-7	107	11	accepted	accept	VERB
aji-7	107	12	05	05	NUM
aji-7	107	13	december	december	PROPN
aji-7	107	14	2019	2019	NUM
aji-7	107	15	published	publish	VERB
aji-7	107	16	10	10	NUM
aji-7	107	17	december	december	PROPN
aji-7	107	18	2019	2019	NUM
aji-7	107	19	abstract	abstract	ADJ
aji-7	107	20	aleglitazar	aleglitazar	NOUN
aji-7	107	21	,	,	PUNCT
aji-7	107	22	is	be	AUX
aji-7	107	23	a	a	DET
aji-7	107	24	novel	novel	ADJ
aji-7	107	25	promising	promise	VERB
aji-7	107	26	drug	drug	NOUN
aji-7	107	27	,	,	PUNCT
aji-7	107	28	that	that	PRON
aji-7	107	29	related	relate	VERB
aji-7	107	30	to	to	PART
aji-7	107	31	peroxisome	peroxisome	VERB
aji-7	107	32	proliferator	proliferator	NOUN
aji-7	107	33	-	-	PUNCT
aji-7	107	34	activated	activate	VERB
aji-7	107	35	receptor	receptor	NOUN
aji-7	107	36	(	(	PUNCT
aji-7	107	37	pparα&γ	pparα&γ	PROPN
aji-7	107	38	)	)	PUNCT
aji-7	107	39	agonists	agonist	NOUN
aji-7	107	40	which	which	PRON
aji-7	107	41	shows	show	VERB
aji-7	107	42	an	an	DET
aji-7	107	43	ant	ant	ADJ
aji-7	107	44	-	-	PUNCT
aji-7	107	45	diabetic	diabetic	ADJ
aji-7	107	46	and	and	CCONJ
aji-7	107	47	anti	anti	ADJ
aji-7	107	48	-	-	ADJ
aji-7	107	49	inflammatory	inflammatory	ADJ
aji-7	107	50	characteristics	characteristic	NOUN
aji-7	107	51	.	.	PUNCT
aji-7	108	1	the	the	DET
aji-7	108	2	goal	goal	NOUN
aji-7	108	3	of	of	ADP
aji-7	108	4	this	this	DET
aji-7	108	5	study	study	NOUN
aji-7	108	6	is	be	AUX
aji-7	108	7	to	to	PART
aji-7	108	8	evaluate	evaluate	VERB
aji-7	108	9	anti	anti	ADJ
aji-7	108	10	-	-	ADJ
aji-7	108	11	inflammatory	inflammatory	ADJ
aji-7	108	12	and	and	CCONJ
aji-7	108	13	anti	anti	ADJ
aji-7	108	14	-	-	ADJ
aji-7	108	15	arthritic	arthritic	ADJ
aji-7	108	16	properties	property	NOUN
aji-7	108	17	of	of	ADP
aji-7	108	18	aleglitazar	aleglitazar	NOUN
aji-7	108	19	in	in	ADP
aji-7	108	20	arthritis	arthritis	NOUN
aji-7	108	21	models	model	NOUN
aji-7	108	22	induced	induce	VERB
aji-7	108	23	in	in	ADP
aji-7	108	24	experimental	experimental	ADJ
aji-7	108	25	animals	animal	NOUN
aji-7	108	26	and	and	CCONJ
aji-7	108	27	to	to	PART
aji-7	108	28	conclude	conclude	VERB
aji-7	108	29	the	the	DET
aji-7	108	30	comparative	comparative	ADJ
aji-7	108	31	ulcerogenic	ulcerogenic	ADJ
aji-7	108	32	potential	potential	NOUN
aji-7	108	33	of	of	ADP
aji-7	108	34	diclofenac	diclofenac	NOUN
aji-7	108	35	in	in	ADP
aji-7	108	36	type	type	NOUN
aji-7	108	37	2	2	NUM
aji-7	108	38	diabetes	diabetes	NOUN
aji-7	108	39	animals	animal	NOUN
aji-7	108	40	.	.	PUNCT
aji-7	109	1	the	the	DET
aji-7	109	2	anti	anti	ADJ
aji-7	109	3	-	-	ADJ
aji-7	109	4	inflammatory	inflammatory	ADJ
aji-7	109	5	characteristics	characteristic	NOUN
aji-7	109	6	of	of	ADP
aji-7	109	7	aleglitazar	aleglitazar	NOUN
aji-7	109	8	will	will	AUX
aji-7	109	9	be	be	AUX
aji-7	109	10	investigated	investigate	VERB
aji-7	109	11	in	in	ADP
aji-7	109	12	carrageenan	carrageenan	NOUN
aji-7	109	13	-	-	PUNCT
aji-7	109	14	induced	induce	VERB
aji-7	109	15	hind	hind	NOUN
aji-7	109	16	paw	paw	NOUN
aji-7	109	17	edema	edema	NOUN
aji-7	109	18	as	as	ADP
aji-7	109	19	acute	acute	ADJ
aji-7	109	20	inflammation	inflammation	NOUN
aji-7	109	21	.	.	PUNCT
aji-7	110	1	the	the	DET
aji-7	110	2	aim	aim	NOUN
aji-7	110	3	of	of	ADP
aji-7	110	4	the	the	DET
aji-7	110	5	review	review	NOUN
aji-7	110	6	:	:	PUNCT
aji-7	110	7	this	this	DET
aji-7	110	8	study	study	NOUN
aji-7	110	9	aims	aim	VERB
aji-7	110	10	to	to	PART
aji-7	110	11	assess	assess	VERB
aji-7	110	12	anti	anti	ADJ
aji-7	110	13	-	-	ADJ
aji-7	110	14	inflammatory	inflammatory	ADJ
aji-7	110	15	and	and	CCONJ
aji-7	110	16	anti	anti	ADJ
aji-7	110	17	-	-	ADJ
aji-7	110	18	arthritic	arthritic	ADJ
aji-7	110	19	activities	activity	NOUN
aji-7	110	20	of	of	ADP
aji-7	110	21	aleglitazar	aleglitazar	NOUN
aji-7	110	22	in	in	ADP
aji-7	110	23	arthritis	arthritis	NOUN
aji-7	110	24	models	model	NOUN
aji-7	110	25	induced	induce	VERB
aji-7	110	26	in	in	ADP
aji-7	110	27	experimental	experimental	ADJ
aji-7	110	28	animals	animal	NOUN
aji-7	110	29	.	.	PUNCT
aji-7	111	1	it	it	PRON
aji-7	111	2	is	be	AUX
aji-7	111	3	to	to	PART
aji-7	111	4	determine	determine	VERB
aji-7	111	5	comparative	comparative	ADJ
aji-7	111	6	ulcerogenic	ulcerogenic	ADJ
aji-7	111	7	potential	potential	ADJ
aji-7	111	8	diclofenac	diclofenac	NOUN
aji-7	111	9	in	in	ADP
aji-7	111	10	type	type	NOUN
aji-7	111	11	2	2	NUM
aji-7	111	12	diabetic	diabetic	ADJ
aji-7	111	13	animals	animal	NOUN
aji-7	111	14	on	on	ADP
aji-7	111	15	gastric	gastric	ADJ
aji-7	111	16	mucosa	mucosa	NOUN
aji-7	111	17	in	in	ADP
aji-7	111	18	rats	rat	NOUN
aji-7	111	19	.	.	PUNCT
aji-7	112	1	keywords	keyword	NOUN
aji-7	112	2	:	:	PUNCT
aji-7	112	3	ppar	ppar	NOUN
aji-7	112	4	;	;	PUNCT
aji-7	112	5	aleglitazar	aleglitazar	PROPN
aji-7	112	6	;	;	PUNCT
aji-7	112	7	tnf	tnf	PROPN
aji-7	112	8	;	;	PUNCT
aji-7	112	9	inflammation	inflammation	ADJ
aji-7	112	10	insulin	insulin	NOUN
aji-7	112	11	resistance	resistance	NOUN
aji-7	112	12	;	;	PUNCT
aji-7	112	13	adipocytes	adipocytes	PROPN
aji-7	112	14	.	.	PUNCT
aji-7	113	1	review	review	NOUN
aji-7	113	2	article	article	NOUN
aji-7	113	3	elsawy	elsawy	NOUN
aji-7	113	4	;	;	PUNCT
aji-7	113	5	aji	aji	NOUN
aji-7	113	6	,	,	PUNCT
aji-7	113	7	2(1	2(1	NUM
aji-7	113	8	):	):	PUNCT
aji-7	113	9	34	34	NUM
aji-7	113	10	-	-	SYM
aji-7	113	11	44	44	NUM
aji-7	113	12	,	,	PUNCT
aji-7	113	13	2019	2019	NUM
aji-7	113	14	;	;	PUNCT
aji-7	113	15	article	article	NOUN
aji-7	113	16	no.aji.53258	no.aji.53258	NOUN
aji-7	113	17	35	35	NUM
aji-7	113	18	abbreviations	abbreviation	NOUN
aji-7	113	19	ang	ang	INTJ
aji-7	113	20	:	:	PUNCT
aji-7	114	1	angiotensin	angiotensin	NOUN
aji-7	114	2	bmi	bmi	PROPN
aji-7	114	3	:	:	PUNCT
aji-7	114	4	body	body	NOUN
aji-7	114	5	mass	mass	PROPN
aji-7	114	6	index	index	NOUN
aji-7	114	7	cox1	cox1	NOUN
aji-7	114	8	:	:	PUNCT
aji-7	114	9	cyclooxygenase-1	cyclooxygenase-1	NUM
aji-7	114	10	enzyme	enzyme	NOUN
aji-7	114	11	cox2	cox2	NOUN
aji-7	114	12	:	:	PUNCT
aji-7	114	13	cyclooxygenase-2	cyclooxygenase-2	NUM
aji-7	114	14	enzyme	enzyme	VERB
aji-7	114	15	crp	crp	NOUN
aji-7	114	16	:	:	PUNCT
aji-7	114	17	c	c	X
aji-7	114	18	-	-	PUNCT
aji-7	114	19	reactive	reactive	ADJ
aji-7	114	20	protein	protein	NOUN
aji-7	114	21	ffa	ffa	NOUN
aji-7	114	22	:	:	PUNCT
aji-7	114	23	free	free	ADJ
aji-7	114	24	fatty	fatty	NOUN
aji-7	114	25	acids	acid	NOUN
aji-7	114	26	gcf	gcf	PROPN
aji-7	114	27	:	:	PUNCT
aji-7	114	28	gingival	gingival	NOUN
aji-7	114	29	crevicular	crevicular	ADJ
aji-7	114	30	fluid	fluid	ADJ
aji-7	114	31	gdm	gdm	NOUN
aji-7	114	32	:	:	PUNCT
aji-7	114	33	gestational	gestational	ADJ
aji-7	114	34	diabetes	diabetes	NOUN
aji-7	114	35	mellitus	mellitus	PROPN
aji-7	114	36	gfr	gfr	PROPN
aji-7	114	37	:	:	PUNCT
aji-7	114	38	glomerular	glomerular	ADJ
aji-7	114	39	filtration	filtration	NOUN
aji-7	114	40	rate	rate	NOUN
aji-7	114	41	1gir	1gir	NUM
aji-7	114	42	:	:	PUNCT
aji-7	114	43	glucose	glucose	NOUN
aji-7	114	44	-	-	PUNCT
aji-7	114	45	insulin	insulin	NOUN
aji-7	114	46	rate	rate	NOUN
aji-7	114	47	hba1c	hba1c	PROPN
aji-7	114	48	:	:	PUNCT
aji-7	114	49	glycated	glycate	VERB
aji-7	114	50	haemoglobin	haemoglobin	PROPN
aji-7	114	51	hdl	hdl	PROPN
aji-7	114	52	:	:	PUNCT
aji-7	114	53	high	high	ADJ
aji-7	114	54	-	-	PUNCT
aji-7	114	55	density	density	NOUN
aji-7	114	56	lipoprotein	lipoprotein	ADJ
aji-7	114	57	cholesterol	cholesterol	NOUN
aji-7	114	58	il-1β	il-1β	PROPN
aji-7	114	59	:	:	PUNCT
aji-7	114	60	interleukin	interleukin	NOUN
aji-7	114	61	1β	1β	PROPN
aji-7	114	62	ldl	ldl	NOUN
aji-7	114	63	:	:	PUNCT
aji-7	114	64	low	low	ADJ
aji-7	114	65	-	-	PUNCT
aji-7	114	66	density	density	NOUN
aji-7	114	67	lipoprotein	lipoprotein	ADJ
aji-7	114	68	cholesterol	cholesterol	NOUN
aji-7	115	1	no	no	DET
aji-7	115	2	:	:	PUNCT
aji-7	115	3	nitric	nitric	ADJ
aji-7	115	4	oxide	oxide	NOUN
aji-7	115	5	no	no	PRON
aji-7	115	6	/	/	SYM
aji-7	115	7	onoo	onoo	ADJ
aji-7	115	8	:	:	PUNCT
aji-7	115	9	nitric	nitric	ADJ
aji-7	115	10	oxide	oxide	NOUN
aji-7	115	11	/	/	SYM
aji-7	115	12	peroxynitrite	peroxynitrite	NOUN
aji-7	115	13	ratio	ratio	NOUN
aji-7	115	14	nsaids	nsaid	NOUN
aji-7	115	15	:	:	PUNCT
aji-7	115	16	nonsteroidal	nonsteroidal	NOUN
aji-7	115	17	antiinflammatory	antiinflammatory	NOUN
aji-7	115	18	class	class	NOUN
aji-7	115	19	of	of	ADP
aji-7	115	20	drugs	drug	NOUN
aji-7	115	21	pge2	pge2	NOUN
aji-7	115	22	:	:	PUNCT
aji-7	115	23	prostaglandin	prostaglandin	NOUN
aji-7	115	24	e2	e2	NOUN
aji-7	115	25	pgs	pgs	NOUN
aji-7	115	26	:	:	PUNCT
aji-7	115	27	prostaglandins	prostaglandin	NOUN
aji-7	115	28	pai-1	pai-1	NUM
aji-7	115	29	:	:	PUNCT
aji-7	115	30	plasminogen	plasminogen	NOUN
aji-7	115	31	activator	activator	NOUN
aji-7	115	32	inhibitor-1	inhibitor-1	NUM
aji-7	115	33	ppar	ppar	NOUN
aji-7	115	34	α	α	NOUN
aji-7	115	35	&	&	CCONJ
aji-7	115	36	γ	γ	PROPN
aji-7	115	37	:	:	PUNCT
aji-7	115	38	peroxisome	peroxisome	VERB
aji-7	115	39	proliferator	proliferator	NOUN
aji-7	115	40	activated	activate	VERB
aji-7	115	41	receptor	receptor	NOUN
aji-7	115	42	α	α	PROPN
aji-7	115	43	&	&	CCONJ
aji-7	115	44	γ	γ	PROPN
aji-7	115	45	sc	sc	PROPN
aji-7	115	46	:	:	PUNCT
aji-7	115	47	serum	serum	NOUN
aji-7	115	48	creatinine	creatinine	NOUN
aji-7	115	49	stz	stz	NOUN
aji-7	115	50	:	:	PUNCT
aji-7	115	51	streptozotocin	streptozotocin	PROPN
aji-7	115	52	tg	tg	INTJ
aji-7	115	53	:	:	PUNCT
aji-7	115	54	triglycerides	triglyceride	NOUN
aji-7	115	55	tnfα	tnfα	NOUN
aji-7	115	56	:	:	PUNCT
aji-7	115	57	tumor	tumor	NOUN
aji-7	115	58	necrosis	necrosis	NOUN
aji-7	115	59	factor	factor	NOUN
aji-7	115	60	alpha	alpha	NOUN
aji-7	115	61	t2	t2	PROPN
aji-7	115	62	dm	dm	NOUN
aji-7	115	63	:	:	PUNCT
aji-7	115	64	type	type	NOUN
aji-7	115	65	2	2	NUM
aji-7	115	66	diabetes	diabetes	NOUN
aji-7	115	67	mellitus	mellitus	NOUN
aji-7	115	68	1	1	X
aji-7	115	69	.	.	PUNCT
aji-7	116	1	introduction	introduction	NOUN
aji-7	116	2	obesity	obesity	NOUN
aji-7	116	3	is	be	AUX
aji-7	116	4	frequently	frequently	ADV
aji-7	116	5	associated	associate	VERB
aji-7	116	6	with	with	ADP
aji-7	116	7	insulin	insulin	NOUN
aji-7	116	8	resistance	resistance	NOUN
aji-7	116	9	,	,	PUNCT
aji-7	116	10	and	and	CCONJ
aji-7	116	11	highly	highly	ADV
aji-7	116	12	responsible	responsible	ADJ
aji-7	116	13	for	for	ADP
aji-7	116	14	developing	develop	VERB
aji-7	116	15	type	type	NOUN
aji-7	116	16	2	2	NUM
aji-7	116	17	diabetes	diabetes	NOUN
aji-7	116	18	(	(	PUNCT
aji-7	116	19	t2d	t2d	NOUN
aji-7	116	20	)	)	PUNCT
aji-7	117	1	[	[	X
aji-7	117	2	1,2	1,2	NUM
aji-7	117	3	]	]	PUNCT
aji-7	117	4	,	,	PUNCT
aji-7	117	5	t2d	t2d	NUM
aji-7	117	6	is	be	AUX
aji-7	117	7	a	a	DET
aji-7	117	8	metabolic	metabolic	NOUN
aji-7	117	9	disease	disease	NOUN
aji-7	117	10	that	that	PRON
aji-7	117	11	causes	cause	VERB
aji-7	117	12	sugar	sugar	NOUN
aji-7	117	13	to	to	PART
aji-7	117	14	increase	increase	VERB
aji-7	117	15	in	in	ADP
aji-7	117	16	blood	blood	NOUN
aji-7	117	17	circulation	circulation	NOUN
aji-7	117	18	results	result	NOUN
aji-7	117	19	from	from	ADP
aji-7	117	20	insulin	insulin	NOUN
aji-7	117	21	resistance	resistance	NOUN
aji-7	117	22	and	and	CCONJ
aji-7	117	23	the	the	DET
aji-7	117	24	primary	primary	ADJ
aji-7	117	25	risk	risk	NOUN
aji-7	117	26	factor	factor	NOUN
aji-7	117	27	of	of	ADP
aji-7	117	28	t2d	t2d	NOUN
aji-7	117	29	is	be	AUX
aji-7	117	30	inflammation	inflammation	NOUN
aji-7	118	1	[	[	X
aji-7	118	2	3	3	NUM
aji-7	118	3	]	]	PUNCT
aji-7	118	4	.	.	PUNCT
aji-7	119	1	diclofenac	diclofenac	NOUN
aji-7	119	2	is	be	AUX
aji-7	119	3	a	a	DET
aji-7	119	4	proven	prove	VERB
aji-7	119	5	,	,	PUNCT
aji-7	119	6	commonly	commonly	ADV
aji-7	119	7	used	use	VERB
aji-7	119	8	nonsteroidal	nonsteroidal	NOUN
aji-7	119	9	anti	anti	ADJ
aji-7	119	10	-	-	ADJ
aji-7	119	11	inflammatory	inflammatory	ADJ
aji-7	119	12	and	and	CCONJ
aji-7	119	13	anti	anti	ADJ
aji-7	119	14	-	-	ADJ
aji-7	119	15	pyritic	pyritic	ADJ
aji-7	119	16	drug	drug	NOUN
aji-7	119	17	.	.	PUNCT
aji-7	120	1	diclofenac	diclofenac	NOUN
aji-7	120	2	exerts	exert	VERB
aji-7	120	3	its	its	PRON
aji-7	120	4	activity	activity	NOUN
aji-7	120	5	by	by	ADP
aji-7	120	6	inhibiting	inhibit	VERB
aji-7	120	7	cyclooxygenase-1	cyclooxygenase-1	PROPN
aji-7	120	8	(	(	PUNCT
aji-7	120	9	cox1	cox1	PROPN
aji-7	120	10	)	)	PUNCT
aji-7	120	11	and	and	CCONJ
aji-7	120	12	cyclooxygenase2	cyclooxygenase2	PROPN
aji-7	120	13	(	(	PUNCT
aji-7	120	14	cox2	cox2	PROPN
aji-7	120	15	)	)	PUNCT
aji-7	120	16	leading	lead	VERB
aji-7	120	17	to	to	PART
aji-7	120	18	inhibit	inhibit	VERB
aji-7	120	19	prostaglandin	prostaglandin	NOUN
aji-7	120	20	synthases	synthase	NOUN
aji-7	120	21	[	[	X
aji-7	120	22	4	4	NUM
aji-7	120	23	]	]	PUNCT
aji-7	120	24	.	.	PUNCT
aji-7	121	1	aleglitazar	aleglitazar	PROPN
aji-7	121	2	is	be	AUX
aji-7	121	3	a	a	DET
aji-7	121	4	new	new	ADJ
aji-7	121	5	drug	drug	NOUN
aji-7	121	6	that	that	PRON
aji-7	121	7	used	use	VERB
aji-7	121	8	as	as	ADP
aji-7	121	9	an	an	DET
aji-7	121	10	antiinflammatory	antiinflammatory	NOUN
aji-7	121	11	drug	drug	NOUN
aji-7	121	12	that	that	PRON
aji-7	121	13	improved	improve	VERB
aji-7	121	14	insulin	insulin	NOUN
aji-7	121	15	sensitivity	sensitivity	NOUN
aji-7	121	16	,	,	PUNCT
aji-7	121	17	and	and	CCONJ
aji-7	121	18	dyslipidemia	dyslipidemia	NOUN
aji-7	121	19	.	.	PUNCT
aji-7	122	1	aleglitazar	aleglitazar	PROPN
aji-7	122	2	is	be	AUX
aji-7	122	3	a	a	DET
aji-7	122	4	single	single	ADJ
aji-7	122	5	novel	novel	NOUN
aji-7	122	6	molecule	molecule	NOUN
aji-7	122	7	that	that	PRON
aji-7	122	8	contains	contain	VERB
aji-7	122	9	the	the	DET
aji-7	122	10	both	both	CCONJ
aji-7	122	11	active	active	ADJ
aji-7	122	12	synthetic	synthetic	NOUN
aji-7	122	13	peroxisome	peroxisome	NOUN
aji-7	122	14	proliferator	proliferator	NOUN
aji-7	122	15	activated	activate	VERB
aji-7	122	16	receptors	receptor	NOUN
aji-7	122	17	(	(	PUNCT
aji-7	122	18	ppars	ppar	NOUN
aji-7	122	19	α&γ	α&γ	PROPN
aji-7	122	20	)	)	PUNCT
aji-7	122	21	has	have	AUX
aji-7	122	22	potent	potent	ADJ
aji-7	122	23	and	and	CCONJ
aji-7	122	24	dual	dual	ADJ
aji-7	122	25	agonist	agonist	NOUN
aji-7	122	26	action	action	NOUN
aji-7	122	27	on	on	ADP
aji-7	122	28	ppars	ppar	NOUN
aji-7	122	29	α&γ	α&γ	PROPN
aji-7	122	30	[	[	X
aji-7	122	31	5	5	NUM
aji-7	122	32	]	]	PUNCT
aji-7	122	33	.	.	PUNCT
aji-7	123	1	2	2	X
aji-7	123	2	.	.	X
aji-7	123	3	obesity	obesity	NOUN
aji-7	123	4	is	be	AUX
aji-7	123	5	a	a	DET
aji-7	123	6	pathological	pathological	ADJ
aji-7	123	7	condition	condition	NOUN
aji-7	123	8	result	result	NOUN
aji-7	123	9	from	from	ADP
aji-7	123	10	an	an	DET
aji-7	123	11	accumulation	accumulation	NOUN
aji-7	123	12	of	of	ADP
aji-7	123	13	excesses	excess	NOUN
aji-7	123	14	adipose	adipose	PRON
aji-7	123	15	tissue	tissue	NOUN
aji-7	123	16	in	in	ADP
aji-7	123	17	a	a	DET
aji-7	123	18	different	different	ADJ
aji-7	123	19	site	site	NOUN
aji-7	123	20	of	of	ADP
aji-7	123	21	the	the	DET
aji-7	123	22	body	body	NOUN
aji-7	123	23	including	include	VERB
aji-7	123	24	liver	liver	NOUN
aji-7	123	25	and	and	CCONJ
aji-7	123	26	skeletal	skeletal	ADJ
aji-7	123	27	muscle	muscle	NOUN
aji-7	123	28	,	,	PUNCT
aji-7	123	29	and	and	CCONJ
aji-7	123	30	it	it	PRON
aji-7	123	31	's	be	AUX
aji-7	123	32	considered	consider	VERB
aji-7	123	33	as	as	SCONJ
aji-7	123	34	a	a	DET
aji-7	123	35	neurochemical	neurochemical	ADJ
aji-7	123	36	imbalance	imbalance	NOUN
aji-7	123	37	can	can	AUX
aji-7	123	38	be	be	AUX
aji-7	123	39	measured	measure	VERB
aji-7	123	40	by	by	ADP
aji-7	123	41	the	the	DET
aji-7	123	42	body	body	NOUN
aji-7	123	43	mass	mass	NOUN
aji-7	123	44	index	index	NOUN
aji-7	123	45	(	(	PUNCT
aji-7	123	46	bmi	bmi	PROPN
aji-7	123	47	)	)	PUNCT
aji-7	123	48	,	,	PUNCT
aji-7	123	49	which	which	PRON
aji-7	123	50	is	be	AUX
aji-7	123	51	a	a	DET
aji-7	123	52	ratio	ratio	NOUN
aji-7	123	53	of	of	ADP
aji-7	123	54	weight	weight	NOUN
aji-7	123	55	to	to	PART
aji-7	123	56	high	high	ADJ
aji-7	123	57	.	.	PUNCT
aji-7	124	1	normal	normal	ADJ
aji-7	124	2	range	range	NOUN
aji-7	124	3	of	of	ADP
aji-7	124	4	bmi	bmi	NOUN
aji-7	124	5	(	(	PUNCT
aji-7	124	6	18.5	18.5	NUM
aji-7	124	7	-	-	SYM
aji-7	124	8	24.9	24.9	NUM
aji-7	124	9	kg	kg	NOUN
aji-7	124	10	/	/	SYM
aji-7	124	11	m	m	PROPN
aji-7	124	12	2	2	NUM
aji-7	124	13	)	)	PUNCT
aji-7	124	14	,	,	PUNCT
aji-7	124	15	overweight	overweight	ADJ
aji-7	124	16	range	range	NOUN
aji-7	124	17	(	(	PUNCT
aji-7	124	18	25	25	NUM
aji-7	124	19	-	-	SYM
aji-7	124	20	29.9	29.9	NUM
aji-7	124	21	kg	kg	NOUN
aji-7	124	22	/	/	SYM
aji-7	124	23	m	m	PROPN
aji-7	124	24	2	2	NUM
aji-7	124	25	)	)	PUNCT
aji-7	124	26	,	,	PUNCT
aji-7	124	27	obesity	obesity	NOUN
aji-7	124	28	bmi	bmi	VERB
aji-7	124	29	30	30	NUM
aji-7	124	30	kg	kg	NOUN
aji-7	124	31	/	/	SYM
aji-7	124	32	m	m	PROPN
aji-7	124	33	2	2	NUM
aji-7	124	34	and	and	CCONJ
aji-7	124	35	more	more	ADJ
aji-7	124	36	[	[	X
aji-7	124	37	6	6	NUM
aji-7	124	38	]	]	PUNCT
aji-7	124	39	(	(	PUNCT
aji-7	124	40	fig	fig	NOUN
aji-7	124	41	.	.	PUNCT
aji-7	124	42	1	1	NUM
aji-7	124	43	)	)	PUNCT
aji-7	124	44	.	.	PUNCT
aji-7	125	1	weight	weight	NOUN
aji-7	125	2	gain	gain	NOUN
aji-7	125	3	and	and	CCONJ
aji-7	125	4	increased	increase	VERB
aji-7	125	5	adipocyte	adipocyte	NOUN
aji-7	125	6	,	,	PUNCT
aji-7	125	7	result	result	VERB
aji-7	125	8	in	in	ADP
aji-7	125	9	hypertrophic	hypertrophic	ADJ
aji-7	125	10	and	and	CCONJ
aji-7	125	11	loss	loss	NOUN
aji-7	125	12	of	of	ADP
aji-7	125	13	function	function	NOUN
aji-7	125	14	of	of	ADP
aji-7	125	15	adipocyte	adipocyte	NOUN
aji-7	125	16	[	[	X
aji-7	125	17	8	8	NUM
aji-7	125	18	]	]	PUNCT
aji-7	125	19	.	.	PUNCT
aji-7	126	1	free	free	ADJ
aji-7	126	2	fatty	fatty	NOUN
aji-7	126	3	acid	acid	NOUN
aji-7	126	4	(	(	PUNCT
aji-7	126	5	ffa	ffa	PROPN
aji-7	126	6	)	)	PUNCT
aji-7	126	7	in	in	ADP
aji-7	126	8	this	this	DET
aji-7	126	9	condition	condition	NOUN
aji-7	126	10	released	release	VERB
aji-7	126	11	in	in	ADP
aji-7	126	12	blood	blood	NOUN
aji-7	126	13	circulation	circulation	NOUN
aji-7	126	14	,	,	PUNCT
aji-7	126	15	pro	pro	ADJ
aji-7	126	16	-	-	ADJ
aji-7	126	17	inflammatory	inflammatory	ADJ
aji-7	126	18	cytokines	cytokine	NOUN
aji-7	126	19	as	as	ADP
aji-7	126	20	tumor	tumor	NOUN
aji-7	126	21	necrosis	necrosis	NOUN
aji-7	126	22	factor	factor	NOUN
aji-7	126	23	alpha	alpha	NOUN
aji-7	126	24	(	(	PUNCT
aji-7	126	25	tnf	tnf	PROPN
aji-7	126	26	-	-	PUNCT
aji-7	126	27	α	α	NOUN
aji-7	126	28	)	)	PUNCT
aji-7	126	29	,	,	PUNCT
aji-7	126	30	plasminogen	plasminogen	NOUN
aji-7	126	31	activator	activator	NOUN
aji-7	126	32	inhibitor	inhibitor	NOUN
aji-7	126	33	(	(	PUNCT
aji-7	126	34	pai)-1	pai)-1	NOUN
aji-7	126	35	,	,	PUNCT
aji-7	126	36	and	and	CCONJ
aji-7	126	37	angiotensin	angiotensin	NOUN
aji-7	126	38	(	(	PUNCT
aji-7	126	39	ang	ang	NOUN
aji-7	126	40	)	)	PUNCT
aji-7	126	41	)	)	PUNCT
aji-7	126	42	,	,	PUNCT
aji-7	126	43	and	and	CCONJ
aji-7	126	44	adiponectin	adiponectin	NOUN
aji-7	126	45	which	which	PRON
aji-7	126	46	is	be	AUX
aji-7	126	47	a	a	DET
aji-7	126	48	specific	specific	ADJ
aji-7	126	49	protein	protein	NOUN
aji-7	126	50	in	in	ADP
aji-7	126	51	adipocyte	adipocyte	NOUN
aji-7	126	52	that	that	PRON
aji-7	126	53	play	play	VERB
aji-7	126	54	a	a	DET
aji-7	126	55	role	role	NOUN
aji-7	126	56	in	in	ADP
aji-7	126	57	insulin	insulin	NOUN
aji-7	126	58	resistance	resistance	NOUN
aji-7	126	59	and	and	CCONJ
aji-7	126	60	atherosclerosis	atherosclerosis	NOUN
aji-7	126	61	[	[	X
aji-7	126	62	9	9	NUM
aji-7	126	63	]	]	PUNCT
aji-7	126	64	.	.	PUNCT
aji-7	127	1	increased	increase	VERB
aji-7	127	2	level	level	NOUN
aji-7	127	3	of	of	ADP
aji-7	127	4	ffa	ffa	NOUN
aji-7	127	5	and	and	CCONJ
aji-7	127	6	pro	pro	ADJ
aji-7	127	7	-	-	ADJ
aji-7	127	8	inflammatory	inflammatory	ADJ
aji-7	127	9	cytokines	cytokine	NOUN
aji-7	127	10	will	will	AUX
aji-7	127	11	lead	lead	VERB
aji-7	127	12	to	to	ADP
aji-7	127	13	deposition	deposition	NOUN
aji-7	127	14	in	in	ADP
aji-7	127	15	non	non	ADJ
aji-7	127	16	-	-	ADJ
aji-7	127	17	adipose	adipose	ADJ
aji-7	127	18	tissues	tissue	NOUN
aji-7	127	19	and	and	CCONJ
aji-7	127	20	decrease	decrease	VERB
aji-7	127	21	systemic	systemic	ADJ
aji-7	127	22	inflammatory	inflammatory	ADJ
aji-7	127	23	grade	grade	NOUN
aji-7	127	24	,	,	PUNCT
aji-7	127	25	resulting	result	VERB
aji-7	127	26	in	in	ADP
aji-7	127	27	activating	activate	VERB
aji-7	127	28	the	the	DET
aji-7	127	29	mechanism	mechanism	NOUN
aji-7	127	30	of	of	ADP
aji-7	127	31	insulin	insulin	NOUN
aji-7	127	32	resistance	resistance	NOUN
aji-7	127	33	in	in	ADP
aji-7	127	34	tissues	tissue	NOUN
aji-7	127	35	(	(	PUNCT
aji-7	127	36	fig	fig	NOUN
aji-7	127	37	.	.	NOUN
aji-7	128	1	2	2	NUM
aji-7	128	2	)	)	PUNCT
aji-7	129	1	[	[	X
aji-7	129	2	8	8	NUM
aji-7	129	3	]	]	PUNCT
aji-7	129	4	.	.	PUNCT
aji-7	130	1	fig	fig	NOUN
aji-7	130	2	.	.	PUNCT
aji-7	131	1	1	1	X
aji-7	131	2	.	.	X
aji-7	132	1	bmi	bmi	PROPN
aji-7	132	2	:	:	PUNCT
aji-7	132	3	it	it	PRON
aji-7	132	4	is	be	AUX
aji-7	132	5	a	a	DET
aji-7	132	6	method	method	NOUN
aji-7	132	7	use	use	NOUN
aji-7	132	8	for	for	ADP
aji-7	132	9	determination	determination	NOUN
aji-7	132	10	if	if	SCONJ
aji-7	132	11	a	a	DET
aji-7	132	12	person	person	NOUN
aji-7	132	13	weight	weight	NOUN
aji-7	132	14	within	within	ADP
aji-7	132	15	the	the	DET
aji-7	132	16	normal	normal	ADJ
aji-7	132	17	range	range	NOUN
aji-7	132	18	or	or	CCONJ
aji-7	132	19	at	at	ADP
aji-7	132	20	high	high	ADJ
aji-7	132	21	risk	risk	NOUN
aji-7	132	22	for	for	ADP
aji-7	132	23	obesity	obesity	NOUN
aji-7	132	24	[	[	X
aji-7	132	25	7	7	NUM
aji-7	132	26	]	]	X
aji-7	132	27	elsawy	elsawy	NOUN
aji-7	132	28	;	;	PUNCT
aji-7	132	29	aji	aji	NOUN
aji-7	132	30	,	,	PUNCT
aji-7	132	31	2(1	2(1	NUM
aji-7	132	32	):	):	PUNCT
aji-7	132	33	34	34	NUM
aji-7	132	34	-	-	SYM
aji-7	132	35	44	44	NUM
aji-7	132	36	,	,	PUNCT
aji-7	132	37	2019	2019	NUM
aji-7	132	38	;	;	PUNCT
aji-7	132	39	article	article	NOUN
aji-7	132	40	no.aji.53258	no.aji.53258	PROPN
aji-7	132	41	36	36	NUM
aji-7	132	42	fig	fig	NOUN
aji-7	132	43	.	.	PUNCT
aji-7	133	1	2	2	NUM
aji-7	133	2	.	.	X
aji-7	133	3	adipose	adipose	ADJ
aji-7	133	4	tissue	tissue	NOUN
aji-7	133	5	expansion	expansion	NOUN
aji-7	133	6	,	,	PUNCT
aji-7	133	7	insulin	insulin	NOUN
aji-7	133	8	resistance	resistance	NOUN
aji-7	133	9	,	,	PUNCT
aji-7	133	10	and	and	CCONJ
aji-7	133	11	the	the	DET
aji-7	133	12	metabolic	metabolic	NOUN
aji-7	133	13	syndrome	syndrome	NOUN
aji-7	133	14	.	.	PUNCT
aji-7	134	1	macrophages	macrophage	NOUN
aji-7	134	2	are	be	AUX
aji-7	134	3	conducted	conduct	VERB
aji-7	134	4	,	,	PUNCT
aji-7	134	5	infiltrate	infiltrate	VERB
aji-7	134	6	and	and	CCONJ
aji-7	134	7	contributing	contribute	VERB
aji-7	134	8	further	far	ADV
aji-7	134	9	to	to	ADP
aji-7	134	10	pro	pro	ADJ
aji-7	134	11	-	-	ADJ
aji-7	134	12	inflammatory	inflammatory	ADJ
aji-7	134	13	m1	m1	NOUN
aji-7	134	14	phenotype	phenotype	NOUN
aji-7	134	15	in	in	ADP
aji-7	134	16	the	the	DET
aji-7	134	17	hypertrophic	hypertrophic	ADJ
aji-7	134	18	adipose	adipose	ADJ
aji-7	134	19	tissue	tissue	NOUN
aji-7	135	1	[	[	X
aji-7	135	2	8	8	NUM
aji-7	135	3	]	]	SYM
aji-7	135	4	3	3	NUM
aji-7	135	5	.	.	X
aji-7	135	6	diabetes	diabetes	NOUN
aji-7	135	7	mellitus	mellitus	NOUN
aji-7	135	8	is	be	AUX
aji-7	135	9	a	a	DET
aji-7	135	10	silent	silent	ADJ
aji-7	135	11	metabolic	metabolic	NOUN
aji-7	135	12	syndrome	syndrome	NOUN
aji-7	135	13	characteristic	characteristic	ADJ
aji-7	135	14	by	by	ADP
aji-7	135	15	hyperglycemia	hyperglycemia	NOUN
aji-7	135	16	resulting	result	VERB
aji-7	135	17	from	from	ADP
aji-7	135	18	lowering	lower	VERB
aji-7	135	19	or	or	CCONJ
aji-7	135	20	impaired	impaired	ADJ
aji-7	135	21	insulin	insulin	NOUN
aji-7	135	22	secretion	secretion	NOUN
aji-7	135	23	or	or	CCONJ
aji-7	135	24	increase	increase	VERB
aji-7	135	25	insulin	insulin	NOUN
aji-7	135	26	resistance	resistance	NOUN
aji-7	135	27	by	by	ADP
aji-7	135	28	the	the	DET
aji-7	135	29	body	body	NOUN
aji-7	135	30	tissue	tissue	NOUN
aji-7	136	1	[	[	X
aji-7	136	2	6	6	NUM
aji-7	136	3	]	]	PUNCT
aji-7	136	4	.	.	PUNCT
aji-7	137	1	3.1	3.1	NUM
aji-7	137	2	types	type	NOUN
aji-7	137	3	of	of	ADP
aji-7	137	4	diabetes	diabetes	NOUN
aji-7	137	5	insulin	insulin	NOUN
aji-7	137	6	treatment	treatment	NOUN
aji-7	137	7	is	be	AUX
aji-7	137	8	required	require	VERB
aji-7	137	9	at	at	ADP
aji-7	137	10	any	any	DET
aji-7	137	11	type	type	NOUN
aji-7	137	12	.	.	PUNCT
aji-7	138	1	most	most	ADV
aji-7	138	2	important	important	ADJ
aji-7	138	3	types	type	NOUN
aji-7	138	4	are	be	AUX
aji-7	138	5	:	:	PUNCT
aji-7	138	6	1gestational	1gestational	ADJ
aji-7	138	7	diabetes	diabetes	NOUN
aji-7	138	8	mellitus	mellitus	NOUN
aji-7	138	9	(	(	PUNCT
aji-7	138	10	gdm	gdm	NOUN
aji-7	138	11	)	)	PUNCT
aji-7	138	12	is	be	AUX
aji-7	138	13	known	know	VERB
aji-7	138	14	as	as	ADP
aji-7	138	15	any	any	DET
aji-7	138	16	degree	degree	NOUN
aji-7	138	17	of	of	ADP
aji-7	138	18	glucose	glucose	NOUN
aji-7	138	19	intolerance	intolerance	NOUN
aji-7	138	20	with	with	ADP
aji-7	138	21	onset	onset	NOUN
aji-7	138	22	or	or	CCONJ
aji-7	138	23	first	first	ADJ
aji-7	138	24	recognition	recognition	NOUN
aji-7	138	25	during	during	ADP
aji-7	138	26	pregnancy	pregnancy	NOUN
aji-7	138	27	.	.	PUNCT
aji-7	139	1	diet	diet	PROPN
aji-7	139	2	modification	modification	NOUN
aji-7	139	3	is	be	AUX
aji-7	139	4	applied	apply	VERB
aji-7	139	5	or	or	CCONJ
aji-7	139	6	insulin	insulin	NOUN
aji-7	139	7	for	for	ADP
aji-7	139	8	treatment	treatment	NOUN
aji-7	139	9	,	,	PUNCT
aji-7	139	10	this	this	DET
aji-7	139	11	condition	condition	NOUN
aji-7	139	12	may	may	AUX
aji-7	139	13	not	not	PART
aji-7	139	14	persistence	persistence	VERB
aji-7	139	15	after	after	ADP
aji-7	139	16	pregnancy	pregnancy	NOUN
aji-7	139	17	[	[	X
aji-7	139	18	10	10	NUM
aji-7	139	19	]	]	PUNCT
aji-7	139	20	.	.	PUNCT
aji-7	140	1	2type	2type	NUM
aji-7	140	2	1	1	NUM
aji-7	140	3	diabetes	diabetes	NOUN
aji-7	140	4	(	(	PUNCT
aji-7	140	5	autoimmune	autoimmune	ADJ
aji-7	140	6	diabetes	diabetes	NOUN
aji-7	140	7	mellitus	mellitus	NOUN
aji-7	140	8	):	):	PUNCT
aji-7	140	9	is	be	AUX
aji-7	140	10	an	an	DET
aji-7	140	11	absolute	absolute	ADJ
aji-7	140	12	insulin	insulin	NOUN
aji-7	140	13	deficiency	deficiency	NOUN
aji-7	140	14	resulting	result	VERB
aji-7	140	15	from	from	ADP
aji-7	140	16	absolute	absolute	ADJ
aji-7	140	17	destruction	destruction	NOUN
aji-7	140	18	of	of	ADP
aji-7	140	19	β	β	NOUN
aji-7	140	20	cells	cell	NOUN
aji-7	140	21	[	[	X
aji-7	140	22	11	11	NUM
aji-7	140	23	]	]	PUNCT
aji-7	140	24	.	.	PUNCT
aji-7	141	1	3type	3type	NUM
aji-7	141	2	2	2	NUM
aji-7	141	3	diabetes	diabetes	NOUN
aji-7	141	4	mellitus	mellitus	NOUN
aji-7	141	5	:	:	PUNCT
aji-7	141	6	is	be	AUX
aji-7	141	7	a	a	DET
aji-7	141	8	relative	relative	ADJ
aji-7	141	9	insulin	insulin	NOUN
aji-7	141	10	reduction	reduction	NOUN
aji-7	141	11	that	that	PRON
aji-7	141	12	resists	resist	VERB
aji-7	141	13	the	the	DET
aji-7	141	14	action	action	NOUN
aji-7	141	15	of	of	ADP
aji-7	141	16	insulin	insulin	NOUN
aji-7	141	17	[	[	X
aji-7	141	18	11	11	NUM
aji-7	141	19	]	]	PUNCT
aji-7	141	20	.	.	PUNCT
aji-7	142	1	people	people	NOUN
aji-7	142	2	suffers	suffer	VERB
aji-7	142	3	from	from	ADP
aji-7	142	4	obesity	obesity	NOUN
aji-7	142	5	are	be	AUX
aji-7	142	6	more	more	ADV
aji-7	142	7	threatened	threaten	VERB
aji-7	142	8	to	to	PART
aji-7	142	9	develop	develop	VERB
aji-7	142	10	t2d	t2d	NUM
aji-7	142	11	,	,	PUNCT
aji-7	142	12	and	and	CCONJ
aji-7	142	13	metabolic	metabolic	NOUN
aji-7	142	14	syndrome	syndrome	NOUN
aji-7	143	1	[	[	X
aji-7	143	2	6	6	NUM
aji-7	143	3	]	]	PUNCT
aji-7	143	4	.	.	PUNCT
aji-7	144	1	3.2	3.2	NUM
aji-7	144	2	complications	complication	NOUN
aji-7	144	3	patients	patient	NOUN
aji-7	144	4	with	with	ADP
aji-7	144	5	t2d	t2d	NUM
aji-7	144	6	may	may	AUX
aji-7	144	7	present	present	VERB
aji-7	144	8	with	with	ADP
aji-7	144	9	characteristic	characteristic	ADJ
aji-7	144	10	symptoms	symptom	NOUN
aji-7	144	11	such	such	ADJ
aji-7	144	12	as	as	ADP
aji-7	144	13	thirst	thirst	NOUN
aji-7	144	14	,	,	PUNCT
aji-7	144	15	polyuria	polyuria	NOUN
aji-7	144	16	,	,	PUNCT
aji-7	144	17	a	a	DET
aji-7	144	18	defect	defect	NOUN
aji-7	144	19	of	of	ADP
aji-7	144	20	vision	vision	NOUN
aji-7	144	21	,	,	PUNCT
aji-7	144	22	and	and	CCONJ
aji-7	144	23	weight	weight	NOUN
aji-7	144	24	loss	loss	NOUN
aji-7	144	25	.	.	PUNCT
aji-7	145	1	in	in	ADP
aji-7	145	2	sever	sever	ADJ
aji-7	145	3	form	form	NOUN
aji-7	145	4	,	,	PUNCT
aji-7	145	5	ketoacidosis	ketoacidosis	NOUN
aji-7	145	6	or	or	CCONJ
aji-7	145	7	a	a	DET
aji-7	145	8	non	non	ADJ
aji-7	145	9	-	-	ADJ
aji-7	145	10	ketotic	ketotic	ADJ
aji-7	145	11	hyperosmolar	hyperosmolar	ADJ
aji-7	145	12	state	state	NOUN
aji-7	145	13	may	may	AUX
aji-7	145	14	lead	lead	VERB
aji-7	145	15	to	to	ADP
aji-7	145	16	loss	loss	NOUN
aji-7	145	17	of	of	ADP
aji-7	145	18	conscious	conscious	ADJ
aji-7	145	19	.	.	PUNCT
aji-7	146	1	t2d	t2d	NOUN
aji-7	146	2	can	can	AUX
aji-7	146	3	cause	cause	VERB
aji-7	146	4	pathological	pathological	ADJ
aji-7	146	5	and	and	CCONJ
aji-7	146	6	functional	functional	ADJ
aji-7	146	7	changes	change	NOUN
aji-7	146	8	in	in	ADP
aji-7	146	9	the	the	DET
aji-7	146	10	organ	organ	NOUN
aji-7	146	11	may	may	AUX
aji-7	146	12	be	be	AUX
aji-7	146	13	present	present	ADJ
aji-7	146	14	for	for	ADP
aji-7	146	15	a	a	DET
aji-7	146	16	long	long	ADJ
aji-7	146	17	time	time	NOUN
aji-7	146	18	before	before	SCONJ
aji-7	146	19	the	the	DET
aji-7	146	20	diagnosis	diagnosis	NOUN
aji-7	146	21	is	be	AUX
aji-7	146	22	made	make	VERB
aji-7	146	23	.	.	PUNCT
aji-7	147	1	the	the	DET
aji-7	147	2	long	long	ADJ
aji-7	147	3	-	-	PUNCT
aji-7	147	4	term	term	NOUN
aji-7	147	5	effects	effect	NOUN
aji-7	147	6	of	of	ADP
aji-7	147	7	t2d	t2d	NOUN
aji-7	147	8	lead	lead	NOUN
aji-7	147	9	to	to	ADP
aji-7	147	10	a	a	DET
aji-7	147	11	gradual	gradual	ADJ
aji-7	147	12	increase	increase	NOUN
aji-7	147	13	of	of	ADP
aji-7	147	14	the	the	DET
aji-7	147	15	specific	specific	ADJ
aji-7	147	16	complications	complication	NOUN
aji-7	147	17	of	of	ADP
aji-7	147	18	retinopathy	retinopathy	ADJ
aji-7	147	19	with	with	ADP
aji-7	147	20	a	a	DET
aji-7	147	21	loss	loss	NOUN
aji-7	147	22	of	of	ADP
aji-7	147	23	vision	vision	NOUN
aji-7	147	24	,	,	PUNCT
aji-7	147	25	and	and	CCONJ
aji-7	147	26	nephropathy	nephropathy	NOUN
aji-7	147	27	that	that	PRON
aji-7	147	28	may	may	AUX
aji-7	147	29	lead	lead	VERB
aji-7	147	30	to	to	ADP
aji-7	147	31	renal	renal	ADJ
aji-7	147	32	failure	failure	NOUN
aji-7	147	33	[	[	X
aji-7	147	34	12	12	NUM
aji-7	147	35	]	]	PUNCT
aji-7	147	36	.	.	PUNCT
aji-7	148	1	3.3	3.3	NUM
aji-7	148	2	induction	induction	NOUN
aji-7	148	3	of	of	ADP
aji-7	148	4	t2d	t2d	NOUN
aji-7	148	5	mellitus	mellitus	NOUN
aji-7	148	6	in	in	ADP
aji-7	148	7	experimental	experimental	ADJ
aji-7	148	8	animals	animal	NOUN
aji-7	148	9	t2d	t2d	CCONJ
aji-7	148	10	induced	induce	VERB
aji-7	148	11	by	by	ADP
aji-7	148	12	streptozotocin	streptozotocin	PROPN
aji-7	148	13	(	(	PUNCT
aji-7	148	14	stz	stz	NOUN
aji-7	148	15	)	)	PUNCT
aji-7	148	16	,	,	PUNCT
aji-7	148	17	which	which	PRON
aji-7	148	18	is	be	AUX
aji-7	148	19	a	a	DET
aji-7	148	20	molecule	molecule	NOUN
aji-7	148	21	that	that	PRON
aji-7	148	22	produces	produce	VERB
aji-7	148	23	a	a	DET
aji-7	148	24	selective	selective	ADJ
aji-7	148	25	toxic	toxic	ADJ
aji-7	148	26	effect	effect	NOUN
aji-7	148	27	in	in	ADP
aji-7	148	28	experimental	experimental	ADJ
aji-7	148	29	animal	animal	NOUN
aji-7	148	30	[	[	X
aji-7	148	31	13	13	NUM
aji-7	148	32	]	]	PUNCT
aji-7	148	33	.	.	PUNCT
aji-7	149	1	doses	dose	NOUN
aji-7	149	2	should	should	AUX
aji-7	149	3	be	be	AUX
aji-7	149	4	fig	fig	NOUN
aji-7	149	5	.	.	PUNCT
aji-7	150	1	3	3	X
aji-7	150	2	.	.	X
aji-7	150	3	induction	induction	NOUN
aji-7	150	4	of	of	ADP
aji-7	150	5	stz	stz	NOUN
aji-7	150	6	.	.	PUNCT
aji-7	151	1	intraperitoneally	intraperitoneally	ADV
aji-7	151	2	in	in	ADP
aji-7	151	3	rat	rat	NOUN
aji-7	151	4	model	model	NOUN
aji-7	151	5	to	to	PART
aji-7	151	6	induce	induce	VERB
aji-7	151	7	t2	t2	NOUN
aji-7	151	8	dm	dm	PROPN
aji-7	151	9	[	[	X
aji-7	151	10	17	17	NUM
aji-7	151	11	]	]	X
aji-7	151	12	elsawy	elsawy	NOUN
aji-7	151	13	;	;	PUNCT
aji-7	151	14	aji	aji	NOUN
aji-7	151	15	,	,	PUNCT
aji-7	151	16	2(1	2(1	NUM
aji-7	151	17	):	):	PUNCT
aji-7	151	18	34	34	NUM
aji-7	151	19	-	-	SYM
aji-7	151	20	44	44	NUM
aji-7	151	21	,	,	PUNCT
aji-7	151	22	2019	2019	NUM
aji-7	151	23	;	;	PUNCT
aji-7	151	24	article	article	NOUN
aji-7	151	25	no.aji.53258	no.aji.53258	PROPN
aji-7	151	26	37	37	NUM
aji-7	151	27	calculated	calculate	VERB
aji-7	151	28	to	to	PART
aji-7	151	29	perform	perform	VERB
aji-7	151	30	a	a	DET
aji-7	151	31	partial	partial	ADJ
aji-7	151	32	destruction	destruction	NOUN
aji-7	151	33	of	of	ADP
aji-7	151	34	β	β	PROPN
aji-7	151	35	cell	cell	NOUN
aji-7	151	36	mass	mass	NOUN
aji-7	151	37	to	to	PART
aji-7	151	38	produce	produce	VERB
aji-7	151	39	a	a	DET
aji-7	151	40	non	non	ADJ
aji-7	151	41	-	-	ADJ
aji-7	151	42	ketotic	ketotic	ADJ
aji-7	151	43	and	and	CCONJ
aji-7	151	44	a	a	DET
aji-7	151	45	mild	mild	ADJ
aji-7	151	46	insulin	insulin	NOUN
aji-7	151	47	deficient	deficient	ADJ
aji-7	151	48	state	state	NOUN
aji-7	151	49	of	of	ADP
aji-7	151	50	t2d	t2d	NOUN
aji-7	152	1	[	[	X
aji-7	152	2	14	14	NUM
aji-7	152	3	]	]	PUNCT
aji-7	152	4	.	.	PUNCT
aji-7	153	1	animals	animal	NOUN
aji-7	153	2	will	will	AUX
aji-7	153	3	be	be	AUX
aji-7	153	4	injected	inject	VERB
aji-7	153	5	with	with	ADP
aji-7	153	6	a	a	DET
aji-7	153	7	single	single	ADJ
aji-7	153	8	dose	dose	NOUN
aji-7	153	9	of	of	ADP
aji-7	153	10	streptozotocin	streptozotocin	PROPN
aji-7	153	11	65	65	NUM
aji-7	153	12	mg	mg	NUM
aji-7	153	13	/	/	SYM
aji-7	153	14	kg	kg	PROPN
aji-7	153	15	intraperitoneally	intraperitoneally	ADV
aji-7	153	16	(	(	PUNCT
aji-7	153	17	fig	fig	NOUN
aji-7	153	18	.	.	PUNCT
aji-7	154	1	3	3	X
aji-7	154	2	)	)	PUNCT
aji-7	155	1	[	[	X
aji-7	155	2	15	15	NUM
aji-7	155	3	]	]	PUNCT
aji-7	155	4	.	.	PUNCT
aji-7	156	1	here	here	ADV
aji-7	156	2	are	be	AUX
aji-7	156	3	other	other	ADJ
aji-7	156	4	ways	way	NOUN
aji-7	156	5	to	to	PART
aji-7	156	6	induce	induce	VERB
aji-7	156	7	diabetes	diabetes	NOUN
aji-7	156	8	in	in	ADP
aji-7	156	9	a	a	DET
aji-7	156	10	model	model	NOUN
aji-7	156	11	rat	rat	NOUN
aji-7	156	12	by	by	ADP
aji-7	156	13	consuming	consume	VERB
aji-7	156	14	of	of	ADP
aji-7	156	15	unbalanced	unbalanced	ADJ
aji-7	156	16	high	high	ADJ
aji-7	156	17	-	-	PUNCT
aji-7	156	18	fat	fat	NOUN
aji-7	156	19	diets	diet	NOUN
aji-7	156	20	that	that	PRON
aji-7	156	21	result	result	VERB
aji-7	156	22	in	in	ADP
aji-7	156	23	accumulation	accumulation	NOUN
aji-7	156	24	of	of	ADP
aji-7	156	25	fat	fat	NOUN
aji-7	156	26	in	in	ADP
aji-7	156	27	adipose	adipose	ADJ
aji-7	156	28	tissue	tissue	NOUN
aji-7	156	29	and	and	CCONJ
aji-7	156	30	increase	increase	VERB
aji-7	156	31	body	body	NOUN
aji-7	156	32	weight	weight	NOUN
aji-7	156	33	.	.	PUNCT
aji-7	157	1	the	the	DET
aji-7	157	2	accumulation	accumulation	NOUN
aji-7	157	3	of	of	ADP
aji-7	157	4	fat	fat	NOUN
aji-7	157	5	will	will	AUX
aji-7	157	6	affect	affect	VERB
aji-7	157	7	the	the	DET
aji-7	157	8	releasing	releasing	NOUN
aji-7	157	9	of	of	ADP
aji-7	157	10	deferent	deferent	ADJ
aji-7	157	11	protein	protein	NOUN
aji-7	157	12	from	from	ADP
aji-7	157	13	the	the	DET
aji-7	157	14	adipose	adipose	ADJ
aji-7	157	15	tissue	tissue	NOUN
aji-7	157	16	called	call	VERB
aji-7	157	17	adipokines	adipokine	NOUN
aji-7	157	18	,	,	PUNCT
aji-7	157	19	that	that	PRON
aji-7	157	20	plays	play	VERB
aji-7	157	21	an	an	DET
aji-7	157	22	important	important	ADJ
aji-7	157	23	role	role	NOUN
aji-7	157	24	in	in	ADP
aji-7	157	25	insulin	insulin	NOUN
aji-7	157	26	sensitivity	sensitivity	NOUN
aji-7	157	27	and	and	CCONJ
aji-7	157	28	inflammation	inflammation	NOUN
aji-7	157	29	,	,	PUNCT
aji-7	157	30	which	which	PRON
aji-7	157	31	can	can	AUX
aji-7	157	32	be	be	AUX
aji-7	157	33	developed	develop	VERB
aji-7	157	34	into	into	ADP
aji-7	157	35	some	some	DET
aji-7	157	36	obesity	obesity	NOUN
aji-7	157	37	-	-	PUNCT
aji-7	157	38	related	relate	VERB
aji-7	157	39	disorder	disorder	NOUN
aji-7	157	40	like	like	ADP
aji-7	157	41	type	type	NOUN
aji-7	157	42	2	2	NUM
aji-7	157	43	diabetes	diabetes	NOUN
aji-7	157	44	[	[	X
aji-7	157	45	16	16	NUM
aji-7	157	46	]	]	PUNCT
aji-7	157	47	.	.	PUNCT
aji-7	158	1	4	4	X
aji-7	158	2	.	.	X
aji-7	158	3	inflammation	inflammation	NOUN
aji-7	158	4	is	be	AUX
aji-7	158	5	a	a	DET
aji-7	158	6	host	host	NOUN
aji-7	158	7	response	response	NOUN
aji-7	158	8	reflection	reflection	NOUN
aji-7	158	9	to	to	ADP
aji-7	158	10	tissue	tissue	NOUN
aji-7	158	11	injury	injury	NOUN
aji-7	158	12	,	,	PUNCT
aji-7	158	13	and	and	CCONJ
aji-7	158	14	indicates	indicate	VERB
aji-7	158	15	the	the	DET
aji-7	158	16	occurrence	occurrence	NOUN
aji-7	158	17	by	by	ADP
aji-7	158	18	four	four	NUM
aji-7	158	19	signs	sign	NOUN
aji-7	158	20	(	(	PUNCT
aji-7	158	21	cardinal	cardinal	ADJ
aji-7	158	22	signs	sign	NOUN
aji-7	158	23	):	):	PUNCT
aji-7	158	24	redness	redness	NOUN
aji-7	158	25	,	,	PUNCT
aji-7	158	26	swelling	swelling	NOUN
aji-7	158	27	,	,	PUNCT
aji-7	158	28	heat	heat	NOUN
aji-7	158	29	,	,	PUNCT
aji-7	158	30	and	and	CCONJ
aji-7	158	31	pain	pain	NOUN
aji-7	158	32	[	[	X
aji-7	158	33	18	18	NUM
aji-7	158	34	]	]	PUNCT
aji-7	158	35	.	.	PUNCT
aji-7	159	1	4.1	4.1	NUM
aji-7	159	2	carrageenan	carrageenan	NOUN
aji-7	159	3	-	-	PUNCT
aji-7	159	4	induced	induce	VERB
aji-7	159	5	hind	hind	NOUN
aji-7	159	6	paw	paw	NOUN
aji-7	159	7	edema	edema	NOUN
aji-7	159	8	in	in	ADP
aji-7	159	9	the	the	DET
aji-7	159	10	mouse	mouse	NOUN
aji-7	159	11	carrageenan	carrageenan	NOUN
aji-7	159	12	induced	induce	VERB
aji-7	159	13	inflammation	inflammation	NOUN
aji-7	159	14	by	by	ADP
aji-7	159	15	subcutaneous	subcutaneous	ADJ
aji-7	159	16	injunction	injunction	NOUN
aji-7	159	17	in	in	ADP
aji-7	159	18	the	the	DET
aji-7	159	19	right	right	ADJ
aji-7	159	20	hind	hind	NOUN
aji-7	159	21	paw	paw	NOUN
aji-7	159	22	100	100	NUM
aji-7	159	23	μl	μl	ADP
aji-7	159	24	(	(	PUNCT
aji-7	159	25	suspended	suspend	VERB
aji-7	159	26	in	in	ADP
aji-7	159	27	1.5	1.5	NUM
aji-7	159	28	%	%	NOUN
aji-7	159	29	vichele	vichele	NOUN
aji-7	159	30	)	)	PUNCT
aji-7	159	31	of	of	ADP
aji-7	159	32	carrageenan	carrageenan	NOUN
aji-7	159	33	that	that	PRON
aji-7	159	34	results	result	VERB
aji-7	159	35	in	in	ADP
aji-7	159	36	acute	acute	ADJ
aji-7	159	37	,	,	PUNCT
aji-7	159	38	non	non	ADJ
aji-7	159	39	-	-	ADJ
aji-7	159	40	immune	immune	ADJ
aji-7	159	41	,	,	PUNCT
aji-7	159	42	well	well	ADV
aji-7	159	43	reached	reach	VERB
aji-7	159	44	,	,	PUNCT
aji-7	159	45	and	and	CCONJ
aji-7	159	46	highly	highly	ADV
aji-7	159	47	reproducible	reproducible	ADJ
aji-7	159	48	inflammation	inflammation	NOUN
aji-7	159	49	,	,	PUNCT
aji-7	159	50	the	the	DET
aji-7	159	51	action	action	NOUN
aji-7	159	52	of	of	ADP
aji-7	159	53	pro	pro	ADJ
aji-7	159	54	-	-	ADJ
aji-7	159	55	inflammatory	inflammatory	ADJ
aji-7	159	56	agents	agent	NOUN
aji-7	159	57	,	,	PUNCT
aji-7	159	58	histamine	histamine	NOUN
aji-7	159	59	,	,	PUNCT
aji-7	159	60	complement	complement	NOUN
aji-7	159	61	,	,	PUNCT
aji-7	159	62	and	and	CCONJ
aji-7	159	63	reactive	reactive	ADJ
aji-7	159	64	oxygen	oxygen	NOUN
aji-7	159	65	will	will	AUX
aji-7	159	66	produce	produce	VERB
aji-7	159	67	cardinal	cardinal	ADJ
aji-7	159	68	signs	sign	NOUN
aji-7	159	69	of	of	ADP
aji-7	159	70	inflammation	inflammation	NOUN
aji-7	159	71	develop	develop	VERB
aji-7	159	72	subsequently	subsequently	ADV
aji-7	159	73	to	to	ADP
aji-7	159	74	the	the	DET
aji-7	159	75	injection	injection	NOUN
aji-7	159	76	.	.	PUNCT
aji-7	160	1	the	the	DET
aji-7	160	2	traditional	traditional	ADJ
aji-7	160	3	method	method	NOUN
aji-7	160	4	to	to	PART
aji-7	160	5	measure	measure	VERB
aji-7	160	6	inflammatory	inflammatory	ADJ
aji-7	160	7	response	response	NOUN
aji-7	160	8	is	be	AUX
aji-7	160	9	quantified	quantify	VERB
aji-7	160	10	by	by	ADP
aji-7	160	11	increasing	increase	VERB
aji-7	160	12	the	the	DET
aji-7	160	13	size	size	NOUN
aji-7	160	14	of	of	ADP
aji-7	160	15	paw	paw	NOUN
aji-7	160	16	oedema	oedema	NOUN
aji-7	160	17	[	[	X
aji-7	160	18	18	18	NUM
aji-7	160	19	]	]	PUNCT
aji-7	160	20	,	,	PUNCT
aji-7	160	21	which	which	PRON
aji-7	160	22	represent	represent	VERB
aji-7	160	23	the	the	DET
aji-7	160	24	magnitude	magnitude	NOUN
aji-7	160	25	of	of	ADP
aji-7	160	26	inflammation	inflammation	ADJ
aji-7	160	27	response	response	NOUN
aji-7	160	28	effectively	effectively	ADV
aji-7	160	29	[	[	X
aji-7	160	30	19	19	NUM
aji-7	160	31	]	]	PUNCT
aji-7	160	32	.	.	PUNCT
aji-7	161	1	hind	hind	PROPN
aji-7	161	2	paw	paw	PROPN
aji-7	161	3	size	size	NOUN
aji-7	161	4	can	can	AUX
aji-7	161	5	be	be	AUX
aji-7	161	6	measured	measure	VERB
aji-7	161	7	either	either	CCONJ
aji-7	161	8	by	by	ADP
aji-7	161	9	plethysmometer	plethysmometer	NOUN
aji-7	161	10	's	's	PART
aji-7	161	11	caliper	caliper	NOUN
aji-7	161	12	which	which	PRON
aji-7	161	13	is	be	AUX
aji-7	161	14	a	a	DET
aji-7	161	15	rough	rough	ADJ
aji-7	161	16	method	method	NOUN
aji-7	161	17	(	(	PUNCT
aji-7	161	18	fig	fig	NOUN
aji-7	161	19	.	.	PUNCT
aji-7	161	20	4	4	NUM
aji-7	161	21	)	)	PUNCT
aji-7	161	22	or	or	CCONJ
aji-7	161	23	by	by	ADP
aji-7	161	24	new	new	ADJ
aji-7	161	25	the	the	DET
aji-7	161	26	new	new	ADJ
aji-7	161	27	technology	technology	NOUN
aji-7	161	28	to	to	ADP
aji-7	161	29	asses	ass	NOUN
aji-7	161	30	induced	induce	VERB
aji-7	161	31	acute	acute	ADJ
aji-7	161	32	paw	paw	NOUN
aji-7	161	33	inflammation	inflammation	NOUN
aji-7	161	34	in	in	ADP
aji-7	161	35	the	the	DET
aji-7	161	36	rats	rat	NOUN
aji-7	161	37	by	by	ADP
aji-7	161	38	epifluorescence	epifluorescence	NOUN
aji-7	161	39	imaging	imaging	NOUN
aji-7	161	40	,	,	PUNCT
aji-7	161	41	a	a	DET
aji-7	161	42	fluorescence	fluorescence	NOUN
aji-7	161	43	intensity	intensity	NOUN
aji-7	161	44	in	in	ADP
aji-7	161	45	the	the	DET
aji-7	161	46	saline	saline	NOUN
aji-7	161	47	and	and	CCONJ
aji-7	161	48	carrageenan	carrageenan	NOUN
aji-7	161	49	-	-	PUNCT
aji-7	161	50	treated	treat	VERB
aji-7	161	51	hindpaw	hindpaw	NOUN
aji-7	161	52	(	(	PUNCT
aji-7	161	53	fig	fig	NOUN
aji-7	161	54	.	.	PUNCT
aji-7	161	55	5	5	NUM
aji-7	161	56	)	)	PUNCT
aji-7	161	57	.	.	PUNCT
aji-7	162	1	carrageenan	carrageenan	NOUN
aji-7	162	2	-	-	PUNCT
aji-7	162	3	induced	induce	VERB
aji-7	162	4	hind	hind	NOUN
aji-7	162	5	paw	paw	NOUN
aji-7	162	6	edema	edema	PROPN
aji-7	162	7	as	as	ADP
aji-7	162	8	acute	acute	ADJ
aji-7	162	9	inflammation	inflammation	NOUN
aji-7	162	10	model	model	NOUN
aji-7	162	11	in	in	ADP
aji-7	162	12	mice	mouse	NOUN
aji-7	162	13	[	[	X
aji-7	162	14	18	18	NUM
aji-7	162	15	]	]	PUNCT
aji-7	162	16	.	.	PUNCT
aji-7	163	1	in	in	ADP
aji-7	163	2	addition	addition	NOUN
aji-7	163	3	,	,	PUNCT
aji-7	163	4	cotton	cotton	NOUN
aji-7	163	5	pellet	pellet	NOUN
aji-7	163	6	-	-	PUNCT
aji-7	163	7	induced	induce	VERB
aji-7	163	8	granuloma	granuloma	NOUN
aji-7	163	9	as	as	ADP
aji-7	163	10	chronic	chronic	ADJ
aji-7	163	11	inflammation	inflammation	NOUN
aji-7	163	12	model	model	NOUN
aji-7	163	13	in	in	ADP
aji-7	163	14	rats	rat	NOUN
aji-7	163	15	[	[	X
aji-7	163	16	20	20	NUM
aji-7	163	17	]	]	PUNCT
aji-7	163	18	.	.	PUNCT
aji-7	164	1	100	100	NUM
aji-7	164	2	µl	µl	NOUN
aji-7	164	3	of	of	ADP
aji-7	164	4	l	l	PROPN
aji-7	164	5	carrageenan	carrageenan	NOUN
aji-7	164	6	suspended	suspend	VERB
aji-7	164	7	in	in	ADP
aji-7	164	8	normal	normal	ADJ
aji-7	164	9	saline	saline	ADJ
aji-7	164	10	1.5	1.5	NUM
aji-7	164	11	%	%	NOUN
aji-7	164	12	concentration	concentration	NOUN
aji-7	164	13	will	will	AUX
aji-7	164	14	be	be	AUX
aji-7	164	15	subcutaneously	subcutaneously	ADV
aji-7	164	16	injected	inject	VERB
aji-7	164	17	into	into	ADP
aji-7	164	18	a	a	DET
aji-7	164	19	hind	hind	NOUN
aji-7	164	20	paw	paw	NOUN
aji-7	164	21	of	of	ADP
aji-7	164	22	the	the	DET
aji-7	164	23	animals	animal	NOUN
aji-7	164	24	on	on	ADP
aji-7	164	25	one	one	NUM
aji-7	164	26	side	side	NOUN
aji-7	164	27	.	.	PUNCT
aji-7	165	1	100	100	NUM
aji-7	165	2	µl	µl	NOUN
aji-7	165	3	of	of	ADP
aji-7	165	4	saline	saline	NOUN
aji-7	165	5	will	will	AUX
aji-7	165	6	be	be	AUX
aji-7	165	7	injected	inject	VERB
aji-7	165	8	into	into	ADP
aji-7	165	9	the	the	DET
aji-7	165	10	contralateral	contralateral	ADJ
aji-7	165	11	hind	hind	NOUN
aji-7	165	12	paw	paw	NOUN
aji-7	165	13	and	and	CCONJ
aji-7	165	14	used	use	VERB
aji-7	165	15	as	as	ADP
aji-7	165	16	a	a	DET
aji-7	165	17	control	control	NOUN
aji-7	165	18	.	.	PUNCT
aji-7	166	1	using	use	VERB
aji-7	166	2	plethysmometer	plethysmometer	NOUN
aji-7	166	3	,	,	PUNCT
aji-7	166	4	the	the	DET
aji-7	166	5	hind	hind	NOUN
aji-7	166	6	paw	paw	NOUN
aji-7	166	7	volumes	volume	NOUN
aji-7	166	8	will	will	AUX
aji-7	166	9	be	be	AUX
aji-7	166	10	measured	measure	VERB
aji-7	166	11	before	before	ADP
aji-7	166	12	and	and	CCONJ
aji-7	166	13	after	after	ADP
aji-7	166	14	six	six	NUM
aji-7	166	15	hours	hour	NOUN
aji-7	166	16	of	of	ADP
aji-7	166	17	carrageenan	carrageenan	NOUN
aji-7	166	18	injection	injection	NOUN
aji-7	166	19	.	.	PUNCT
aji-7	167	1	oedema	oedema	PROPN
aji-7	167	2	is	be	AUX
aji-7	167	3	expressed	express	VERB
aji-7	167	4	as	as	ADP
aji-7	167	5	the	the	DET
aji-7	167	6	variation	variation	NOUN
aji-7	167	7	between	between	ADP
aji-7	167	8	the	the	DET
aji-7	167	9	change	change	NOUN
aji-7	167	10	in	in	ADP
aji-7	167	11	carrageenan	carrageenan	NOUN
aji-7	167	12	-	-	PUNCT
aji-7	167	13	treated	treat	VERB
aji-7	167	14	hind	hind	NOUN
aji-7	167	15	paw	paw	NOUN
aji-7	167	16	volume	volume	NOUN
aji-7	167	17	and	and	CCONJ
aji-7	167	18	the	the	DET
aji-7	167	19	control	control	NOUN
aji-7	167	20	saline	saline	NOUN
aji-7	167	21	-	-	PUNCT
aji-7	167	22	treated	treat	VERB
aji-7	167	23	(	(	PUNCT
aji-7	167	24	fig	fig	NOUN
aji-7	167	25	.	.	NOUN
aji-7	168	1	6	6	NUM
aji-7	168	2	)	)	PUNCT
aji-7	169	1	[	[	X
aji-7	169	2	18	18	NUM
aji-7	169	3	]	]	PUNCT
aji-7	169	4	.	.	PUNCT
aji-7	170	1	the	the	DET
aji-7	170	2	results	result	NOUN
aji-7	170	3	will	will	AUX
aji-7	170	4	be	be	AUX
aji-7	170	5	expressed	express	VERB
aji-7	170	6	as	as	ADP
aji-7	170	7	percentage	percentage	NOUN
aji-7	170	8	of	of	ADP
aji-7	170	9	puffiness	puffiness	NOUN
aji-7	170	10	calculated	calculate	VERB
aji-7	170	11	as	as	ADP
aji-7	170	12	following	follow	VERB
aji-7	170	13	the	the	DET
aji-7	170	14	formula	formula	NOUN
aji-7	170	15	:	:	PUNCT
aji-7	170	16	alteration	alteration	NOUN
aji-7	170	17	=	=	SYM
aji-7	170	18	(	(	PUNCT
aji-7	170	19	width	width	NOUN
aji-7	170	20	of	of	ADP
aji-7	170	21	the	the	DET
aji-7	170	22	hind	hind	NOUN
aji-7	170	23	paw	paw	NOUN
aji-7	170	24	at	at	ADP
aji-7	170	25	the	the	DET
aji-7	170	26	end	end	NOUN
aji-7	170	27	day	day	NOUN
aji-7	170	28	of	of	ADP
aji-7	170	29	experiment−	experiment−	NOUN
aji-7	170	30	width	width	NOUN
aji-7	170	31	of	of	ADP
aji-7	170	32	the	the	DET
aji-7	170	33	hind	hind	NOUN
aji-7	170	34	paw	paw	PROPN
aji-7	170	35	prior	prior	ADJ
aji-7	170	36	carrageenan	carrageenan	NOUN
aji-7	170	37	/	/	SYM
aji-7	170	38	width	width	NOUN
aji-7	170	39	of	of	ADP
aji-7	170	40	the	the	DET
aji-7	170	41	hind	hind	NOUN
aji-7	170	42	paw	paw	PROPN
aji-7	170	43	prior	prior	ADJ
aji-7	170	44	carrageenan	carrageenan	PROPN
aji-7	170	45	×	×	PROPN
aji-7	170	46	100	100	NUM
aji-7	170	47	%	%	NOUN
aji-7	170	48	)	)	PUNCT
aji-7	171	1	[	[	X
aji-7	171	2	21	21	NUM
aji-7	171	3	]	]	PUNCT
aji-7	171	4	.	.	PUNCT
aji-7	172	1	fig	fig	NOUN
aji-7	172	2	.	.	PUNCT
aji-7	173	1	4	4	X
aji-7	173	2	.	.	X
aji-7	173	3	hind	hind	PROPN
aji-7	173	4	paw	paw	PROPN
aji-7	173	5	measurement	measurement	NOUN
aji-7	173	6	by	by	ADP
aji-7	173	7	caliper	caliper	NOUN
aji-7	173	8	.	.	PUNCT
aji-7	174	1	the	the	DET
aji-7	174	2	paw	paw	NOUN
aji-7	174	3	measure	measure	NOUN
aji-7	174	4	by	by	ADP
aji-7	174	5	placing	place	VERB
aji-7	174	6	the	the	DET
aji-7	174	7	paw	paw	NOUN
aji-7	174	8	in	in	ADP
aji-7	174	9	the	the	DET
aji-7	174	10	caliper	caliper	NOUN
aji-7	174	11	paw	paw	NOUN
aji-7	174	12	touch	touch	NOUN
aji-7	174	13	either	either	DET
aji-7	174	14	side	side	NOUN
aji-7	174	15	of	of	ADP
aji-7	174	16	the	the	DET
aji-7	174	17	caliper	caliper	NOUN
aji-7	174	18	,	,	PUNCT
aji-7	174	19	measurements	measurement	NOUN
aji-7	174	20	read	read	VERB
aji-7	174	21	in	in	ADP
aji-7	174	22	mm	mm	PROPN
aji-7	174	23	[	[	X
aji-7	174	24	19	19	NUM
aji-7	174	25	]	]	X
aji-7	174	26	elsawy	elsawy	NOUN
aji-7	174	27	;	;	PUNCT
aji-7	174	28	aji	aji	NOUN
aji-7	174	29	,	,	PUNCT
aji-7	174	30	2(1	2(1	NUM
aji-7	174	31	):	):	PUNCT
aji-7	174	32	34	34	NUM
aji-7	174	33	-	-	SYM
aji-7	174	34	44	44	NUM
aji-7	174	35	,	,	PUNCT
aji-7	174	36	2019	2019	NUM
aji-7	174	37	;	;	PUNCT
aji-7	174	38	article	article	NOUN
aji-7	174	39	no.aji.53258	no.aji.53258	PROPN
aji-7	174	40	38	38	NUM
aji-7	174	41	fig	fig	NOUN
aji-7	174	42	.	.	PUNCT
aji-7	175	1	5	5	NUM
aji-7	175	2	.	.	X
aji-7	175	3	carrageenan	carrageenan	NOUN
aji-7	175	4	-	-	PUNCT
aji-7	175	5	induced	induce	VERB
aji-7	175	6	acute	acute	ADJ
aji-7	175	7	paw	paw	NOUN
aji-7	175	8	inflammation	inflammation	NOUN
aji-7	175	9	in	in	ADP
aji-7	175	10	the	the	DET
aji-7	175	11	rat	rat	NOUN
aji-7	175	12	(	(	PUNCT
aji-7	175	13	fluorescence	fluorescence	NOUN
aji-7	175	14	intensity	intensity	NOUN
aji-7	175	15	in	in	ADP
aji-7	175	16	the	the	DET
aji-7	175	17	saline	saline	NOUN
aji-7	175	18	and	and	CCONJ
aji-7	175	19	carrageenan	carrageenan	NOUN
aji-7	175	20	)	)	PUNCT
aji-7	175	21	measured	measure	VERB
aji-7	175	22	after	after	ADP
aji-7	175	23	injection	injection	NOUN
aji-7	175	24	by	by	ADP
aji-7	175	25	epifluorescence	epifluorescence	NOUN
aji-7	175	26	imaging	imaging	NOUN
aji-7	175	27	60	60	NUM
aji-7	175	28	and	and	CCONJ
aji-7	175	29	120	120	NUM
aji-7	175	30	min	min	NOUN
aji-7	176	1	[	[	X
aji-7	176	2	22	22	NUM
aji-7	176	3	]	]	PUNCT
aji-7	176	4	fig	fig	NOUN
aji-7	176	5	.	.	PUNCT
aji-7	177	1	6	6	NUM
aji-7	177	2	.	.	X
aji-7	177	3	carrageenan	carrageenan	NOUN
aji-7	177	4	control	control	NOUN
aji-7	177	5	and	and	CCONJ
aji-7	177	6	injected	inject	VERB
aji-7	177	7	hind	hind	NOUN
aji-7	177	8	paw	paw	NOUN
aji-7	177	9	(	(	PUNCT
aji-7	177	10	a	a	NOUN
aji-7	177	11	)	)	PUNCT
aji-7	177	12	control	control	NOUN
aji-7	177	13	hind	hind	PROPN
aji-7	177	14	paw	paw	NOUN
aji-7	177	15	,	,	PUNCT
aji-7	177	16	(	(	PUNCT
aji-7	177	17	b	b	NOUN
aji-7	177	18	)	)	PUNCT
aji-7	177	19	injected	inject	VERB
aji-7	177	20	hind	hind	NOUN
aji-7	177	21	paw	paw	NOUN
aji-7	177	22	by	by	ADP
aji-7	177	23	carrageenan	carrageenan	NOUN
aji-7	177	24	100	100	NUM
aji-7	177	25	μl	μl	ADP
aji-7	177	26	suspended	suspend	VERB
aji-7	177	27	in	in	ADP
aji-7	177	28	1.5	1.5	NUM
aji-7	177	29	%	%	NOUN
aji-7	177	30	vichele	vichele	NOUN
aji-7	177	31	,	,	PUNCT
aji-7	177	32	show	show	VERB
aji-7	177	33	an	an	DET
aji-7	177	34	edema	edema	NOUN
aji-7	177	35	and	and	CCONJ
aji-7	177	36	redness	redness	NOUN
aji-7	177	37	[	[	X
aji-7	177	38	23	23	NUM
aji-7	177	39	]	]	SYM
aji-7	177	40	5	5	NUM
aji-7	177	41	.	.	X
aji-7	177	42	anti	anti	ADJ
aji-7	177	43	-	-	ADJ
aji-7	177	44	inflammatory	inflammatory	ADJ
aji-7	177	45	drugs	drug	NOUN
aji-7	177	46	5.1	5.1	NUM
aji-7	177	47	diclofenac	diclofenac	NOUN
aji-7	177	48	diclofenac	diclofenac	NOUN
aji-7	177	49	sodium	sodium	NOUN
aji-7	177	50	is	be	AUX
aji-7	177	51	a	a	DET
aji-7	177	52	nonsteroidal	nonsteroidal	NOUN
aji-7	177	53	antiinflammatory	antiinflammatory	NOUN
aji-7	177	54	class	class	NOUN
aji-7	177	55	of	of	ADP
aji-7	177	56	drugs	drug	NOUN
aji-7	177	57	(	(	PUNCT
aji-7	177	58	nsaids	nsaid	NOUN
aji-7	177	59	)	)	PUNCT
aji-7	177	60	,	,	PUNCT
aji-7	177	61	that	that	PRON
aji-7	177	62	used	use	VERB
aji-7	177	63	as	as	ADP
aji-7	177	64	anti	anti	ADJ
aji-7	177	65	-	-	ADJ
aji-7	177	66	inflammatory	inflammatory	ADJ
aji-7	177	67	and	and	CCONJ
aji-7	177	68	painkiller	painkiller	NOUN
aji-7	177	69	drug	drug	NOUN
aji-7	177	70	.	.	PUNCT
aji-7	178	1	diclofenac	diclofenac	NOUN
aji-7	178	2	interposed	interpose	VERB
aji-7	178	3	by	by	ADP
aji-7	178	4	inhibiting	inhibit	VERB
aji-7	178	5	the	the	DET
aji-7	178	6	release	release	NOUN
aji-7	178	7	ofcyclooxygenase-1	ofcyclooxygenase-1	PROPN
aji-7	178	8	(	(	PUNCT
aji-7	178	9	cox1	cox1	PROPN
aji-7	178	10	)	)	PUNCT
aji-7	178	11	and	and	CCONJ
aji-7	178	12	cyclooxygenase-2	cyclooxygenase-2	NUM
aji-7	178	13	(	(	PUNCT
aji-7	178	14	cox2	cox2	PROPN
aji-7	178	15	)	)	PUNCT
aji-7	178	16	,	,	PUNCT
aji-7	178	17	that	that	PRON
aji-7	178	18	convert	convert	VERB
aji-7	178	19	arachidonic	arachidonic	ADJ
aji-7	178	20	acid	acid	NOUN
aji-7	178	21	into	into	ADP
aji-7	178	22	prostaglandins	prostaglandin	NOUN
aji-7	178	23	(	(	PUNCT
aji-7	178	24	pgs	pgs	NOUN
aji-7	178	25	)	)	PUNCT
aji-7	178	26	.	.	PUNCT
aji-7	179	1	diclofenac	diclofenac	NOUN
aji-7	179	2	should	should	AUX
aji-7	179	3	be	be	AUX
aji-7	179	4	used	use	VERB
aji-7	179	5	in	in	ADP
aji-7	179	6	minimal	minimal	ADJ
aji-7	179	7	dose	dose	NOUN
aji-7	179	8	due	due	ADP
aji-7	179	9	to	to	ADP
aji-7	179	10	its	its	PRON
aji-7	179	11	toxicity	toxicity	NOUN
aji-7	179	12	.	.	PUNCT
aji-7	180	1	diclofenac	diclofenac	NOUN
aji-7	180	2	at	at	ADP
aji-7	180	3	5	5	NUM
aji-7	180	4	mg	mg	PROPN
aji-7	180	5	/	/	SYM
aji-7	180	6	kg	kg	PROPN
aji-7	180	7	dose	dose	NOUN
aji-7	180	8	started	start	VERB
aji-7	180	9	to	to	PART
aji-7	180	10	show	show	VERB
aji-7	180	11	an	an	DET
aji-7	180	12	inhibition	inhibition	NOUN
aji-7	180	13	in	in	ADP
aji-7	180	14	hind	hind	ADJ
aji-7	180	15	paw	paw	NOUN
aji-7	180	16	edema	edema	NOUN
aji-7	180	17	after	after	ADP
aji-7	180	18	2	2	NUM
aji-7	180	19	hours	hour	NOUN
aji-7	180	20	[	[	X
aji-7	180	21	24	24	NUM
aji-7	180	22	]	]	PUNCT
aji-7	180	23	.	.	PUNCT
aji-7	181	1	diclofenac	diclofenac	NOUN
aji-7	181	2	can	can	AUX
aji-7	181	3	increase	increase	VERB
aji-7	181	4	the	the	DET
aji-7	181	5	risk	risk	NOUN
aji-7	181	6	of	of	ADP
aji-7	181	7	heart	heart	NOUN
aji-7	181	8	attack	attack	NOUN
aji-7	181	9	,	,	PUNCT
aji-7	181	10	strokes	stroke	NOUN
aji-7	181	11	,	,	PUNCT
aji-7	181	12	blood	blood	NOUN
aji-7	181	13	clots	clot	NOUN
aji-7	181	14	and	and	CCONJ
aji-7	181	15	gastroduodenal	gastroduodenal	ADJ
aji-7	181	16	ulceration	ulceration	NOUN
aji-7	181	17	[	[	X
aji-7	181	18	25	25	NUM
aji-7	181	19	]	]	PUNCT
aji-7	181	20	.	.	PUNCT
aji-7	182	1	gastroduodenal	gastroduodenal	ADJ
aji-7	182	2	ulceration	ulceration	NOUN
aji-7	182	3	and	and	CCONJ
aji-7	182	4	bleeding	bleeding	NOUN
aji-7	182	5	are	be	AUX
aji-7	182	6	the	the	DET
aji-7	182	7	major	major	ADJ
aji-7	182	8	limitations	limitation	NOUN
aji-7	182	9	to	to	ADP
aji-7	182	10	the	the	DET
aji-7	182	11	use	use	NOUN
aji-7	182	12	of	of	ADP
aji-7	182	13	nsaids	nsaid	NOUN
aji-7	182	14	.	.	PUNCT
aji-7	183	1	it	it	PRON
aji-7	183	2	's	be	AUX
aji-7	183	3	lead	lead	NOUN
aji-7	183	4	to	to	PART
aji-7	183	5	damage	damage	NOUN
aji-7	183	6	to	to	ADP
aji-7	183	7	the	the	DET
aji-7	183	8	gastroduodenal	gastroduodenal	ADJ
aji-7	183	9	mucosa	mucosa	NOUN
aji-7	183	10	via	via	ADP
aji-7	183	11	several	several	ADJ
aji-7	183	12	mechanisms	mechanism	NOUN
aji-7	183	13	,	,	PUNCT
aji-7	183	14	including	include	VERB
aji-7	183	15	the	the	DET
aji-7	183	16	topical	topical	ADJ
aji-7	183	17	irritant	irritant	ADJ
aji-7	183	18	effect	effect	NOUN
aji-7	183	19	of	of	ADP
aji-7	183	20	these	these	DET
aji-7	183	21	drugs	drug	NOUN
aji-7	183	22	on	on	ADP
aji-7	183	23	the	the	DET
aji-7	183	24	epithelium	epithelium	NOUN
aji-7	183	25	,	,	PUNCT
aji-7	183	26	weakness	weakness	NOUN
aji-7	183	27	of	of	ADP
aji-7	183	28	the	the	DET
aji-7	183	29	barrier	barrier	NOUN
aji-7	183	30	properties	property	NOUN
aji-7	183	31	of	of	ADP
aji-7	183	32	the	the	DET
aji-7	183	33	mucosa	mucosa	NOUN
aji-7	183	34	,	,	PUNCT
aji-7	183	35	inhibition	inhibition	VERB
aji-7	183	36	synthesis	synthesis	NOUN
aji-7	183	37	of	of	ADP
aji-7	183	38	the	the	DET
aji-7	183	39	gastric	gastric	ADJ
aji-7	183	40	prostaglandin	prostaglandin	NOUN
aji-7	183	41	,	,	PUNCT
aji-7	183	42	decrees	decree	VERB
aji-7	183	43	blood	blood	NOUN
aji-7	183	44	flow	flow	NOUN
aji-7	183	45	through	through	ADP
aji-7	183	46	the	the	DET
aji-7	183	47	gastric	gastric	ADJ
aji-7	183	48	mucosa	mucosa	NOUN
aji-7	183	49	and	and	CCONJ
aji-7	183	50	interference	interference	NOUN
aji-7	183	51	with	with	ADP
aji-7	183	52	the	the	DET
aji-7	183	53	repair	repair	NOUN
aji-7	183	54	of	of	ADP
aji-7	183	55	superficial	superficial	ADJ
aji-7	183	56	injury	injury	NOUN
aji-7	183	57	.	.	PUNCT
aji-7	184	1	the	the	DET
aji-7	184	2	presence	presence	NOUN
aji-7	184	3	of	of	ADP
aji-7	184	4	acid	acid	NOUN
aji-7	184	5	in	in	ADP
aji-7	184	6	the	the	DET
aji-7	184	7	lumen	luman	NOUN
aji-7	184	8	of	of	ADP
aji-7	184	9	the	the	DET
aji-7	184	10	stomach	stomach	NOUN
aji-7	184	11	also	also	ADV
aji-7	184	12	help	help	VERB
aji-7	184	13	in	in	ADP
aji-7	184	14	increase	increase	NOUN
aji-7	184	15	rate	rate	NOUN
aji-7	184	16	of	of	ADP
aji-7	184	17	the	the	DET
aji-7	184	18	pathogenesis	pathogenesis	NOUN
aji-7	184	19	of	of	ADP
aji-7	184	20	nsaids	nsaid	NOUN
aji-7	184	21	induced	induced	ADJ
aji-7	184	22	ulcers	ulcer	NOUN
aji-7	184	23	and	and	CCONJ
aji-7	184	24	bleeding	bleeding	NOUN
aji-7	184	25	,	,	PUNCT
aji-7	184	26	through	through	ADP
aji-7	184	27	impairing	impair	VERB
aji-7	184	28	the	the	DET
aji-7	184	29	restitution	restitution	NOUN
aji-7	184	30	process	process	NOUN
aji-7	184	31	,	,	PUNCT
aji-7	184	32	interfering	interfere	VERB
aji-7	184	33	with	with	ADP
aji-7	184	34	haemostasis	haemostasis	NOUN
aji-7	184	35	and	and	CCONJ
aji-7	184	36	inactivating	inactivate	VERB
aji-7	184	37	several	several	ADJ
aji-7	184	38	growth	growth	NOUN
aji-7	184	39	factors	factor	NOUN
aji-7	184	40	that	that	PRON
aji-7	184	41	are	be	AUX
aji-7	184	42	important	important	ADJ
aji-7	184	43	in	in	ADP
aji-7	184	44	mucosal	mucosal	NOUN
aji-7	184	45	defence	defence	NOUN
aji-7	184	46	and	and	CCONJ
aji-7	184	47	repair	repair	NOUN
aji-7	184	48	[	[	X
aji-7	184	49	26	26	NUM
aji-7	184	50	]	]	PUNCT
aji-7	184	51	(	(	PUNCT
aji-7	184	52	fig	fig	NOUN
aji-7	184	53	.	.	PUNCT
aji-7	184	54	7	7	NUM
aji-7	184	55	)	)	PUNCT
aji-7	184	56	.	.	PUNCT
aji-7	185	1	5.2	5.2	NUM
aji-7	185	2	aleglitazar	aleglitazar	NOUN
aji-7	185	3	aleglitazar	aleglitazar	NOUN
aji-7	185	4	is	be	AUX
aji-7	185	5	a	a	DET
aji-7	185	6	combination	combination	NOUN
aji-7	185	7	of	of	ADP
aji-7	185	8	pparα	pparα	NOUN
aji-7	185	9	and	and	CCONJ
aji-7	185	10	γ	γ	NOUN
aji-7	185	11	agonist	agonist	NOUN
aji-7	185	12	and	and	CCONJ
aji-7	185	13	designed	design	VERB
aji-7	185	14	to	to	PART
aji-7	185	15	stimulate	stimulate	VERB
aji-7	185	16	both	both	PRON
aji-7	185	17	α	α	NOUN
aji-7	185	18	and	and	CCONJ
aji-7	185	19	γ	γ	NOUN
aji-7	185	20	receptors	receptor	NOUN
aji-7	185	21	at	at	ADP
aji-7	185	22	minimum	minimum	ADJ
aji-7	185	23	concentrations	concentration	NOUN
aji-7	185	24	.	.	PUNCT
aji-7	186	1	ppars	ppar	NOUN
aji-7	186	2	elsawy	elsawy	PROPN
aji-7	186	3	;	;	PUNCT
aji-7	186	4	aji	aji	NOUN
aji-7	186	5	,	,	PUNCT
aji-7	186	6	2(1	2(1	NUM
aji-7	186	7	):	):	PUNCT
aji-7	186	8	34	34	NUM
aji-7	186	9	-	-	SYM
aji-7	186	10	44	44	NUM
aji-7	186	11	,	,	PUNCT
aji-7	186	12	2019	2019	NUM
aji-7	186	13	;	;	PUNCT
aji-7	186	14	article	article	NOUN
aji-7	186	15	no.aji.53258	no.aji.53258	PROPN
aji-7	186	16	39	39	NUM
aji-7	186	17	fig	fig	NOUN
aji-7	186	18	.	.	PUNCT
aji-7	187	1	7	7	X
aji-7	187	2	.	.	NOUN
aji-7	187	3	morphological	morphological	ADJ
aji-7	187	4	and	and	CCONJ
aji-7	187	5	histological	histological	ADJ
aji-7	187	6	examination	examination	NOUN
aji-7	187	7	of	of	ADP
aji-7	187	8	rats	rat	NOUN
aji-7	187	9	gastric	gastric	ADJ
aji-7	187	10	mucosa	mucosa	NOUN
aji-7	187	11	in	in	ADP
aji-7	187	12	diclofenacinduced	diclofenacinduce	VERB
aji-7	187	13	ulcer	ulcer	NOUN
aji-7	187	14	model	model	NOUN
aji-7	187	15	(	(	PUNCT
aji-7	187	16	section	section	NOUN
aji-7	187	17	was	be	AUX
aji-7	187	18	stained	stain	VERB
aji-7	187	19	with	with	ADP
aji-7	187	20	haematoxylin	haematoxylin	NOUN
aji-7	187	21	and	and	CCONJ
aji-7	187	22	eosin	eosin	NOUN
aji-7	187	23	and	and	CCONJ
aji-7	187	24	magnified	magnify	VERB
aji-7	187	25	by	by	ADP
aji-7	187	26	20×	20×	NUM
aji-7	187	27	)	)	PUNCT
aji-7	187	28	.	.	PUNCT
aji-7	188	1	a.	a.	NOUN
aji-7	188	2	stomach	stomach	NOUN
aji-7	188	3	of	of	ADP
aji-7	188	4	control	control	NOUN
aji-7	188	5	rat	rat	NOUN
aji-7	188	6	;	;	PUNCT
aji-7	188	7	b.	b.	PROPN
aji-7	188	8	stomach	stomach	NOUN
aji-7	188	9	of	of	ADP
aji-7	188	10	diclofenac	diclofenac	NOUN
aji-7	188	11	-	-	PUNCT
aji-7	188	12	induced	induce	VERB
aji-7	188	13	ulcer	ulcer	NOUN
aji-7	188	14	rat	rat	NOUN
aji-7	188	15	at	at	ADP
aji-7	188	16	a	a	DET
aji-7	188	17	dose	dose	NOUN
aji-7	188	18	of	of	ADP
aji-7	188	19	(	(	PUNCT
aji-7	188	20	100	100	NUM
aji-7	188	21	mg	mg	PROPN
aji-7	188	22	/	/	SYM
aji-7	188	23	kg	kg	NOUN
aji-7	188	24	)	)	PUNCT
aji-7	189	1	[	[	X
aji-7	189	2	27	27	NUM
aji-7	189	3	]	]	PUNCT
aji-7	189	4	are	be	AUX
aji-7	189	5	one	one	NUM
aji-7	189	6	of	of	ADP
aji-7	189	7	nuclear	nuclear	ADJ
aji-7	189	8	receptor	receptor	NOUN
aji-7	189	9	superfamily	superfamily	NOUN
aji-7	189	10	,	,	PUNCT
aji-7	189	11	which	which	PRON
aji-7	189	12	participated	participate	VERB
aji-7	189	13	in	in	ADP
aji-7	189	14	the	the	DET
aji-7	189	15	transcriptional	transcriptional	ADJ
aji-7	189	16	control	control	NOUN
aji-7	189	17	of	of	ADP
aji-7	189	18	genes	gene	NOUN
aji-7	189	19	contributing	contribute	VERB
aji-7	189	20	in	in	ADP
aji-7	189	21	lipid	lipid	NOUN
aji-7	189	22	and	and	CCONJ
aji-7	189	23	carbohydrate	carbohydrate	VERB
aji-7	189	24	metabolism	metabolism	NOUN
aji-7	189	25	,	,	PUNCT
aji-7	189	26	and	and	CCONJ
aji-7	189	27	inflammation	inflammation	NOUN
aji-7	189	28	,	,	PUNCT
aji-7	189	29	especially	especially	ADV
aji-7	189	30	in	in	ADP
aji-7	189	31	the	the	DET
aji-7	189	32	setting	setting	NOUN
aji-7	189	33	of	of	ADP
aji-7	189	34	obesity	obesity	NOUN
aji-7	189	35	,	,	PUNCT
aji-7	189	36	hypercholesterolemia	hypercholesterolemia	NOUN
aji-7	189	37	,	,	PUNCT
aji-7	189	38	insulin	insulin	NOUN
aji-7	189	39	resistance	resistance	NOUN
aji-7	189	40	,	,	PUNCT
aji-7	189	41	and	and	CCONJ
aji-7	189	42	atherosclerosis	atherosclerosis	NOUN
aji-7	189	43	.	.	PUNCT
aji-7	190	1	ppars	ppar	NOUN
aji-7	190	2	are	be	AUX
aji-7	190	3	divided	divide	VERB
aji-7	190	4	into	into	ADP
aji-7	190	5	3	3	NUM
aji-7	190	6	subtypes	subtype	NOUN
aji-7	190	7	:	:	PUNCT
aji-7	190	8	pparα	pparα	NOUN
aji-7	190	9	,	,	PUNCT
aji-7	190	10	pparγ	pparγ	ADJ
aji-7	190	11	,	,	PUNCT
aji-7	190	12	and	and	CCONJ
aji-7	190	13	ppar	ppar	NOUN
aji-7	190	14	δ	δ	PROPN
aji-7	190	15	.	.	PUNCT
aji-7	191	1	ppar	ppar	NOUN
aji-7	191	2	α	α	PRON
aji-7	191	3	found	find	VERB
aji-7	191	4	at	at	ADP
aji-7	191	5	high	high	ADJ
aji-7	191	6	concentration	concentration	NOUN
aji-7	191	7	in	in	ADP
aji-7	191	8	liver	liver	NOUN
aji-7	191	9	,	,	PUNCT
aji-7	191	10	kidney	kidney	NOUN
aji-7	191	11	and	and	CCONJ
aji-7	191	12	the	the	DET
aji-7	191	13	skeletal	skeletal	ADJ
aji-7	191	14	muscle	muscle	NOUN
aji-7	191	15	and	and	CCONJ
aji-7	191	16	ppar	ppar	NOUN
aji-7	191	17	γ	γ	NOUN
aji-7	191	18	found	find	VERB
aji-7	191	19	at	at	ADP
aji-7	191	20	high	high	ADJ
aji-7	191	21	concentration	concentration	NOUN
aji-7	191	22	in	in	ADP
aji-7	191	23	adipocytes	adipocyte	NOUN
aji-7	191	24	,	,	PUNCT
aji-7	191	25	muscle	muscle	NOUN
aji-7	191	26	cells	cell	NOUN
aji-7	191	27	,	,	PUNCT
aji-7	191	28	the	the	DET
aji-7	191	29	liver	liver	NOUN
aji-7	191	30	and	and	CCONJ
aji-7	191	31	the	the	DET
aji-7	191	32	kidney	kidney	NOUN
aji-7	191	33	[	[	X
aji-7	191	34	5	5	NUM
aji-7	191	35	]	]	PUNCT
aji-7	191	36	.	.	PUNCT
aji-7	192	1	the	the	DET
aji-7	192	2	synthetic	synthetic	ADJ
aji-7	192	3	agonists	agonist	NOUN
aji-7	192	4	of	of	ADP
aji-7	192	5	ppar	ppar	NOUN
aji-7	192	6	α	α	PRON
aji-7	192	7	e.g.	e.g.	ADV
aji-7	192	8	fibrate	fibrate	NOUN
aji-7	192	9	used	use	VERB
aji-7	192	10	for	for	ADP
aji-7	192	11	lowering	lower	VERB
aji-7	192	12	triglycerides	triglyceride	NOUN
aji-7	192	13	(	(	PUNCT
aji-7	192	14	tg	tg	NOUN
aji-7	192	15	)	)	PUNCT
aji-7	192	16	and	and	CCONJ
aji-7	192	17	raising	raise	VERB
aji-7	192	18	highdensity	highdensity	NOUN
aji-7	192	19	lipoprotein	lipoprotein	ADJ
aji-7	192	20	cholesterol	cholesterol	NOUN
aji-7	192	21	(	(	PUNCT
aji-7	192	22	hdl	hdl	NOUN
aji-7	192	23	)	)	PUNCT
aji-7	192	24	in	in	ADP
aji-7	192	25	plasma	plasma	NOUN
aji-7	192	26	,	,	PUNCT
aji-7	192	27	while	while	SCONJ
aji-7	192	28	the	the	DET
aji-7	192	29	synthetic	synthetic	ADJ
aji-7	192	30	ppar	ppar	NOUN
aji-7	192	31	γ	γ	PROPN
aji-7	192	32	agonists	agonist	NOUN
aji-7	192	33	e.g.	e.g.	ADV
aji-7	192	34	thiazolidinediones	thiazolidinedione	NOUN
aji-7	192	35	pioglitazone	pioglitazone	NOUN
aji-7	192	36	used	use	VERB
aji-7	192	37	as	as	ADP
aji-7	192	38	antidiabetics	antidiabetic	NOUN
aji-7	192	39	[	[	X
aji-7	192	40	1	1	NUM
aji-7	192	41	]	]	PUNCT
aji-7	192	42	.	.	PUNCT
aji-7	193	1	5.3	5.3	NUM
aji-7	193	2	mechanism	mechanism	NOUN
aji-7	193	3	of	of	ADP
aji-7	193	4	action	action	NOUN
aji-7	193	5	aleglitazar	aleglitazar	NOUN
aji-7	193	6	prepared	prepare	VERB
aji-7	193	7	to	to	PART
aji-7	193	8	be	be	AUX
aji-7	193	9	an	an	DET
aji-7	193	10	agonist	agonist	NOUN
aji-7	193	11	for	for	ADP
aji-7	193	12	both	both	DET
aji-7	193	13	ppar	ppar	NOUN
aji-7	193	14	α&γ.pparα	α&γ.pparα	NOUN
aji-7	193	15	the	the	DET
aji-7	193	16	agonistic	agonistic	ADJ
aji-7	193	17	action	action	NOUN
aji-7	193	18	is	be	AUX
aji-7	193	19	controlled	control	VERB
aji-7	193	20	lipid	lipid	NOUN
aji-7	193	21	levels	level	NOUN
aji-7	193	22	,	,	PUNCT
aji-7	193	23	thus	thus	ADV
aji-7	193	24	improving	improve	VERB
aji-7	193	25	dyslipidemia	dyslipidemia	NOUN
aji-7	193	26	.	.	PUNCT
aji-7	194	1	in	in	ADP
aji-7	194	2	addition	addition	NOUN
aji-7	194	3	,	,	PUNCT
aji-7	194	4	pparγ	pparγ	NOUN
aji-7	194	5	controls	control	VERB
aji-7	194	6	glucose	glucose	NOUN
aji-7	194	7	level	level	NOUN
aji-7	194	8	and	and	CCONJ
aji-7	194	9	resulting	result	VERB
aji-7	194	10	in	in	ADP
aji-7	194	11	reduce	reduce	VERB
aji-7	194	12	insulin	insulin	NOUN
aji-7	194	13	resistance	resistance	NOUN
aji-7	194	14	in	in	ADP
aji-7	194	15	diabetic	diabetic	ADJ
aji-7	194	16	patients	patient	NOUN
aji-7	194	17	[	[	X
aji-7	194	18	28	28	NUM
aji-7	194	19	]	]	PUNCT
aji-7	194	20	.	.	PUNCT
aji-7	195	1	5.4	5.4	NUM
aji-7	195	2	optimal	optimal	ADJ
aji-7	195	3	dose	dose	NOUN
aji-7	195	4	aleglitazar	aleglitazar	NOUN
aji-7	195	5	(	(	PUNCT
aji-7	195	6	150	150	NUM
aji-7	195	7	ug	ug	ADP
aji-7	195	8	/	/	SYM
aji-7	195	9	kg	kg	PROPN
aji-7	195	10	/	/	SYM
aji-7	195	11	day	day	NOUN
aji-7	195	12	)	)	PUNCT
aji-7	195	13	for	for	ADP
aji-7	195	14	16	16	NUM
aji-7	195	15	weeks	week	NOUN
aji-7	195	16	was	be	AUX
aji-7	195	17	selected	select	VERB
aji-7	195	18	to	to	PART
aji-7	195	19	explore	explore	VERB
aji-7	195	20	any	any	DET
aji-7	195	21	potential	potential	ADJ
aji-7	195	22	association	association	NOUN
aji-7	195	23	of	of	ADP
aji-7	195	24	this	this	DET
aji-7	195	25	dual	dual	ADJ
aji-7	195	26	ppar	ppar	NOUN
aji-7	195	27	α	α	X
aji-7	195	28	/	/	SYM
aji-7	195	29	γ	γ	NOUN
aji-7	195	30	agonist	agonist	NOUN
aji-7	195	31	with	with	ADP
aji-7	195	32	anti	anti	ADJ
aji-7	195	33	-	-	ADJ
aji-7	195	34	arthritic	arthritic	ADJ
aji-7	195	35	and	and	CCONJ
aji-7	195	36	anti	anti	ADJ
aji-7	195	37	-	-	ADJ
aji-7	195	38	inflammatory	inflammatory	ADJ
aji-7	195	39	properties	property	NOUN
aji-7	195	40	[	[	X
aji-7	195	41	29	29	NUM
aji-7	195	42	]	]	PUNCT
aji-7	195	43	.	.	PUNCT
aji-7	196	1	supratherapeutic	supratherapeutic	ADJ
aji-7	196	2	dose	dose	PROPN
aji-7	196	3	(	(	PUNCT
aji-7	196	4	600	600	NUM
aji-7	196	5	μg	μg	NOUN
aji-7	196	6	)	)	PUNCT
aji-7	196	7	of	of	ADP
aji-7	196	8	aleglitazar	aleglitazar	NOUN
aji-7	196	9	for	for	ADP
aji-7	196	10	26	26	NUM
aji-7	196	11	weeks	week	NOUN
aji-7	196	12	in	in	ADP
aji-7	196	13	patients	patient	NOUN
aji-7	196	14	with	with	ADP
aji-7	196	15	normal	normal	ADJ
aji-7	196	16	to	to	PART
aji-7	196	17	borderline	borderline	VERB
aji-7	196	18	impaired	impair	VERB
aji-7	196	19	renal	renal	ADJ
aji-7	196	20	function	function	NOUN
aji-7	196	21	with	with	ADP
aji-7	196	22	glomerular	glomerular	ADJ
aji-7	196	23	filtration	filtration	NOUN
aji-7	196	24	rate	rate	NOUN
aji-7	196	25	(	(	PUNCT
aji-7	196	26	egfr	egfr	NOUN
aji-7	196	27	60	60	NUM
aji-7	196	28	ml	ml	NOUN
aji-7	196	29	/	/	SYM
aji-7	196	30	min	min	NOUN
aji-7	196	31	per	per	ADP
aji-7	196	32	1.73	1.73	NUM
aji-7	196	33	m2	m2	NOUN
aji-7	196	34	)	)	PUNCT
aji-7	196	35	,	,	PUNCT
aji-7	196	36	raised	raise	VERB
aji-7	196	37	serum	serum	NOUN
aji-7	196	38	creatinine	creatinine	NOUN
aji-7	196	39	by	by	ADP
aji-7	196	40	a	a	DET
aji-7	196	41	mean	mean	ADJ
aji-7	196	42	22	22	NUM
aji-7	196	43	%	%	NOUN
aji-7	196	44	to	to	ADP
aji-7	196	45	a	a	DET
aji-7	196	46	plateau	plateau	NOUN
aji-7	196	47	after	after	ADP
aji-7	196	48	4	4	NUM
aji-7	196	49	weeks	week	NOUN
aji-7	196	50	.	.	PUNCT
aji-7	197	1	then	then	ADV
aji-7	197	2	,	,	PUNCT
aji-7	197	3	serum	serum	PROPN
aji-7	197	4	creatinine	creatinine	NOUN
aji-7	197	5	resumed	resume	VERB
aji-7	197	6	to	to	PART
aji-7	197	7	baseline	baseline	VERB
aji-7	197	8	after	after	ADP
aji-7	197	9	4	4	NUM
aji-7	197	10	to	to	PART
aji-7	197	11	8	8	NUM
aji-7	197	12	weeks	week	NOUN
aji-7	197	13	of	of	ADP
aji-7	197	14	drug	drug	NOUN
aji-7	197	15	cessation	cessation	NOUN
aji-7	197	16	[	[	X
aji-7	197	17	29	29	NUM
aji-7	197	18	]	]	SYM
aji-7	197	19	.	.	PUNCT
aji-7	198	1	5.5	5.5	NUM
aji-7	198	2	side	side	NOUN
aji-7	198	3	effect	effect	NOUN
aji-7	198	4	in	in	ADP
aji-7	198	5	increase	increase	NOUN
aji-7	198	6	the	the	DET
aji-7	198	7	incidence	incidence	NOUN
aji-7	198	8	of	of	ADP
aji-7	198	9	the	the	DET
aji-7	198	10	expected	expect	VERB
aji-7	198	11	dose	dose	NOUN
aji-7	198	12	,	,	PUNCT
aji-7	198	13	will	will	AUX
aji-7	198	14	lead	lead	VERB
aji-7	198	15	to	to	PART
aji-7	198	16	increase	increase	VERB
aji-7	198	17	in	in	ADP
aji-7	198	18	serum	serum	NOUN
aji-7	198	19	creatinine	creatinine	NOUN
aji-7	198	20	,	,	PUNCT
aji-7	198	21	decrease	decrease	VERB
aji-7	198	22	glomerular	glomerular	ADJ
aji-7	198	23	filtration	filtration	NOUN
aji-7	198	24	rate	rate	NOUN
aji-7	198	25	,	,	PUNCT
aji-7	198	26	progressive	progressive	ADJ
aji-7	198	27	nephropathy	nephropathy	NOUN
aji-7	198	28	and	and	CCONJ
aji-7	198	29	bilateral	bilateral	ADJ
aji-7	198	30	oedema	oedema	NOUN
aji-7	198	31	[	[	X
aji-7	198	32	29	29	NUM
aji-7	198	33	]	]	PUNCT
aji-7	198	34	.	.	PUNCT
aji-7	199	1	5.6	5.6	NUM
aji-7	199	2	ulcergenic	ulcergenic	ADJ
aji-7	199	3	effect	effect	NOUN
aji-7	199	4	aaleglitazar	aaleglitazar	NOUN
aji-7	199	5	with	with	ADP
aji-7	199	6	a	a	DET
aji-7	199	7	dose	dose	NOUN
aji-7	199	8	of	of	ADP
aji-7	199	9	(	(	PUNCT
aji-7	199	10	150	150	NUM
aji-7	199	11	µg	µg	NOUN
aji-7	199	12	/	/	SYM
aji-7	199	13	kg	kg	NOUN
aji-7	199	14	)	)	PUNCT
aji-7	199	15	shows	show	VERB
aji-7	199	16	pharmacological	pharmacological	ADJ
aji-7	199	17	effects	effect	NOUN
aji-7	199	18	on	on	ADP
aji-7	199	19	the	the	DET
aji-7	199	20	8	8	NUM
aji-7	199	21	th	th	NUM
aji-7	199	22	day	day	NOUN
aji-7	199	23	after	after	ADP
aji-7	199	24	pellets	pellet	NOUN
aji-7	199	25	.	.	PUNCT
aji-7	200	1	the	the	DET
aji-7	200	2	day	day	NOUN
aji-7	200	3	before	before	ADP
aji-7	200	4	scarification	scarification	NOUN
aji-7	200	5	,	,	PUNCT
aji-7	200	6	all	all	DET
aji-7	200	7	rats	rat	NOUN
aji-7	200	8	prevented	prevent	VERB
aji-7	200	9	from	from	ADP
aji-7	200	10	food	food	NOUN
aji-7	200	11	and	and	CCONJ
aji-7	200	12	liquid	liquid	NOUN
aji-7	200	13	for	for	ADP
aji-7	200	14	12	12	NUM
aji-7	200	15	hours	hour	NOUN
aji-7	200	16	.	.	PUNCT
aji-7	201	1	gastric	gastric	ADJ
aji-7	201	2	tissue	tissue	NOUN
aji-7	201	3	will	will	AUX
aji-7	201	4	be	be	AUX
aji-7	201	5	removed	remove	VERB
aji-7	201	6	and	and	CCONJ
aji-7	201	7	taken	take	VERB
aji-7	201	8	out	out	ADP
aji-7	201	9	,	,	PUNCT
aji-7	201	10	after	after	SCONJ
aji-7	201	11	cut	cut	VERB
aji-7	201	12	open	open	ADJ
aji-7	201	13	to	to	ADP
aji-7	201	14	the	the	DET
aji-7	201	15	stomach	stomach	NOUN
aji-7	201	16	the	the	DET
aji-7	201	17	inner	inner	ADJ
aji-7	201	18	surface	surface	NOUN
aji-7	201	19	will	will	AUX
aji-7	201	20	be	be	AUX
aji-7	201	21	cleansed	cleanse	VERB
aji-7	201	22	with	with	ADP
aji-7	201	23	saline	saline	NOUN
aji-7	201	24	0.9	0.9	NUM
aji-7	201	25	%	%	NOUN
aji-7	201	26	to	to	PART
aji-7	201	27	clean	clean	VERB
aji-7	201	28	any	any	DET
aji-7	201	29	remains	remain	NOUN
aji-7	201	30	inside	inside	ADP
aji-7	201	31	the	the	DET
aji-7	201	32	stomach	stomach	NOUN
aji-7	201	33	and	and	CCONJ
aji-7	201	34	hold	hold	VERB
aji-7	201	35	it	it	PRON
aji-7	201	36	by	by	ADP
aji-7	201	37	bins	bin	NOUN
aji-7	201	38	to	to	PART
aji-7	201	39	exposed	expose	VERB
aji-7	201	40	its	its	PRON
aji-7	201	41	mucosa	mucosa	NOUN
aji-7	201	42	and	and	CCONJ
aji-7	201	43	stomach	stomach	NOUN
aji-7	201	44	ulcer	ulcer	NOUN
aji-7	201	45	will	will	AUX
aji-7	201	46	examined	examine	VERB
aji-7	201	47	under	under	ADP
aji-7	201	48	magnifying	magnify	VERB
aji-7	201	49	land	land	NOUN
aji-7	201	50	lens	len	NOUN
aji-7	201	51	to	to	PART
aji-7	201	52	calculate	calculate	VERB
aji-7	201	53	ulcer	ulcer	NOUN
aji-7	201	54	index	index	NOUN
aji-7	201	55	by	by	ADP
aji-7	201	56	the	the	DET
aji-7	201	57	number	number	NOUN
aji-7	201	58	and	and	CCONJ
aji-7	201	59	depth	depth	NOUN
aji-7	201	60	of	of	ADP
aji-7	201	61	the	the	DET
aji-7	201	62	ulcers	ulcer	NOUN
aji-7	201	63	(	(	PUNCT
aji-7	201	64	gastric	gastric	ADJ
aji-7	201	65	ulcer	ulcer	NOUN
aji-7	201	66	scoring	scoring	NOUN
aji-7	201	67	)	)	PUNCT
aji-7	201	68	,	,	PUNCT
aji-7	202	1	[	[	X
aji-7	202	2	30	30	NUM
aji-7	202	3	]	]	PUNCT
aji-7	202	4	.	.	PUNCT
aji-7	203	1	part	part	NOUN
aji-7	203	2	of	of	ADP
aji-7	203	3	the	the	DET
aji-7	203	4	stomach	stomach	NOUN
aji-7	203	5	(	(	PUNCT
aji-7	203	6	fundus	fundus	NOUN
aji-7	203	7	)	)	PUNCT
aji-7	203	8	fixed	fix	VERB
aji-7	203	9	in	in	ADP
aji-7	203	10	formalin	formalin	NOUN
aji-7	203	11	and	and	CCONJ
aji-7	203	12	exposed	expose	VERB
aji-7	203	13	to	to	ADP
aji-7	203	14	histopathological	histopathological	ADJ
aji-7	203	15	study	study	NOUN
aji-7	203	16	to	to	PART
aji-7	203	17	compare	compare	VERB
aji-7	203	18	it	it	PRON
aji-7	203	19	with	with	ADP
aji-7	203	20	diclofenac	diclofenac	NOUN
aji-7	203	21	[	[	X
aji-7	203	22	27	27	NUM
aji-7	203	23	]	]	SYM
aji-7	203	24	.	.	PUNCT
aji-7	204	1	5.7	5.7	NUM
aji-7	204	2	drug	drug	NOUN
aji-7	204	3	-	-	PUNCT
aji-7	204	4	drug	drug	NOUN
aji-7	204	5	interaction	interaction	NOUN
aji-7	204	6	aleglitazar	aleglitazar	NOUN
aji-7	204	7	used	use	VERB
aji-7	204	8	in	in	ADP
aji-7	204	9	combination	combination	NOUN
aji-7	204	10	with	with	ADP
aji-7	204	11	warfarin	warfarin	NOUN
aji-7	204	12	which	which	PRON
aji-7	204	13	used	use	VERB
aji-7	204	14	as	as	ADP
aji-7	204	15	an	an	DET
aji-7	204	16	anticoagulant	anticoagulant	ADJ
aji-7	204	17	drug	drug	NOUN
aji-7	204	18	,	,	PUNCT
aji-7	204	19	it	it	PRON
aji-7	204	20	affects	affect	VERB
aji-7	204	21	elsawy	elsawy	NOUN
aji-7	204	22	;	;	PUNCT
aji-7	204	23	aji	aji	NOUN
aji-7	204	24	,	,	PUNCT
aji-7	204	25	2(1	2(1	NUM
aji-7	204	26	):	):	PUNCT
aji-7	204	27	34	34	NUM
aji-7	204	28	-	-	SYM
aji-7	204	29	44	44	NUM
aji-7	204	30	,	,	PUNCT
aji-7	204	31	2019	2019	NUM
aji-7	204	32	;	;	PUNCT
aji-7	204	33	article	article	NOUN
aji-7	204	34	no.aji.53258	no.aji.53258	NOUN
aji-7	204	35	40	40	NUM
aji-7	204	36	the	the	DET
aji-7	204	37	efficacy	efficacy	NOUN
aji-7	204	38	and	and	CCONJ
aji-7	204	39	safety	safety	NOUN
aji-7	204	40	by	by	ADP
aji-7	204	41	affecting	affect	VERB
aji-7	204	42	the	the	DET
aji-7	204	43	viscosity	viscosity	NOUN
aji-7	204	44	of	of	ADP
aji-7	204	45	the	the	DET
aji-7	204	46	blood	blood	NOUN
aji-7	204	47	through	through	ADP
aji-7	204	48	angiotensin-2	angiotensin-2	VERB
aji-7	204	49	receptor	receptor	NOUN
aji-7	204	50	blocker	blocker	NOUN
aji-7	204	51	so	so	SCONJ
aji-7	204	52	the	the	DET
aji-7	204	53	blood	blood	NOUN
aji-7	204	54	vessels	vessel	NOUN
aji-7	204	55	dilated	dilate	VERB
aji-7	204	56	that	that	DET
aji-7	204	57	lead	lead	NOUN
aji-7	204	58	to	to	PART
aji-7	204	59	decrease	decrease	VERB
aji-7	204	60	the	the	DET
aji-7	204	61	velocity	velocity	NOUN
aji-7	204	62	of	of	ADP
aji-7	204	63	the	the	DET
aji-7	204	64	blood	blood	NOUN
aji-7	204	65	stream	stream	NOUN
aji-7	204	66	and	and	CCONJ
aji-7	204	67	increase	increase	VERB
aji-7	204	68	the	the	DET
aji-7	204	69	susceptibility	susceptibility	NOUN
aji-7	204	70	of	of	ADP
aji-7	204	71	thrombosis	thrombosis	NOUN
aji-7	205	1	[	[	X
aji-7	205	2	31	31	NUM
aji-7	205	3	]	]	PUNCT
aji-7	205	4	.	.	PUNCT
aji-7	206	1	in	in	ADP
aji-7	206	2	patients	patient	NOUN
aji-7	206	3	with	with	ADP
aji-7	206	4	normal	normal	ADJ
aji-7	206	5	to	to	PART
aji-7	206	6	borderline	borderline	VERB
aji-7	206	7	impaired	impair	VERB
aji-7	206	8	renal	renal	ADJ
aji-7	206	9	function	function	NOUN
aji-7	206	10	and	and	CCONJ
aji-7	206	11	impaired	impair	VERB
aji-7	206	12	glomerular	glomerular	ADJ
aji-7	206	13	filtration	filtration	NOUN
aji-7	206	14	rate	rate	NOUN
aji-7	206	15	using	use	VERB
aji-7	206	16	aleglitazar	aleglitazar	NOUN
aji-7	206	17	in	in	ADP
aji-7	206	18	supratherapeutic	supratherapeutic	ADJ
aji-7	206	19	dose	dose	NOUN
aji-7	206	20	will	will	AUX
aji-7	206	21	increase	increase	VERB
aji-7	206	22	serum	serum	NOUN
aji-7	206	23	creatinine	creatinine	NOUN
aji-7	206	24	and	and	CCONJ
aji-7	206	25	decrease	decrease	VERB
aji-7	206	26	glomerular	glomerular	ADJ
aji-7	206	27	filtration	filtration	NOUN
aji-7	206	28	rate	rate	NOUN
aji-7	206	29	that	that	PRON
aji-7	206	30	leads	lead	VERB
aji-7	206	31	to	to	ADP
aji-7	206	32	progressive	progressive	ADJ
aji-7	206	33	nephropathy	nephropathy	NOUN
aji-7	206	34	and	and	CCONJ
aji-7	206	35	bilateral	bilateral	ADJ
aji-7	206	36	oedema	oedema	NOUN
aji-7	206	37	so	so	SCONJ
aji-7	206	38	it	it	PRON
aji-7	206	39	interacts	interact	VERB
aji-7	206	40	with	with	ADP
aji-7	206	41	diuretics	diuretic	NOUN
aji-7	206	42	[	[	X
aji-7	206	43	31	31	NUM
aji-7	206	44	]	]	SYM
aji-7	206	45	.	.	PUNCT
aji-7	207	1	6	6	NUM
aji-7	207	2	biochemical	biochemical	ADJ
aji-7	207	3	tests	test	NOUN
aji-7	207	4	6.1	6.1	NUM
aji-7	207	5	fasting	fast	VERB
aji-7	207	6	blood	blood	NOUN
aji-7	207	7	glucose	glucose	NOUN
aji-7	207	8	a	a	DET
aji-7	207	9	daily	daily	ADJ
aji-7	207	10	dose	dose	NOUN
aji-7	207	11	of	of	ADP
aji-7	207	12	aleglitazar150	aleglitazar150	PROPN
aji-7	207	13	μg	μg	PROPN
aji-7	207	14	observed	observe	VERB
aji-7	207	15	to	to	PART
aji-7	207	16	modulate	modulate	VERB
aji-7	207	17	the	the	DET
aji-7	207	18	fasting	fast	VERB
aji-7	207	19	plasma	plasma	NOUN
aji-7	207	20	glucose	glucose	NOUN
aji-7	207	21	(	(	PUNCT
aji-7	207	22	fbg	fbg	PROPN
aji-7	207	23	)	)	PUNCT
aji-7	208	1	[	[	X
aji-7	208	2	5	5	NUM
aji-7	208	3	]	]	PUNCT
aji-7	208	4	.	.	PUNCT
aji-7	209	1	6.2	6.2	NUM
aji-7	209	2	insulin	insulin	NOUN
aji-7	209	3	aleglitazar	aleglitazar	NOUN
aji-7	209	4	treatment	treatment	NOUN
aji-7	209	5	helped	help	VERB
aji-7	209	6	to	to	PART
aji-7	209	7	increase	increase	VERB
aji-7	209	8	body	body	NOUN
aji-7	209	9	's	's	PART
aji-7	209	10	sensitivity	sensitivity	NOUN
aji-7	209	11	to	to	ADP
aji-7	209	12	insulin	insulin	NOUN
aji-7	209	13	significantly	significantly	ADV
aji-7	209	14	compared	compare	VERB
aji-7	209	15	to	to	ADP
aji-7	209	16	placebo	placebo	NOUN
aji-7	209	17	.	.	PUNCT
aji-7	210	1	6.3	6.3	NUM
aji-7	211	1	hba1c	hba1c	PRON
aji-7	211	2	clinical	clinical	ADJ
aji-7	211	3	trials	trial	NOUN
aji-7	211	4	of	of	ADP
aji-7	211	5	aleglitazar	aleglitazar	NOUN
aji-7	211	6	in	in	ADP
aji-7	211	7	patients	patient	NOUN
aji-7	211	8	with	with	ADP
aji-7	211	9	type	type	NOUN
aji-7	211	10	2	2	NUM
aji-7	211	11	diabetes	diabetes	NOUN
aji-7	211	12	were	be	AUX
aji-7	211	13	conducted	conduct	VERB
aji-7	211	14	for	for	ADP
aji-7	211	15	26	26	NUM
aji-7	211	16	weeks	week	NOUN
aji-7	211	17	(	(	PUNCT
aji-7	211	18	150	150	NUM
aji-7	211	19	 	 	SPACE
aji-7	211	20	µg	µg	ADJ
aji-7	211	21	/	/	SYM
aji-7	211	22	day	day	NOUN
aji-7	211	23	)	)	PUNCT
aji-7	211	24	.	.	PUNCT
aji-7	212	1	the	the	DET
aji-7	212	2	primary	primary	ADJ
aji-7	212	3	endpoint	endpoint	NOUN
aji-7	212	4	was	be	AUX
aji-7	212	5	significant	significant	ADJ
aji-7	212	6	reduction	reduction	NOUN
aji-7	212	7	in	in	ADP
aji-7	212	8	glycated	glycate	VERB
aji-7	212	9	hemoglobin	hemoglobin	NOUN
aji-7	212	10	(	(	PUNCT
aji-7	212	11	hba1c	hba1c	NOUN
aji-7	212	12	)	)	PUNCT
aji-7	212	13	concentration	concentration	NOUN
aji-7	212	14	from	from	ADP
aji-7	212	15	baseline	baseline	NOUN
aji-7	212	16	to	to	ADP
aji-7	212	17	week	week	NOUN
aji-7	212	18	26	26	NUM
aji-7	213	1	[	[	X
aji-7	213	2	32	32	NUM
aji-7	213	3	]	]	PUNCT
aji-7	213	4	(	(	PUNCT
aji-7	213	5	fig	fig	NOUN
aji-7	213	6	.	.	PUNCT
aji-7	214	1	8)	8)	NUM
aji-7	214	2	.	.	NOUN
aji-7	214	3	6.4	6.4	NUM
aji-7	214	4	serum	serum	PROPN
aji-7	214	5	creatinine	creatinine	NOUN
aji-7	214	6	serum	serum	NOUN
aji-7	214	7	creatinine	creatinine	PROPN
aji-7	214	8	(	(	PUNCT
aji-7	214	9	sc	sc	PROPN
aji-7	214	10	)	)	PUNCT
aji-7	214	11	is	be	AUX
aji-7	214	12	a	a	DET
aji-7	214	13	routine	routine	ADJ
aji-7	214	14	test	test	NOUN
aji-7	214	15	for	for	ADP
aji-7	214	16	kidney	kidney	NOUN
aji-7	214	17	function	function	NOUN
aji-7	214	18	assessment	assessment	NOUN
aji-7	214	19	[	[	X
aji-7	214	20	33	33	NUM
aji-7	214	21	]	]	PUNCT
aji-7	214	22	.	.	PUNCT
aji-7	215	1	serum	serum	PROPN
aji-7	215	2	creatinine	creatinine	PROPN
aji-7	215	3	showed	show	VERB
aji-7	215	4	to	to	PART
aji-7	215	5	increase	increase	VERB
aji-7	215	6	and	and	CCONJ
aji-7	215	7	show	show	VERB
aji-7	215	8	to	to	PART
aji-7	215	9	be	be	AUX
aji-7	215	10	reversible	reversible	ADJ
aji-7	215	11	after	after	ADP
aji-7	215	12	cessation	cessation	NOUN
aji-7	215	13	of	of	ADP
aji-7	215	14	aleglitazar	aleglitazar	NOUN
aji-7	215	15	within	within	ADP
aji-7	215	16	a	a	DET
aji-7	215	17	follow	follow	NOUN
aji-7	215	18	-	-	PUNCT
aji-7	215	19	up	up	NOUN
aji-7	215	20	period	period	NOUN
aji-7	215	21	from	from	ADP
aji-7	215	22	4	4	NUM
aji-7	215	23	to	to	PART
aji-7	215	24	8	8	NUM
aji-7	215	25	weeks	week	NOUN
aji-7	215	26	[	[	X
aji-7	215	27	29	29	NUM
aji-7	215	28	]	]	PUNCT
aji-7	215	29	.	.	PUNCT
aji-7	216	1	6.5	6.5	NUM
aji-7	216	2	immuno	immuno	ADJ
aji-7	216	3	-	-	PUNCT
aji-7	216	4	inflammatory	inflammatory	ADJ
aji-7	216	5	reactions	reaction	NOUN
aji-7	216	6	in	in	ADP
aji-7	216	7	obesity	obesity	NOUN
aji-7	216	8	-	-	PUNCT
aji-7	216	9	related	relate	VERB
aji-7	216	10	disorders	disorder	NOUN
aji-7	216	11	c	c	NOUN
aji-7	216	12	-	-	PUNCT
aji-7	216	13	reactive	reactive	ADJ
aji-7	216	14	protein	protein	NOUN
aji-7	216	15	(	(	PUNCT
aji-7	216	16	crp	crp	PROPN
aji-7	216	17	)	)	PUNCT
aji-7	216	18	is	be	AUX
aji-7	216	19	a	a	DET
aji-7	216	20	crucial	crucial	ADJ
aji-7	216	21	inflammatory	inflammatory	ADJ
aji-7	216	22	biomarker	biomarker	NOUN
aji-7	217	1	[	[	X
aji-7	217	2	34	34	NUM
aji-7	217	3	]	]	PUNCT
aji-7	217	4	.	.	PUNCT
aji-7	218	1	high	high	ADJ
aji-7	218	2	sensitivity	sensitivity	NOUN
aji-7	218	3	to	to	PART
aji-7	218	4	aleglitazar	aleglitazar	PROPN
aji-7	218	5	shows	show	VERB
aji-7	218	6	a	a	DET
aji-7	218	7	significant	significant	ADJ
aji-7	218	8	reduction	reduction	NOUN
aji-7	218	9	in	in	ADP
aji-7	218	10	crp	crp	PROPN
aji-7	219	1	[	[	X
aji-7	219	2	35	35	NUM
aji-7	219	3	]	]	PUNCT
aji-7	219	4	.	.	PUNCT
aji-7	220	1	6.6	6.6	NUM
aji-7	220	2	free	free	ADJ
aji-7	220	3	fatty	fatty	NOUN
aji-7	220	4	acids	acid	NOUN
aji-7	220	5	(	(	PUNCT
aji-7	220	6	ffa	ffa	NOUN
aji-7	220	7	)	)	PUNCT
aji-7	220	8	and	and	CCONJ
aji-7	220	9	triglycerides	triglyceride	NOUN
aji-7	220	10	and	and	CCONJ
aji-7	220	11	–	–	PUNCT
aji-7	220	12	hdl	hdl	PROPN
aji-7	220	13	pparα	pparα	NOUN
aji-7	220	14	and	and	CCONJ
aji-7	220	15	pparδ	pparδ	NOUN
aji-7	220	16	enhance	enhance	VERB
aji-7	220	17	the	the	DET
aji-7	220	18	movement	movement	NOUN
aji-7	220	19	of	of	ADP
aji-7	220	20	lipid	lipid	NOUN
aji-7	220	21	out	out	ADP
aji-7	220	22	of	of	ADP
aji-7	220	23	circulation	circulation	NOUN
aji-7	220	24	by	by	ADP
aji-7	220	25	increase	increase	NOUN
aji-7	220	26	uptake	uptake	ADJ
aji-7	220	27	of	of	ADP
aji-7	220	28	free	free	ADJ
aji-7	220	29	fatty	fatty	NOUN
aji-7	220	30	acid	acid	NOUN
aji-7	220	31	and	and	CCONJ
aji-7	220	32	oxidation	oxidation	NOUN
aji-7	220	33	in	in	ADP
aji-7	220	34	tissue	tissue	NOUN
aji-7	220	35	,	,	PUNCT
aji-7	220	36	while	while	SCONJ
aji-7	220	37	ppar	ppar	NOUN
aji-7	220	38	γwill	γwill	NOUN
aji-7	220	39	stimulate	stimulate	VERB
aji-7	220	40	the	the	DET
aji-7	220	41	process	process	NOUN
aji-7	220	42	of	of	ADP
aji-7	220	43	lipid	lipid	ADJ
aji-7	220	44	storage	storage	NOUN
aji-7	220	45	in	in	ADP
aji-7	220	46	adipose	adipose	ADJ
aji-7	220	47	tissue	tissue	NOUN
aji-7	220	48	.	.	PUNCT
aji-7	221	1	[	[	X
aji-7	221	2	36	36	NUM
aji-7	221	3	]	]	PUNCT
aji-7	221	4	.	.	PUNCT
aji-7	222	1	it	it	PRON
aji-7	222	2	has	have	VERB
aji-7	222	3	the	the	DET
aji-7	222	4	most	most	ADV
aji-7	222	5	effective	effective	ADJ
aji-7	222	6	improvement	improvement	NOUN
aji-7	222	7	in	in	ADP
aji-7	222	8	highdensity	highdensity	NOUN
aji-7	222	9	lipoprotein	lipoprotein	ADJ
aji-7	222	10	cholesterol	cholesterol	NOUN
aji-7	222	11	,	,	PUNCT
aji-7	222	12	low	low	ADJ
aji-7	222	13	-	-	PUNCT
aji-7	222	14	density	density	NOUN
aji-7	222	15	lipoprotein	lipoprotein	ADJ
aji-7	222	16	cholesterol	cholesterol	NOUN
aji-7	222	17	(	(	PUNCT
aji-7	222	18	ldl	ldl	NOUN
aji-7	222	19	)	)	PUNCT
aji-7	222	20	,	,	PUNCT
aji-7	222	21	and	and	CCONJ
aji-7	222	22	triglycerides	triglyceride	NOUN
aji-7	222	23	.	.	PUNCT
aji-7	223	1	the	the	DET
aji-7	223	2	result	result	NOUN
aji-7	223	3	of	of	ADP
aji-7	223	4	lowering	lower	VERB
aji-7	223	5	lipid	lipid	NOUN
aji-7	223	6	profile	profile	NOUN
aji-7	223	7	reduce	reduce	VERB
aji-7	223	8	the	the	DET
aji-7	223	9	risk	risk	NOUN
aji-7	223	10	of	of	ADP
aji-7	223	11	cardiovascular	cardiovascular	ADJ
aji-7	223	12	disease	disease	NOUN
aji-7	223	13	and	and	CCONJ
aji-7	223	14	particularly	particularly	ADV
aji-7	223	15	atherosclerosis	atherosclerosis	NOUN
aji-7	223	16	[	[	X
aji-7	223	17	5	5	NUM
aji-7	223	18	]	]	PUNCT
aji-7	223	19	.	.	PUNCT
aji-7	224	1	6.7	6.7	NUM
aji-7	224	2	detection	detection	NOUN
aji-7	224	3	and	and	CCONJ
aji-7	224	4	estimation	estimation	NOUN
aji-7	224	5	of	of	ADP
aji-7	224	6	serum	serum	NOUN
aji-7	224	7	level	level	NOUN
aji-7	224	8	of	of	ADP
aji-7	224	9	tumor	tumor	NOUN
aji-7	224	10	necrosis	necrosis	NOUN
aji-7	224	11	factor	factor	NOUN
aji-7	224	12	alpha	alpha	NOUN
aji-7	224	13	(	(	PUNCT
aji-7	224	14	tnf	tnf	PROPN
aji-7	224	15	-	-	PUNCT
aji-7	224	16	α	α	NOUN
aji-7	224	17	)	)	PUNCT
aji-7	224	18	in	in	ADP
aji-7	224	19	the	the	DET
aji-7	224	20	patient	patient	NOUN
aji-7	224	21	with	with	ADP
aji-7	224	22	diabetes	diabetes	NOUN
aji-7	224	23	the	the	DET
aji-7	224	24	inflammatory	inflammatory	ADJ
aji-7	224	25	mediators	mediator	NOUN
aji-7	224	26	levels	level	NOUN
aji-7	224	27	of	of	ADP
aji-7	224	28	gingival	gingival	NOUN
aji-7	224	29	crevicular	crevicular	ADJ
aji-7	224	30	fluid	fluid	NOUN
aji-7	224	31	(	(	PUNCT
aji-7	224	32	gcf	gcf	PROPN
aji-7	224	33	)	)	PUNCT
aji-7	224	34	,	,	PUNCT
aji-7	224	35	interleukin	interleukin	NOUN
aji-7	224	36	1	1	NUM
aji-7	224	37	beta	beta	NOUN
aji-7	224	38	(	(	PUNCT
aji-7	224	39	il-1beta	il-1beta	X
aji-7	224	40	)	)	PUNCT
aji-7	224	41	and	and	CCONJ
aji-7	224	42	monocytic	monocytic	ADJ
aji-7	224	43	secretion	secretion	NOUN
aji-7	224	44	of	of	ADP
aji-7	224	45	prostaglandin	prostaglandin	PROPN
aji-7	224	46	e2	e2	PROPN
aji-7	224	47	(	(	PUNCT
aji-7	224	48	pge2	pge2	PROPN
aji-7	224	49	)	)	PUNCT
aji-7	224	50	are	be	AUX
aji-7	224	51	increased	increase	VERB
aji-7	224	52	more	more	ADJ
aji-7	224	53	than	than	ADP
aji-7	224	54	the	the	DET
aji-7	224	55	non	non	ADJ
aji-7	224	56	-	-	ADJ
aji-7	224	57	diabetic	diabetic	ADJ
aji-7	224	58	patient	patient	NOUN
aji-7	224	59	[	[	X
aji-7	224	60	37	37	NUM
aji-7	224	61	]	]	PUNCT
aji-7	224	62	.	.	PUNCT
aji-7	225	1	tumor	tumor	NOUN
aji-7	225	2	necrosis	necrosis	NOUN
aji-7	225	3	factor	factor	NOUN
aji-7	225	4	-	-	PUNCT
aji-7	225	5	alpha	alpha	NOUN
aji-7	225	6	(	(	PUNCT
aji-7	225	7	tnf	tnf	PROPN
aji-7	225	8	-	-	PUNCT
aji-7	225	9	α	α	NOUN
aji-7	225	10	)	)	PUNCT
aji-7	225	11	synthesis	synthesis	NOUN
aji-7	225	12	in	in	ADP
aji-7	225	13	adipose	adipose	ADJ
aji-7	225	14	tissue	tissue	NOUN
aji-7	225	15	,	,	PUNCT
aji-7	225	16	the	the	DET
aji-7	225	17	degree	degree	NOUN
aji-7	225	18	of	of	ADP
aji-7	225	19	adipose	adipose	ADJ
aji-7	225	20	tissue	tissue	NOUN
aji-7	225	21	related	relate	VERB
aji-7	225	22	to	to	ADP
aji-7	225	23	the	the	DET
aji-7	225	24	level	level	NOUN
aji-7	225	25	of	of	ADP
aji-7	225	26	synthetase	synthetase	NOUN
aji-7	225	27	fig	fig	NOUN
aji-7	225	28	.	.	PUNCT
aji-7	226	1	8	8	X
aji-7	226	2	.	.	PUNCT
aji-7	226	3	gradually	gradually	ADV
aji-7	226	4	reduction	reduction	NOUN
aji-7	226	5	inhba1c	inhba1c	NOUN
aji-7	226	6	.	.	PUNCT
aji-7	227	1	significant	significant	ADJ
aji-7	227	2	reduction	reduction	NOUN
aji-7	227	3	in	in	ADP
aji-7	227	4	hba1c	hba1c	PROPN
aji-7	227	5	by	by	ADP
aji-7	227	6	aleglitazar	aleglitazar	NOUN
aji-7	227	7	was	be	AUX
aji-7	227	8	apparent	apparent	ADJ
aji-7	227	9	by	by	ADP
aji-7	227	10	week	week	NOUN
aji-7	227	11	[	[	X
aji-7	227	12	32	32	NUM
aji-7	227	13	]	]	PUNCT
aji-7	227	14	elsawy	elsawy	NOUN
aji-7	227	15	;	;	PUNCT
aji-7	227	16	aji	aji	NOUN
aji-7	227	17	,	,	PUNCT
aji-7	227	18	2(1	2(1	NUM
aji-7	227	19	):	):	PUNCT
aji-7	227	20	34	34	NUM
aji-7	227	21	-	-	SYM
aji-7	227	22	44	44	NUM
aji-7	227	23	,	,	PUNCT
aji-7	227	24	2019	2019	NUM
aji-7	227	25	;	;	PUNCT
aji-7	227	26	article	article	NOUN
aji-7	227	27	no.aji.53258	no.aji.53258	PROPN
aji-7	227	28	41	41	NUM
aji-7	227	29	fig	fig	NOUN
aji-7	227	30	.	.	PUNCT
aji-7	228	1	9	9	NUM
aji-7	228	2	.	.	X
aji-7	228	3	tnf	tnf	PROPN
aji-7	228	4	-	-	PUNCT
aji-7	228	5	α	α	PROPN
aji-7	228	6	concentration	concentration	NOUN
aji-7	228	7	in	in	ADP
aji-7	228	8	t2	t2	NOUN
aji-7	228	9	dm	dm	PROPN
aji-7	228	10	.	.	PUNCT
aji-7	229	1	(	(	PUNCT
aji-7	229	2	4.4+/-0.2	4.4+/-0.2	NUM
aji-7	229	3	pg	pg	PROPN
aji-7	229	4	/	/	SYM
aji-7	229	5	ml	ml	NOUN
aji-7	229	6	)	)	PUNCT
aji-7	230	1	[	[	X
aji-7	230	2	41	41	NUM
aji-7	230	3	]	]	PUNCT
aji-7	230	4	of	of	ADP
aji-7	230	5	tnf	tnf	PROPN
aji-7	230	6	-	-	PUNCT
aji-7	230	7	α	α	PROPN
aji-7	230	8	,	,	PUNCT
aji-7	230	9	this	this	PRON
aji-7	230	10	is	be	AUX
aji-7	230	11	the	the	DET
aji-7	230	12	bond	bond	NOUN
aji-7	230	13	between	between	ADP
aji-7	230	14	obesity	obesity	NOUN
aji-7	230	15	and	and	CCONJ
aji-7	230	16	t2	t2	NOUN
aji-7	230	17	dm	dm	X
aji-7	231	1	[	[	X
aji-7	231	2	38	38	NUM
aji-7	231	3	]	]	PUNCT
aji-7	231	4	.	.	PUNCT
aji-7	232	1	serum	serum	NOUN
aji-7	232	2	level	level	NOUN
aji-7	232	3	of	of	ADP
aji-7	232	4	tnfα	tnfα	NOUN
aji-7	232	5	in	in	ADP
aji-7	232	6	obese	obese	ADJ
aji-7	232	7	patients	patient	NOUN
aji-7	232	8	with	with	ADP
aji-7	232	9	t2	t2	PROPN
aji-7	232	10	dm	dm	PRON
aji-7	232	11	increased	increase	VERB
aji-7	232	12	than	than	ADP
aji-7	232	13	normal	normal	ADJ
aji-7	232	14	or	or	CCONJ
aji-7	232	15	non	non	ADJ
aji-7	232	16	-	-	ADJ
aji-7	232	17	obese	obese	ADJ
aji-7	232	18	patient	patient	NOUN
aji-7	232	19	with	with	ADP
aji-7	232	20	t2	t2	PROPN
aji-7	232	21	dm	dm	PROPN
aji-7	232	22	,	,	PUNCT
aji-7	232	23	serum	serum	NOUN
aji-7	232	24	level	level	NOUN
aji-7	232	25	of	of	ADP
aji-7	232	26	tnfα	tnfα	NOUN
aji-7	232	27	show	show	VERB
aji-7	232	28	positive	positive	ADJ
aji-7	232	29	correlation	correlation	NOUN
aji-7	232	30	to	to	ADP
aji-7	232	31	degree	degree	NOUN
aji-7	232	32	of	of	ADP
aji-7	232	33	adipose	adipose	ADJ
aji-7	232	34	tissue	tissue	NOUN
aji-7	232	35	and	and	CCONJ
aji-7	232	36	negative	negative	ADJ
aji-7	232	37	correlation	correlation	NOUN
aji-7	232	38	with	with	ADP
aji-7	232	39	glucose	glucose	NOUN
aji-7	232	40	-	-	PUNCT
aji-7	232	41	insulin	insulin	NOUN
aji-7	232	42	rate	rate	NOUN
aji-7	232	43	(	(	PUNCT
aji-7	232	44	gir),increase	gir),increase	PROPN
aji-7	232	45	tnfα	tnfα	NOUN
aji-7	232	46	highly	highly	ADV
aji-7	232	47	associated	associate	VERB
aji-7	232	48	with	with	ADP
aji-7	232	49	increased	increase	VERB
aji-7	232	50	insulin	insulin	NOUN
aji-7	232	51	resistance	resistance	NOUN
aji-7	232	52	(	(	PUNCT
aji-7	232	53	fig	fig	NOUN
aji-7	232	54	.	.	PUNCT
aji-7	233	1	9	9	NUM
aji-7	233	2	)	)	PUNCT
aji-7	234	1	[	[	X
aji-7	234	2	39	39	NUM
aji-7	234	3	]	]	PUNCT
aji-7	234	4	.	.	PUNCT
aji-7	235	1	6.8	6.8	NUM
aji-7	235	2	nitric	nitric	ADJ
aji-7	235	3	oxide	oxide	NOUN
aji-7	235	4	(	(	PUNCT
aji-7	235	5	no	no	NOUN
aji-7	235	6	)	)	PUNCT
aji-7	235	7	concentrations	concentration	NOUN
aji-7	235	8	in	in	ADP
aji-7	235	9	serum	serum	NOUN
aji-7	235	10	obese	obese	NOUN
aji-7	235	11	rats	rat	NOUN
aji-7	235	12	were	be	AUX
aji-7	235	13	assigned	assign	VERB
aji-7	235	14	to	to	ADP
aji-7	235	15	treatment	treatment	NOUN
aji-7	235	16	by	by	ADP
aji-7	235	17	aleglitazar	aleglitazar	NOUN
aji-7	235	18	,	,	PUNCT
aji-7	235	19	the	the	DET
aji-7	235	20	treatment	treatment	NOUN
aji-7	235	21	was	be	AUX
aji-7	235	22	administered	administer	VERB
aji-7	235	23	for	for	ADP
aji-7	235	24	nine	nine	NUM
aji-7	235	25	weeks	week	NOUN
aji-7	235	26	.	.	PUNCT
aji-7	235	27	nitric	nitric	ADJ
aji-7	235	28	oxide	oxide	NOUN
aji-7	235	29	(	(	PUNCT
aji-7	235	30	no	no	NOUN
aji-7	235	31	)	)	PUNCT
aji-7	235	32	was	be	AUX
aji-7	235	33	measured	measure	VERB
aji-7	235	34	.	.	PUNCT
aji-7	236	1	aleglitazar	aleglitazar	PROPN
aji-7	236	2	increased	increase	VERB
aji-7	236	3	no	no	DET
aji-7	236	4	release	release	NOUN
aji-7	236	5	by	by	ADP
aji-7	236	6	25	25	NUM
aji-7	236	7	%	%	NOUN
aji-7	236	8	as	as	ADP
aji-7	236	9	the	the	DET
aji-7	236	10	nitric	nitric	ADJ
aji-7	236	11	oxide	oxide	NOUN
aji-7	236	12	/	/	SYM
aji-7	236	13	peroxynitrite	peroxynitrite	NOUN
aji-7	236	14	ratio	ratio	NOUN
aji-7	236	15	(	(	PUNCT
aji-7	236	16	no	no	NOUN
aji-7	236	17	/	/	SYM
aji-7	236	18	onoo-	onoo-	NOUN
aji-7	236	19	)	)	PUNCT
aji-7	236	20	which	which	PRON
aji-7	236	21	is	be	AUX
aji-7	236	22	an	an	DET
aji-7	236	23	indicator	indicator	NOUN
aji-7	236	24	of	of	ADP
aji-7	236	25	no	no	DET
aji-7	236	26	synthase	synthase	NOUN
aji-7	236	27	uncoupling	uncoupling	NOUN
aji-7	236	28	increased	increase	VERB
aji-7	236	29	by	by	ADP
aji-7	236	30	33	33	NUM
aji-7	236	31	%	%	NOUN
aji-7	236	32	with	with	ADP
aji-7	236	33	aleglitazar	aleglitazar	NOUN
aji-7	236	34	treatment	treatment	NOUN
aji-7	236	35	[	[	X
aji-7	236	36	40	40	NUM
aji-7	236	37	]	]	PUNCT
aji-7	236	38	.	.	PUNCT
aji-7	237	1	7	7	X
aji-7	237	2	.	.	X
aji-7	237	3	conclusion	conclusion	NOUN
aji-7	237	4	aleglitazar	aleglitazar	NOUN
aji-7	237	5	is	be	AUX
aji-7	237	6	a	a	DET
aji-7	237	7	new	new	ADJ
aji-7	237	8	promising	promising	ADJ
aji-7	237	9	drug	drug	NOUN
aji-7	237	10	,	,	PUNCT
aji-7	237	11	used	use	VERB
aji-7	237	12	as	as	ADP
aji-7	237	13	an	an	DET
aji-7	237	14	anti	anti	ADJ
aji-7	237	15	-	-	ADJ
aji-7	237	16	inflammatory	inflammatory	ADJ
aji-7	237	17	,	,	PUNCT
aji-7	237	18	anti	anti	ADJ
aji-7	237	19	-	-	ADJ
aji-7	237	20	diabetic	diabetic	ADJ
aji-7	237	21	,	,	PUNCT
aji-7	237	22	and	and	CCONJ
aji-7	237	23	antihyperlipidemic	antihyperlipidemic	ADJ
aji-7	237	24	drug	drug	NOUN
aji-7	237	25	.	.	PUNCT
aji-7	238	1	in	in	ADP
aji-7	238	2	comparison	comparison	NOUN
aji-7	238	3	with	with	ADP
aji-7	238	4	diclofenac	diclofenac	NOUN
aji-7	238	5	the	the	DET
aji-7	238	6	standard	standard	ADJ
aji-7	238	7	anti	anti	ADJ
aji-7	238	8	-	-	ADJ
aji-7	238	9	inflammatory	inflammatory	ADJ
aji-7	238	10	drug	drug	NOUN
aji-7	238	11	.	.	PUNCT
aji-7	239	1	inthe	inthe	DET
aji-7	239	2	field	field	NOUN
aji-7	239	3	of	of	ADP
aji-7	239	4	pharmacokinetics	pharmacokinetic	NOUN
aji-7	239	5	the	the	DET
aji-7	239	6	auc	auc	NOUN
aji-7	239	7	of	of	ADP
aji-7	239	8	aleglitazar	aleglitazar	NOUN
aji-7	239	9	.	.	PUNCT
aji-7	239	10	increased	increase	VERB
aji-7	239	11	with	with	ADP
aji-7	239	12	dose	dose	NOUN
aji-7	239	13	with	with	ADP
aji-7	239	14	values	value	NOUN
aji-7	239	15	of	of	ADP
aji-7	239	16	(	(	PUNCT
aji-7	239	17	8.66	8.66	NUM
aji-7	239	18	402	402	NUM
aji-7	239	19	)	)	PUNCT
aji-7	239	20	ng.h	ng.h	NOUN
aji-7	239	21	/	/	SYM
aji-7	239	22	ml	ml	NOUN
aji-7	239	23	while	while	SCONJ
aji-7	239	24	in	in	ADP
aji-7	239	25	diclofenac	diclofenac	NOUN
aji-7	239	26	the	the	DET
aji-7	239	27	auc	auc	NOUN
aji-7	239	28	is	be	AUX
aji-7	239	29	between	between	ADP
aji-7	239	30	(	(	PUNCT
aji-7	239	31	72.6	72.6	NUM
aji-7	239	32	177.5	177.5	NUM
aji-7	239	33	)	)	PUNCT
aji-7	239	34	ng.h	ng.h	PROPN
aji-7	239	35	/	/	SYM
aji-7	239	36	ml	ml	NOUN
aji-7	239	37	.	.	PUNCT
aji-7	239	38	aleglitazar	aleglitazar	PROPN
aji-7	239	39	has	have	VERB
aji-7	239	40	more	more	ADV
aji-7	239	41	potent	potent	ADJ
aji-7	239	42	and	and	CCONJ
aji-7	239	43	has	have	VERB
aji-7	239	44	less	less	ADJ
aji-7	239	45	side	side	ADJ
aji-7	239	46	effect	effect	NOUN
aji-7	239	47	than	than	ADP
aji-7	239	48	diclofenac	diclofenac	NOUN
aji-7	239	49	.	.	PUNCT
aji-7	240	1	but	but	CCONJ
aji-7	240	2	in	in	ADP
aji-7	240	3	some	some	DET
aji-7	240	4	cases	case	NOUN
aji-7	240	5	aleglitazar	aleglitazar	NOUN
aji-7	240	6	must	must	AUX
aji-7	240	7	be	be	AUX
aji-7	240	8	monitored	monitor	VERB
aji-7	240	9	under	under	ADP
aji-7	240	10	the	the	DET
aji-7	240	11	supervision	supervision	NOUN
aji-7	240	12	of	of	ADP
aji-7	240	13	a	a	DET
aji-7	240	14	physician	physician	NOUN
aji-7	240	15	because	because	SCONJ
aji-7	240	16	it	it	PRON
aji-7	240	17	affects	affect	VERB
aji-7	240	18	the	the	DET
aji-7	240	19	safety	safety	NOUN
aji-7	240	20	and	and	CCONJ
aji-7	240	21	efficacy	efficacy	NOUN
aji-7	240	22	of	of	ADP
aji-7	240	23	warfarin	warfarin	NOUN
aji-7	240	24	and	and	CCONJ
aji-7	240	25	diuretics	diuretic	NOUN
aji-7	240	26	.	.	PUNCT
aji-7	241	1	consent	consent	NOUN
aji-7	241	2	it	it	PRON
aji-7	241	3	is	be	AUX
aji-7	241	4	not	not	PART
aji-7	241	5	applicable	applicable	ADJ
aji-7	241	6	.	.	PUNCT
aji-7	242	1	ethical	ethical	ADJ
aji-7	242	2	approval	approval	NOUN
aji-7	242	3	as	as	SCONJ
aji-7	242	4	per	per	ADP
aji-7	242	5	international	international	ADJ
aji-7	242	6	standard	standard	NOUN
aji-7	242	7	or	or	CCONJ
aji-7	242	8	university	university	NOUN
aji-7	242	9	standard	standard	ADJ
aji-7	242	10	ethical	ethical	ADJ
aji-7	242	11	approval	approval	NOUN
aji-7	242	12	has	have	AUX
aji-7	242	13	been	be	AUX
aji-7	242	14	collected	collect	VERB
aji-7	242	15	and	and	CCONJ
aji-7	242	16	preserved	preserve	VERB
aji-7	242	17	by	by	ADP
aji-7	242	18	the	the	DET
aji-7	242	19	authors	author	NOUN
aji-7	242	20	.	.	PUNCT
aji-7	243	1	competing	compete	VERB
aji-7	243	2	interests	interest	NOUN
aji-7	243	3	author	author	NOUN
aji-7	243	4	has	have	AUX
aji-7	243	5	declared	declare	VERB
aji-7	243	6	that	that	SCONJ
aji-7	243	7	no	no	DET
aji-7	243	8	competing	compete	VERB
aji-7	243	9	interests	interest	NOUN
aji-7	243	10	exist	exist	VERB
aji-7	243	11	.	.	PUNCT
aji-7	244	1	references	reference	NOUN
aji-7	244	2	1	1	NUM
aji-7	244	3	.	.	PUNCT
aji-7	244	4	massaro	massaro	PROPN
aji-7	244	5	m	m	PROPN
aji-7	244	6	,	,	PUNCT
aji-7	244	7	scoditti	scoditti	ADJ
aji-7	244	8	e	e	NOUN
aji-7	244	9	,	,	PUNCT
aji-7	244	10	pellegrino	pellegrino	PROPN
aji-7	244	11	m	m	PROPN
aji-7	244	12	,	,	PUNCT
aji-7	244	13	carluccio	carluccio	PROPN
aji-7	244	14	m	m	PROPN
aji-7	244	15	,	,	PUNCT
aji-7	244	16	calabriso	calabriso	PROPN
aji-7	244	17	n	n	CCONJ
aji-7	244	18	,	,	PUNCT
aji-7	244	19	wabitsch	wabitsch	PROPN
aji-7	244	20	m	m	PROPN
aji-7	244	21	,	,	PUNCT
aji-7	244	22	storelli	storelli	PROPN
aji-7	244	23	c	c	PROPN
aji-7	244	24	,	,	PUNCT
aji-7	244	25	wright	wright	PROPN
aji-7	244	26	m	m	PROPN
aji-7	244	27	,	,	PUNCT
aji-7	244	28	de	de	PROPN
aji-7	244	29	caterina	caterina	PROPN
aji-7	244	30	r.	r.	PROPN
aji-7	244	31	therapeutic	therapeutic	PROPN
aji-7	244	32	potential	potential	NOUN
aji-7	244	33	of	of	ADP
aji-7	244	34	the	the	DET
aji-7	244	35	dual	dual	ADJ
aji-7	244	36	peroxisome	peroxisome	NOUN
aji-7	244	37	proliferator	proliferator	NOUN
aji-7	244	38	activated	activate	VERB
aji-7	244	39	receptor	receptor	NOUN
aji-7	244	40	(	(	PUNCT
aji-7	244	41	ppar)î±/î³	ppar)î±/î³	ADJ
aji-7	244	42	agonist	agonist	NOUN
aji-7	244	43	aleglitazar	aleglitazar	NOUN
aji-7	244	44	in	in	ADP
aji-7	244	45	attenuating	attenuate	VERB
aji-7	244	46	tnf	tnf	PROPN
aji-7	244	47	-	-	PUNCT
aji-7	244	48	î±-mediated	î±-mediate	VERB
aji-7	244	49	inflammation	inflammation	NOUN
aji-7	244	50	and	and	CCONJ
aji-7	244	51	insulin	insulin	NOUN
aji-7	244	52	resistance	resistance	NOUN
aji-7	244	53	in	in	ADP
aji-7	244	54	human	human	ADJ
aji-7	244	55	adipocytes	adipocyte	NOUN
aji-7	244	56	.	.	PUNCT
aji-7	245	1	pharmacological	pharmacological	ADJ
aji-7	245	2	research	research	NOUN
aji-7	245	3	,	,	PUNCT
aji-7	246	1	[	[	X
aji-7	246	2	online	online	X
aji-7	246	3	]	]	X
aji-7	246	4	.	.	PUNCT
aji-7	247	1	2016;107:125	2016;107:125	X
aji-7	247	2	-	-	SYM
aji-7	247	3	136	136	NUM
aji-7	247	4	.	.	PUNCT
aji-7	248	1	available	available	ADJ
aji-7	248	2	:	:	PUNCT
aji-7	249	1	http://dx.doi.org/10.1016	http://dx.doi.org/10.1016	ADJ
aji-7	249	2	/	/	SYM
aji-7	249	3	j.phrs.2	j.phrs.2	NOUN
aji-7	249	4	016.02.027	016.02.027	PUNCT
aji-7	250	1	[	[	X
aji-7	250	2	accessed	access	VERB
aji-7	250	3	20	20	NUM
aji-7	250	4	mar	mar	PROPN
aji-7	250	5	.	.	PROPN
aji-7	250	6	2017	2017	NUM
aji-7	250	7	]	]	PUNCT
aji-7	250	8	2	2	X
aji-7	250	9	.	.	PUNCT
aji-7	250	10	type	type	NOUN
aji-7	250	11	2	2	NUM
aji-7	250	12	diabetes	diabetes	NOUN
aji-7	250	13	:	:	PUNCT
aji-7	250	14	overview	overview	NOUN
aji-7	250	15	.	.	PUNCT
aji-7	251	1	institute	institute	NOUN
aji-7	251	2	for	for	ADP
aji-7	251	3	quality	quality	NOUN
aji-7	251	4	and	and	CCONJ
aji-7	251	5	efficiency	efficiency	NOUN
aji-7	251	6	in	in	ADP
aji-7	251	7	health	health	NOUN
aji-7	251	8	care	care	NOUN
aji-7	251	9	(	(	PUNCT
aji-7	251	10	iqwig	iqwig	PROPN
aji-7	251	11	)	)	PUNCT
aji-7	251	12	.	.	PUNCT
aji-7	252	1	[	[	X
aji-7	252	2	online	online	X
aji-7	252	3	]	]	X
aji-7	252	4	;	;	PUNCT
aji-7	252	5	2014	2014	NUM
aji-7	252	6	.	.	PUNCT
aji-7	253	1	available	available	ADJ
aji-7	253	2	:	:	PUNCT
aji-7	253	3	https://www.ncbi.nlm.nih.gov	https://www.ncbi.nlm.nih.gov	ADJ
aji-7	253	4	/	/	SYM
aji-7	253	5	pub	pub	NOUN
aji-7	253	6	medhealth	medhealth	NOUN
aji-7	253	7	/	/	SYM
aji-7	253	8	pmh0072693/	pmh0072693/	PROPN
aji-7	253	9	[	[	X
aji-7	253	10	accessed	access	VERB
aji-7	253	11	20	20	NUM
aji-7	253	12	mar	mar	PROPN
aji-7	253	13	.	.	PROPN
aji-7	253	14	2017	2017	NUM
aji-7	253	15	]	]	PUNCT
aji-7	254	1	3	3	X
aji-7	254	2	.	.	X
aji-7	254	3	yue	yue	PROPN
aji-7	254	4	x	x	PROPN
aji-7	254	5	,	,	PUNCT
aji-7	254	6	li	li	PROPN
aji-7	254	7	s	s	PROPN
aji-7	254	8	,	,	PUNCT
aji-7	254	9	zhang	zhang	PROPN
aji-7	254	10	y	y	PROPN
aji-7	254	11	,	,	PUNCT
aji-7	254	12	yang	yang	PROPN
aji-7	254	13	z	z	PROPN
aji-7	254	14	,	,	PUNCT
aji-7	254	15	li	li	PROPN
aji-7	254	16	h.	h.	PROPN
aji-7	254	17	regulation	regulation	PROPN
aji-7	254	18	of	of	ADP
aji-7	254	19	diabetes	diabetes	NOUN
aji-7	254	20	-	-	PUNCT
aji-7	254	21	induced	induce	VERB
aji-7	254	22	in	in	ADP
aji-7	254	23	ammation	ammation	NOUN
aji-7	254	24	in	in	ADP
aji-7	254	25	macrophages	macrophage	NOUN
aji-7	254	26	by	by	ADP
aji-7	254	27	microrna26a-5p	microrna26a-5p	PROPN
aji-7	254	28	.	.	PUNCT
aji-7	255	1	[	[	X
aji-7	255	2	ebook	ebook	X
aji-7	255	3	]	]	X
aji-7	255	4	zhengzhou	zhengzhou	PROPN
aji-7	255	5	,	,	PUNCT
aji-7	255	6	china	china	PROPN
aji-7	255	7	.	.	PUNCT
aji-7	256	1	2016;1	2016;1	NUM
aji-7	256	2	.	.	PUNCT
aji-7	257	1	available	available	ADJ
aji-7	257	2	:	:	PUNCT
aji-7	257	3	http://ijcep.com	http://ijcep.com	NUM
aji-7	257	4	/	/	SYM
aji-7	257	5	files	file	NOUN
aji-7	257	6	/	/	SYM
aji-7	257	7	ijcep003429	ijcep003429	NOUN
aji-7	257	8	0.pdf	0.pdf	NOUN
aji-7	257	9	4	4	NUM
aji-7	257	10	.	.	PUNCT
aji-7	257	11	gan	gan	PROPN
aji-7	257	12	t.	t.	PROPN
aji-7	257	13	diclofenac	diclofenac	PROPN
aji-7	257	14	:	:	PUNCT
aji-7	257	15	an	an	DET
aji-7	257	16	update	update	NOUN
aji-7	257	17	on	on	ADP
aji-7	257	18	its	its	PRON
aji-7	257	19	mechanism	mechanism	NOUN
aji-7	257	20	of	of	ADP
aji-7	257	21	action	action	NOUN
aji-7	257	22	and	and	CCONJ
aji-7	257	23	safety	safety	NOUN
aji-7	257	24	profile	profile	NOUN
aji-7	257	25	.	.	PUNCT
aji-7	258	1	http://ijcep.com/files/ijcep0034290.pdf	http://ijcep.com/files/ijcep0034290.pdf	PROPN
aji-7	258	2	http://ijcep.com/files/ijcep0034290.pdf	http://ijcep.com/files/ijcep0034290.pdf	PROPN
aji-7	258	3	elsawy	elsawy	PROPN
aji-7	258	4	;	;	PUNCT
aji-7	258	5	aji	aji	NOUN
aji-7	258	6	,	,	PUNCT
aji-7	258	7	2(1	2(1	NUM
aji-7	258	8	):	):	PUNCT
aji-7	258	9	34	34	NUM
aji-7	258	10	-	-	SYM
aji-7	258	11	44	44	NUM
aji-7	258	12	,	,	PUNCT
aji-7	258	13	2019	2019	NUM
aji-7	258	14	;	;	PUNCT
aji-7	258	15	article	article	NOUN
aji-7	258	16	no.aji.53258	no.aji.53258	NOUN
aji-7	258	17	42	42	NUM
aji-7	258	18	current	current	ADJ
aji-7	258	19	medical	medical	ADJ
aji-7	258	20	research	research	NOUN
aji-7	258	21	and	and	CCONJ
aji-7	258	22	opinion	opinion	NOUN
aji-7	258	23	,	,	PUNCT
aji-7	258	24	[	[	X
aji-7	258	25	online	online	X
aji-7	258	26	]	]	X
aji-7	258	27	.	.	PUNCT
aji-7	259	1	2010;26(7):1715	2010;26(7):1715	NUM
aji-7	259	2	-	-	SYM
aji-7	259	3	1731	1731	NUM
aji-7	259	4	.	.	PUNCT
aji-7	260	1	available	available	ADJ
aji-7	260	2	:	:	PUNCT
aji-7	260	3	http://dx.doi.org/10.1185/030079	http://dx.doi.org/10.1185/030079	NOUN
aji-7	260	4	95.2010.486301	95.2010.486301	NUM
aji-7	260	5	[	[	X
aji-7	260	6	accessed	access	VERB
aji-7	260	7	20	20	NUM
aji-7	260	8	mar	mar	PROPN
aji-7	260	9	.	.	PROPN
aji-7	260	10	2017	2017	NUM
aji-7	260	11	]	]	PUNCT
aji-7	260	12	5	5	X
aji-7	260	13	.	.	PUNCT
aji-7	260	14	ruilope	ruilope	PROPN
aji-7	260	15	l	l	PROPN
aji-7	260	16	,	,	PUNCT
aji-7	260	17	hanefeld	hanefeld	PROPN
aji-7	260	18	m	m	PROPN
aji-7	260	19	,	,	PUNCT
aji-7	260	20	lincoff	lincoff	NOUN
aji-7	260	21	a	a	PRON
aji-7	260	22	,	,	PUNCT
aji-7	260	23	viberti	viberti	NOUN
aji-7	260	24	g	g	PROPN
aji-7	260	25	,	,	PUNCT
aji-7	260	26	meyer	meyer	PROPN
aji-7	260	27	-	-	PUNCT
aji-7	260	28	reigner	reigner	NOUN
aji-7	260	29	s	s	PROPN
aji-7	260	30	,	,	PUNCT
aji-7	260	31	mudie	mudie	PROPN
aji-7	260	32	n	n	CCONJ
aji-7	260	33	,	,	PUNCT
aji-7	261	1	wieczorek	wieczorek	PROPN
aji-7	261	2	kirk	kirk	PROPN
aji-7	261	3	d	d	PROPN
aji-7	261	4	,	,	PUNCT
aji-7	261	5	malmberg	malmberg	PROPN
aji-7	261	6	k	k	PROPN
aji-7	261	7	,	,	PUNCT
aji-7	261	8	herz	herz	PROPN
aji-7	261	9	m.	m.	NOUN
aji-7	261	10	effects	effect	NOUN
aji-7	261	11	of	of	ADP
aji-7	261	12	the	the	DET
aji-7	261	13	dual	dual	ADJ
aji-7	261	14	peroxisome	peroxisome	NOUN
aji-7	261	15	proliferator	proliferator	NOUN
aji-7	261	16	-	-	PUNCT
aji-7	261	17	activated	activate	VERB
aji-7	261	18	receptorî±/î³	receptorî±/î³	ADJ
aji-7	261	19	agonist	agonist	NOUN
aji-7	261	20	aleglitazar	aleglitazar	NOUN
aji-7	261	21	on	on	ADP
aji-7	261	22	renal	renal	ADJ
aji-7	261	23	function	function	NOUN
aji-7	261	24	in	in	ADP
aji-7	261	25	patients	patient	NOUN
aji-7	261	26	with	with	ADP
aji-7	261	27	stage	stage	NOUN
aji-7	261	28	3	3	NUM
aji-7	261	29	chronic	chronic	ADJ
aji-7	261	30	kidney	kidney	NOUN
aji-7	261	31	disease	disease	NOUN
aji-7	261	32	and	and	CCONJ
aji-7	261	33	type	type	NOUN
aji-7	261	34	2	2	NUM
aji-7	261	35	diabetes	diabetes	NOUN
aji-7	261	36	:	:	PUNCT
aji-7	261	37	a	a	DET
aji-7	261	38	phase	phase	NOUN
aji-7	261	39	iib	iib	NOUN
aji-7	261	40	;	;	PUNCT
aji-7	261	41	2014	2014	NUM
aji-7	261	42	.	.	PUNCT
aji-7	262	1	6	6	NUM
aji-7	262	2	.	.	X
aji-7	262	3	camargo	camargo	PROPN
aji-7	262	4	e	e	PROPN
aji-7	262	5	,	,	PUNCT
aji-7	262	6	launer	launer	PROPN
aji-7	262	7	l.	l.	PROPN
aji-7	262	8	metabolic	metabolic	PROPN
aji-7	262	9	dysfunction	dysfunction	NOUN
aji-7	262	10	as	as	ADP
aji-7	262	11	a	a	DET
aji-7	262	12	risk	risk	NOUN
aji-7	262	13	factor	factor	NOUN
aji-7	262	14	for	for	ADP
aji-7	262	15	stroke	stroke	NOUN
aji-7	262	16	obesity	obesity	NOUN
aji-7	262	17	,	,	PUNCT
aji-7	262	18	metabolic	metabolic	NOUN
aji-7	262	19	syndrome	syndrome	NOUN
aji-7	262	20	and	and	CCONJ
aji-7	262	21	diabetes	diabetes	NOUN
aji-7	262	22	mellitus	mellitus	NOUN
aji-7	262	23	.	.	PUNCT
aji-7	263	1	in	in	ADP
aji-7	263	2	:	:	PUNCT
aji-7	263	3	s.	s.	PROPN
aji-7	263	4	seshadri	seshadri	PROPN
aji-7	263	5	and	and	CCONJ
aji-7	263	6	s.	s.	PROPN
aji-7	263	7	debette	debette	PROPN
aji-7	263	8	,	,	PUNCT
aji-7	263	9	ed	ed	NOUN
aji-7	263	10	.	.	PROPN
aji-7	263	11	,	,	PUNCT
aji-7	263	12	risk	risk	NOUN
aji-7	263	13	factors	factor	NOUN
aji-7	263	14	for	for	ADP
aji-7	263	15	cerebrovascular	cerebrovascular	ADJ
aji-7	263	16	disease	disease	NOUN
aji-7	263	17	and	and	CCONJ
aji-7	263	18	stroke	stroke	NOUN
aji-7	263	19	,	,	PUNCT
aji-7	263	20	1	1	NUM
aji-7	263	21	st	st	NOUN
aji-7	263	22	ed	ed	NOUN
aji-7	263	23	.	.	PUNCT
aji-7	264	1	[	[	X
aji-7	264	2	online	online	X
aji-7	264	3	]	]	X
aji-7	264	4	united	united	PROPN
aji-7	264	5	states	states	PROPN
aji-7	264	6	of	of	ADP
aji-7	264	7	america	america	PROPN
aji-7	264	8	:	:	PUNCT
aji-7	264	9	oxford	oxford	PROPN
aji-7	264	10	university	university	PROPN
aji-7	264	11	press	press	NOUN
aji-7	264	12	;	;	PUNCT
aji-7	264	13	2016	2016	NUM
aji-7	264	14	.	.	PUNCT
aji-7	265	1	7	7	X
aji-7	265	2	.	.	X
aji-7	265	3	bariatric	bariatric	ADJ
aji-7	265	4	lifestyle	lifestyle	NOUN
aji-7	265	5	diet	diet	PROPN
aji-7	265	6	.	.	PUNCT
aji-7	266	1	what	what	PRON
aji-7	266	2	is	be	AUX
aji-7	266	3	body	body	NOUN
aji-7	266	4	mass	mass	NOUN
aji-7	266	5	index	index	NOUN
aji-7	266	6	?	?	PUNCT
aji-7	267	1	bariatric	bariatric	ADJ
aji-7	267	2	lifestyle	lifestyle	NOUN
aji-7	267	3	diet	diet	NOUN
aji-7	267	4	.	.	PUNCT
aji-7	268	1	[	[	X
aji-7	268	2	online	online	X
aji-7	268	3	]	]	X
aji-7	268	4	;	;	PUNCT
aji-7	268	5	2017	2017	NUM
aji-7	268	6	.	.	PUNCT
aji-7	269	1	available	available	ADJ
aji-7	269	2	:	:	PUNCT
aji-7	269	3	https://www.bariatriclifestylediet.c	https://www.bariatriclifestylediet.c	ADV
aji-7	269	4	om	om	PROPN
aji-7	269	5	/	/	SYM
aji-7	269	6	blog	blog	NOUN
aji-7	269	7	/	/	SYM
aji-7	269	8	body	body	NOUN
aji-7	269	9	-	-	PUNCT
aji-7	269	10	mass	mass	NOUN
aji-7	269	11	-	-	PUNCT
aji-7	269	12	index/	index/	NUM
aji-7	270	1	[	[	X
aji-7	270	2	accessed	access	VERB
aji-7	270	3	10	10	NUM
aji-7	270	4	mar	mar	PROPN
aji-7	270	5	.	.	PROPN
aji-7	270	6	2017	2017	NUM
aji-7	270	7	]	]	PUNCT
aji-7	270	8	8	8	NUM
aji-7	270	9	.	.	PUNCT
aji-7	271	1	tsatsoulis	tsatsoulis	PROPN
aji-7	271	2	a	a	DET
aji-7	271	3	,	,	PUNCT
aji-7	271	4	mantzaris	mantzaris	PROPN
aji-7	271	5	m	m	PROPN
aji-7	271	6	,	,	PUNCT
aji-7	271	7	bellou	bellou	PROPN
aji-7	271	8	s	s	PROPN
aji-7	271	9	,	,	PUNCT
aji-7	271	10	andrikoula	andrikoula	NOUN
aji-7	271	11	m.	m.	NOUN
aji-7	271	12	insulin	insulin	NOUN
aji-7	271	13	resistance	resistance	NOUN
aji-7	271	14	:	:	PUNCT
aji-7	271	15	an	an	DET
aji-7	271	16	adaptive	adaptive	ADJ
aji-7	271	17	mechanism	mechanism	NOUN
aji-7	271	18	becomes	become	VERB
aji-7	271	19	maladaptive	maladaptive	ADJ
aji-7	271	20	in	in	ADP
aji-7	271	21	the	the	DET
aji-7	271	22	current	current	ADJ
aji-7	271	23	environment	environment	NOUN
aji-7	271	24	—	—	PUNCT
aji-7	271	25	an	an	DET
aji-7	271	26	evolutionary	evolutionary	ADJ
aji-7	271	27	perspective	perspective	NOUN
aji-7	271	28	.	.	PUNCT
aji-7	272	1	metabolism	metabolism	NOUN
aji-7	272	2	.	.	PUNCT
aji-7	273	1	2013;62(5):622	2013;62(5):622	NUM
aji-7	273	2	-	-	PUNCT
aji-7	273	3	633	633	NUM
aji-7	273	4	.	.	PUNCT
aji-7	274	1	9	9	X
aji-7	274	2	.	.	X
aji-7	274	3	lihn	lihn	VERB
aji-7	274	4	a	a	PRON
aji-7	274	5	,	,	PUNCT
aji-7	274	6	pedersen	pedersen	PROPN
aji-7	274	7	s	s	PROPN
aji-7	274	8	,	,	PUNCT
aji-7	274	9	richelsen	richelsen	PROPN
aji-7	274	10	b.	b.	PROPN
aji-7	274	11	adiponectin	adiponectin	NOUN
aji-7	274	12	:	:	PUNCT
aji-7	274	13	action	action	NOUN
aji-7	274	14	,	,	PUNCT
aji-7	274	15	regulation	regulation	NOUN
aji-7	274	16	and	and	CCONJ
aji-7	274	17	association	association	NOUN
aji-7	274	18	to	to	ADP
aji-7	274	19	insulin	insulin	NOUN
aji-7	274	20	sensitivity	sensitivity	NOUN
aji-7	274	21	.	.	PUNCT
aji-7	275	1	obesity	obesity	NOUN
aji-7	275	2	reviews	review	NOUN
aji-7	275	3	,	,	PUNCT
aji-7	275	4	[	[	X
aji-7	275	5	online	online	X
aji-7	275	6	]	]	X
aji-7	275	7	.	.	PUNCT
aji-7	276	1	2005;6(1):13	2005;6(1):13	NUM
aji-7	276	2	-	-	SYM
aji-7	276	3	21	21	NUM
aji-7	276	4	.	.	PUNCT
aji-7	277	1	available	available	ADJ
aji-7	277	2	:	:	PUNCT
aji-7	277	3	http://dx.doi.org/10.1111	http://dx.doi.org/10.1111	NOUN
aji-7	277	4	/	/	SYM
aji-7	277	5	j.1467789x.2005.00159.x	j.1467789x.2005.00159.x	NOUN
aji-7	278	1	[	[	X
aji-7	278	2	accessed	access	VERB
aji-7	278	3	26	26	NUM
aji-7	278	4	mar	mar	PROPN
aji-7	278	5	.	.	PROPN
aji-7	278	6	2017	2017	NUM
aji-7	278	7	]	]	PUNCT
aji-7	278	8	10	10	NUM
aji-7	278	9	.	.	PUNCT
aji-7	279	1	gestational	gestational	ADJ
aji-7	279	2	diabetes	diabetes	NOUN
aji-7	279	3	mellitus	mellitus	NOUN
aji-7	279	4	.	.	PUNCT
aji-7	280	1	diabetes	diabetes	NOUN
aji-7	280	2	care	care	NOUN
aji-7	280	3	.	.	PUNCT
aji-7	281	1	2003;26(supplement	2003;26(supplement	PROPN
aji-7	281	2	1):s103	1):s103	NUM
aji-7	281	3	-	-	PUNCT
aji-7	281	4	s105	s105	PROPN
aji-7	281	5	.	.	NOUN
aji-7	281	6	11	11	NUM
aji-7	281	7	.	.	PUNCT
aji-7	282	1	lillioja	lillioja	PROPN
aji-7	282	2	s	s	PROPN
aji-7	282	3	,	,	PUNCT
aji-7	282	4	mott	mott	PROPN
aji-7	282	5	d	d	PROPN
aji-7	282	6	,	,	PUNCT
aji-7	282	7	spraul	spraul	PROPN
aji-7	282	8	m	m	PROPN
aji-7	282	9	,	,	PUNCT
aji-7	282	10	ferraro	ferraro	PROPN
aji-7	282	11	r	r	NOUN
aji-7	282	12	,	,	PUNCT
aji-7	282	13	foley	foley	PROPN
aji-7	282	14	j	j	PROPN
aji-7	282	15	,	,	PUNCT
aji-7	282	16	ravussin	ravussin	NOUN
aji-7	282	17	e	e	NOUN
aji-7	282	18	,	,	PUNCT
aji-7	282	19	knowler	knowler	PROPN
aji-7	282	20	w	w	PROPN
aji-7	282	21	,	,	PUNCT
aji-7	282	22	bennett	bennett	PROPN
aji-7	282	23	p	p	PROPN
aji-7	282	24	,	,	PUNCT
aji-7	282	25	bogardus	bogardus	PROPN
aji-7	282	26	c.	c.	PROPN
aji-7	282	27	insulin	insulin	PROPN
aji-7	282	28	resistance	resistance	NOUN
aji-7	282	29	and	and	CCONJ
aji-7	282	30	insulin	insulin	NOUN
aji-7	282	31	secretory	secretory	ADJ
aji-7	282	32	dysfunction	dysfunction	NOUN
aji-7	282	33	as	as	ADP
aji-7	282	34	precursors	precursor	NOUN
aji-7	282	35	of	of	ADP
aji-7	282	36	non	non	ADJ
aji-7	282	37	-	-	ADJ
aji-7	282	38	insulin	insulin	ADJ
aji-7	282	39	-	-	PUNCT
aji-7	282	40	dependent	dependent	ADJ
aji-7	282	41	diabetes	diabetes	NOUN
aji-7	282	42	mellitus	mellitus	NOUN
aji-7	282	43	:	:	PUNCT
aji-7	282	44	prospective	prospective	ADJ
aji-7	282	45	studies	study	NOUN
aji-7	282	46	of	of	ADP
aji-7	282	47	pima	pima	PROPN
aji-7	282	48	indians	indians	PROPN
aji-7	282	49	.	.	PUNCT
aji-7	283	1	new	new	PROPN
aji-7	283	2	england	england	PROPN
aji-7	283	3	journal	journal	PROPN
aji-7	283	4	of	of	ADP
aji-7	283	5	medicine	medicine	NOUN
aji-7	283	6	,	,	PUNCT
aji-7	284	1	[	[	X
aji-7	284	2	online	online	X
aji-7	284	3	]	]	X
aji-7	284	4	.	.	PUNCT
aji-7	285	1	1993;329(27):1988	1993;329(27):1988	NUM
aji-7	285	2	-	-	SYM
aji-7	285	3	1992	1992	NUM
aji-7	285	4	.	.	PUNCT
aji-7	286	1	available	available	ADJ
aji-7	286	2	:	:	PUNCT
aji-7	286	3	http://dx.doi.org/10.1056	http://dx.doi.org/10.1056	NOUN
aji-7	286	4	/	/	SYM
aji-7	286	5	nejm19	nejm19	NOUN
aji-7	286	6	9312303292703	9312303292703	NUM
aji-7	286	7	[	[	X
aji-7	286	8	accessed	access	VERB
aji-7	286	9	25	25	NUM
aji-7	286	10	feb	feb	NOUN
aji-7	286	11	.	.	PROPN
aji-7	286	12	2017	2017	NUM
aji-7	286	13	]	]	PUNCT
aji-7	286	14	12	12	NUM
aji-7	286	15	.	.	PUNCT
aji-7	287	1	alberti	alberti	PROPN
aji-7	287	2	k	k	PROPN
aji-7	287	3	,	,	PUNCT
aji-7	287	4	zimmet	zimmet	NOUN
aji-7	287	5	p.	p.	NOUN
aji-7	287	6	definition	definition	NOUN
aji-7	287	7	,	,	PUNCT
aji-7	287	8	diagnosis	diagnosis	NOUN
aji-7	287	9	and	and	CCONJ
aji-7	287	10	classification	classification	NOUN
aji-7	287	11	of	of	ADP
aji-7	287	12	diabetes	diabetes	NOUN
aji-7	287	13	mellitus	mellitus	NOUN
aji-7	287	14	and	and	CCONJ
aji-7	287	15	its	its	PRON
aji-7	287	16	complications	complication	NOUN
aji-7	287	17	.	.	PUNCT
aji-7	288	1	part	part	NOUN
aji-7	288	2	1	1	NUM
aji-7	288	3	:	:	PUNCT
aji-7	288	4	diagnosis	diagnosis	NOUN
aji-7	288	5	and	and	CCONJ
aji-7	288	6	classification	classification	NOUN
aji-7	288	7	of	of	ADP
aji-7	288	8	diabetes	diabetes	NOUN
aji-7	288	9	mellitus	mellitus	NOUN
aji-7	288	10	.	.	PUNCT
aji-7	289	1	provisional	provisional	ADJ
aji-7	289	2	report	report	NOUN
aji-7	289	3	of	of	ADP
aji-7	289	4	a	a	DET
aji-7	289	5	who	who	PRON
aji-7	289	6	consultation	consultation	NOUN
aji-7	289	7	.	.	PUNCT
aji-7	290	1	diabetic	diabetic	ADJ
aji-7	290	2	medicine	medicine	NOUN
aji-7	290	3	,	,	PUNCT
aji-7	291	1	[	[	X
aji-7	291	2	online	online	X
aji-7	291	3	]	]	X
aji-7	291	4	.	.	PUNCT
aji-7	292	1	1998;15(7	1998;15(7	NUM
aji-7	292	2	):	):	PUNCT
aji-7	292	3	539	539	NUM
aji-7	292	4	-	-	SYM
aji-7	292	5	553	553	NUM
aji-7	292	6	.	.	PUNCT
aji-7	293	1	available	available	ADJ
aji-7	293	2	:	:	PUNCT
aji-7	293	3	http://dx.doi.org/10.1002/(sici)10	http://dx.doi.org/10.1002/(sici)10	PROPN
aji-7	293	4	96	96	NUM
aji-7	293	5	-	-	PUNCT
aji-7	293	6	9136(199807)15:7<539::aiddia668>3.0.co;2	9136(199807)15:7<539::aiddia668>3.0.co;2	NUM
aji-7	293	7	-	-	PUNCT
aji-7	293	8	s	s	NOUN
aji-7	294	1	[	[	PUNCT
aji-7	294	2	accessed	access	VERB
aji-7	294	3	25	25	NUM
aji-7	294	4	feb	feb	NOUN
aji-7	294	5	.	.	PROPN
aji-7	294	6	2017	2017	NUM
aji-7	294	7	]	]	PUNCT
aji-7	294	8	13	13	NUM
aji-7	294	9	.	.	PUNCT
aji-7	295	1	wahl	wahl	PROPN
aji-7	295	2	p	p	NOUN
aji-7	295	3	,	,	PUNCT
aji-7	295	4	savage	savage	NOUN
aji-7	295	5	p	p	NOUN
aji-7	295	6	,	,	PUNCT
aji-7	295	7	psaty	psaty	NOUN
aji-7	295	8	b	b	NOUN
aji-7	295	9	,	,	PUNCT
aji-7	295	10	orchard	orchard	NOUN
aji-7	295	11	t	t	PROPN
aji-7	295	12	,	,	PUNCT
aji-7	295	13	robbins	robbins	PROPN
aji-7	295	14	j	j	PROPN
aji-7	295	15	,	,	PUNCT
aji-7	295	16	tracy	tracy	PROPN
aji-7	295	17	r.	r.	PROPN
aji-7	295	18	diabetes	diabetes	PROPN
aji-7	295	19	in	in	ADP
aji-7	295	20	older	old	ADJ
aji-7	295	21	adults	adult	NOUN
aji-7	295	22	:	:	PUNCT
aji-7	295	23	comparison	comparison	NOUN
aji-7	295	24	of	of	ADP
aji-7	295	25	1997	1997	NUM
aji-7	295	26	american	american	ADJ
aji-7	295	27	diabetes	diabetes	PROPN
aji-7	295	28	association	association	NOUN
aji-7	295	29	classification	classification	NOUN
aji-7	295	30	of	of	ADP
aji-7	295	31	diabetes	diabetes	NOUN
aji-7	295	32	mellitus	mellitus	NOUN
aji-7	295	33	with	with	ADP
aji-7	295	34	1985	1985	NUM
aji-7	295	35	who	who	PRON
aji-7	295	36	classification	classification	VERB
aji-7	295	37	.	.	PUNCT
aji-7	296	1	the	the	DET
aji-7	296	2	lancet	lancet	NOUN
aji-7	296	3	,	,	PUNCT
aji-7	297	1	[	[	X
aji-7	297	2	online	online	X
aji-7	297	3	]	]	X
aji-7	297	4	.	.	PUNCT
aji-7	298	1	1998;352(9133):1012	1998;352(9133):1012	NUM
aji-7	298	2	-	-	SYM
aji-7	298	3	1015	1015	NUM
aji-7	298	4	.	.	PUNCT
aji-7	299	1	available	available	ADJ
aji-7	299	2	:	:	PUNCT
aji-7	299	3	http://dx.doi.org/10.1016	http://dx.doi.org/10.1016	NOUN
aji-7	299	4	/	/	SYM
aji-7	299	5	s01406736(98)04055	s01406736(98)04055	NOUN
aji-7	299	6	-	-	PUNCT
aji-7	299	7	0	0	PUNCT
aji-7	300	1	[	[	X
aji-7	300	2	accessed	access	VERB
aji-7	300	3	25	25	NUM
aji-7	300	4	feb	feb	NOUN
aji-7	300	5	.	.	PROPN
aji-7	300	6	2017	2017	NUM
aji-7	300	7	]	]	PUNCT
aji-7	300	8	14	14	NUM
aji-7	300	9	.	.	PUNCT
aji-7	301	1	ramachandran	ramachandran	PROPN
aji-7	301	2	a	a	PRON
aji-7	301	3	,	,	PUNCT
aji-7	301	4	snehalatha	snehalatha	VERB
aji-7	301	5	c	c	X
aji-7	301	6	,	,	PUNCT
aji-7	301	7	latha	latha	PROPN
aji-7	301	8	e	e	NOUN
aji-7	301	9	,	,	PUNCT
aji-7	301	10	vijay	vijay	NOUN
aji-7	301	11	v.	v.	ADP
aji-7	301	12	evaluation	evaluation	NOUN
aji-7	301	13	of	of	ADP
aji-7	301	14	the	the	DET
aji-7	301	15	use	use	NOUN
aji-7	301	16	of	of	ADP
aji-7	301	17	fasting	fast	VERB
aji-7	301	18	plasma	plasma	NOUN
aji-7	301	19	glucose	glucose	NOUN
aji-7	301	20	as	as	ADP
aji-7	301	21	a	a	DET
aji-7	301	22	new	new	ADJ
aji-7	301	23	diagnostic	diagnostic	ADJ
aji-7	301	24	criterion	criterion	NOUN
aji-7	301	25	for	for	ADP
aji-7	301	26	diabetes	diabetes	NOUN
aji-7	301	27	in	in	ADP
aji-7	301	28	asian	asian	PROPN
aji-7	301	29	indian	indian	ADJ
aji-7	301	30	population	population	NOUN
aji-7	301	31	.	.	PUNCT
aji-7	302	1	diabetes	diabetes	NOUN
aji-7	302	2	;	;	PUNCT
aji-7	302	3	1998	1998	NUM
aji-7	302	4	.	.	PUNCT
aji-7	303	1	15	15	NUM
aji-7	303	2	.	.	PUNCT
aji-7	304	1	furman	furman	PROPN
aji-7	304	2	bl	bl	PROPN
aji-7	304	3	.	.	PUNCT
aji-7	304	4	streptozotocin	streptozotocin	PROPN
aji-7	304	5	-	-	PUNCT
aji-7	304	6	induced	induce	VERB
aji-7	304	7	diabetic	diabetic	ADJ
aji-7	304	8	models	model	NOUN
aji-7	304	9	in	in	ADP
aji-7	304	10	mice	mouse	NOUN
aji-7	304	11	and	and	CCONJ
aji-7	304	12	rats	rat	NOUN
aji-7	304	13	.	.	PUNCT
aji-7	305	1	curr	curr	AUX
aji-7	305	2	.	.	PUNCT
aji-7	305	3	protoc	protoc	VERB
aji-7	305	4	.	.	PUNCT
aji-7	306	1	pharmacol	pharmacol	NOUN
aji-7	306	2	.	.	PUNCT
aji-7	307	1	2015;70:5.47.15.47.20	2015;70:5.47.15.47.20	NUM
aji-7	307	2	.	.	PUNCT
aji-7	307	3	doi	doi	NOUN
aji-7	307	4	:	:	PUNCT
aji-7	307	5	10.1002/0471141755.ph0547s70	10.1002/0471141755.ph0547s70	NUM
aji-7	307	6	16	16	NUM
aji-7	307	7	.	.	PUNCT
aji-7	308	1	estrany	estrany	PROPN
aji-7	308	2	m	m	PROPN
aji-7	308	3	,	,	PUNCT
aji-7	308	4	proenza	proenza	PROPN
aji-7	308	5	a	a	NOUN
aji-7	308	6	,	,	PUNCT
aji-7	308	7	gianotti	gianotti	NOUN
aji-7	308	8	m	m	PROPN
aji-7	308	9	,	,	PUNCT
aji-7	308	10	lladó	lladó	PROPN
aji-7	308	11	i.	i.	PROPN
aji-7	308	12	high	high	ADJ
aji-7	308	13	-	-	PUNCT
aji-7	308	14	fat	fat	NOUN
aji-7	308	15	diet	diet	NOUN
aji-7	308	16	feeding	feeding	NOUN
aji-7	308	17	induces	induce	VERB
aji-7	308	18	sexdependent	sexdependent	ADJ
aji-7	308	19	changes	change	NOUN
aji-7	308	20	in	in	ADP
aji-7	308	21	inflammatory	inflammatory	ADJ
aji-7	308	22	and	and	CCONJ
aji-7	308	23	insulin	insulin	NOUN
aji-7	308	24	sensitivity	sensitivity	NOUN
aji-7	308	25	profiles	profile	NOUN
aji-7	308	26	of	of	ADP
aji-7	308	27	rat	rat	NOUN
aji-7	308	28	adipose	adipose	ADJ
aji-7	308	29	tissue	tissue	NOUN
aji-7	308	30	.	.	PUNCT
aji-7	309	1	cell	cell	NOUN
aji-7	309	2	biochemistry	biochemistry	NOUN
aji-7	309	3	and	and	CCONJ
aji-7	309	4	function	function	NOUN
aji-7	309	5	.	.	PUNCT
aji-7	310	1	2012;31(6):504	2012;31(6):504	NUM
aji-7	310	2	-	-	SYM
aji-7	310	3	510	510	NUM
aji-7	310	4	.	.	PUNCT
aji-7	310	5	17	17	NUM
aji-7	310	6	.	.	PUNCT
aji-7	311	1	sakata	sakata	PROPN
aji-7	311	2	n	n	CCONJ
aji-7	311	3	,	,	PUNCT
aji-7	311	4	yoshimatsu	yoshimatsu	NOUN
aji-7	311	5	g	g	PROPN
aji-7	311	6	,	,	PUNCT
aji-7	311	7	tsuchiya	tsuchiya	PROPN
aji-7	311	8	h	h	PROPN
aji-7	311	9	,	,	PUNCT
aji-7	311	10	egawa	egawa	PROPN
aji-7	311	11	s	s	PART
aji-7	311	12	,	,	PUNCT
aji-7	311	13	unno	unno	ADJ
aji-7	311	14	m.	m.	NOUN
aji-7	311	15	animal	animal	NOUN
aji-7	311	16	models	model	NOUN
aji-7	311	17	of	of	ADP
aji-7	311	18	diabetes	diabetes	NOUN
aji-7	311	19	mellitus	mellitus	NOUN
aji-7	311	20	for	for	ADP
aji-7	311	21	islet	islet	NOUN
aji-7	311	22	transplantation	transplantation	NOUN
aji-7	311	23	.	.	PUNCT
aji-7	312	1	experimental	experimental	ADJ
aji-7	312	2	diabetes	diabetes	NOUN
aji-7	312	3	research	research	NOUN
aji-7	312	4	.	.	PUNCT
aji-7	313	1	2012;111	2012;111	NUM
aji-7	313	2	.	.	PUNCT
aji-7	314	1	18	18	NUM
aji-7	314	2	.	.	PUNCT
aji-7	315	1	winyard	winyard	PROPN
aji-7	315	2	p	p	NOUN
aji-7	315	3	,	,	PUNCT
aji-7	315	4	willoughby	willoughby	PROPN
aji-7	315	5	d.	d.	PROPN
aji-7	315	6	inflammation	inflammation	PROPN
aji-7	315	7	protocols	protocols	PROPN
aji-7	315	8	.	.	PUNCT
aji-7	316	1	totowa	totowa	PROPN
aji-7	316	2	,	,	PUNCT
aji-7	316	3	n.j	n.j	PROPN
aji-7	316	4	.	.	PROPN
aji-7	316	5	:	:	PUNCT
aji-7	317	1	humana	humana	PROPN
aji-7	317	2	press	press	PROPN
aji-7	317	3	;	;	PUNCT
aji-7	317	4	2003	2003	NUM
aji-7	317	5	.	.	PUNCT
aji-7	318	1	19	19	NUM
aji-7	318	2	.	.	PUNCT
aji-7	318	3	pietrosimone	pietrosimone	PROPN
aji-7	318	4	,	,	PUNCT
aji-7	318	5	kathryn	kathryn	PROPN
aji-7	318	6	m	m	PROPN
aji-7	318	7	,	,	PUNCT
aji-7	318	8	et	et	PROPN
aji-7	318	9	al	al	PROPN
aji-7	318	10	.	.	PROPN
aji-7	318	11	measure	measure	NOUN
aji-7	318	12	.	.	PUNCT
aji-7	319	1	the	the	DET
aji-7	319	2	hind	hind	NOUN
aji-7	319	3	paws	paw	NOUN
aji-7	319	4	;	;	PUNCT
aji-7	319	5	2017	2017	NUM
aji-7	319	6	.	.	PUNCT
aji-7	320	1	(	(	PUNCT
aji-7	320	2	web	web	NOUN
aji-7	320	3	.	.	PROPN
aji-7	320	4	27	27	NUM
aji-7	320	5	feb	feb	NOUN
aji-7	320	6	.	.	PROPN
aji-7	320	7	2017	2017	NUM
aji-7	320	8	)	)	PUNCT
aji-7	320	9	20	20	NUM
aji-7	320	10	.	.	PUNCT
aji-7	321	1	odabasoglu	odabasoglu	PROPN
aji-7	321	2	f	f	PROPN
aji-7	321	3	,	,	PUNCT
aji-7	321	4	halici	halici	PROPN
aji-7	321	5	z	z	PROPN
aji-7	321	6	,	,	PUNCT
aji-7	321	7	aygun	aygun	ADJ
aji-7	321	8	h	h	NOUN
aji-7	321	9	,	,	PUNCT
aji-7	321	10	halici	halici	PROPN
aji-7	321	11	m	m	PROPN
aji-7	321	12	,	,	PUNCT
aji-7	321	13	atalay	atalay	VERB
aji-7	321	14	f	f	X
aji-7	321	15	,	,	PUNCT
aji-7	321	16	cakir	cakir	VERB
aji-7	321	17	a	a	DET
aji-7	321	18	,	,	PUNCT
aji-7	321	19	cadirci	cadirci	ADJ
aji-7	321	20	e	e	NOUN
aji-7	321	21	,	,	PUNCT
aji-7	321	22	bayir	bayir	NOUN
aji-7	321	23	y	y	PROPN
aji-7	321	24	,	,	PUNCT
aji-7	321	25	suleyman	suleyman	PROPN
aji-7	321	26	h.	h.	PROPN
aji-7	321	27	î±-lipoic	î±-lipoic	PROPN
aji-7	321	28	acid	acid	PROPN
aji-7	321	29	has	have	VERB
aji-7	321	30	antiinflammatory	antiinflammatory	NOUN
aji-7	321	31	and	and	CCONJ
aji-7	321	32	anti	anti	ADJ
aji-7	321	33	-	-	ADJ
aji-7	321	34	oxidative	oxidative	ADJ
aji-7	321	35	properties	property	NOUN
aji-7	321	36	:	:	PUNCT
aji-7	321	37	an	an	DET
aji-7	321	38	experimental	experimental	ADJ
aji-7	321	39	study	study	NOUN
aji-7	321	40	in	in	ADP
aji-7	321	41	rats	rat	NOUN
aji-7	321	42	with	with	ADP
aji-7	321	43	carrageenan	carrageenan	NOUN
aji-7	321	44	-	-	PUNCT
aji-7	321	45	induced	induce	VERB
aji-7	321	46	acute	acute	ADJ
aji-7	321	47	and	and	CCONJ
aji-7	321	48	cotton	cotton	NOUN
aji-7	321	49	pellet	pellet	NOUN
aji-7	321	50	-	-	PUNCT
aji-7	321	51	induced	induce	VERB
aji-7	321	52	chronic	chronic	ADJ
aji-7	321	53	inflammations	inflammation	NOUN
aji-7	321	54	.	.	PUNCT
aji-7	322	1	british	british	ADJ
aji-7	322	2	journal	journal	PROPN
aji-7	322	3	of	of	ADP
aji-7	322	4	nutrition	nutrition	NOUN
aji-7	322	5	,	,	PUNCT
aji-7	323	1	[	[	X
aji-7	323	2	online	online	X
aji-7	323	3	]	]	X
aji-7	323	4	.	.	PUNCT
aji-7	324	1	2010;105(01):31	2010;105(01):31	NUM
aji-7	324	2	-	-	SYM
aji-7	324	3	43	43	NUM
aji-7	324	4	.	.	PUNCT
aji-7	325	1	available	available	ADJ
aji-7	325	2	:	:	PUNCT
aji-7	325	3	http://dx.doi.org/10.1017	http://dx.doi.org/10.1017	X
aji-7	325	4	/	/	SYM
aji-7	325	5	s00071	s00071	ADJ
aji-7	325	6	14510003107	14510003107	NUM
aji-7	325	7	[	[	X
aji-7	325	8	accessed	access	VERB
aji-7	325	9	28	28	NUM
aji-7	325	10	mar	mar	PROPN
aji-7	325	11	.	.	PROPN
aji-7	325	12	2017	2017	NUM
aji-7	325	13	]	]	PUNCT
aji-7	325	14	elsawy	elsawy	NOUN
aji-7	325	15	;	;	PUNCT
aji-7	325	16	aji	aji	NOUN
aji-7	325	17	,	,	PUNCT
aji-7	325	18	2(1	2(1	NUM
aji-7	325	19	):	):	PUNCT
aji-7	325	20	34	34	NUM
aji-7	325	21	-	-	SYM
aji-7	325	22	44	44	NUM
aji-7	325	23	,	,	PUNCT
aji-7	325	24	2019	2019	NUM
aji-7	325	25	;	;	PUNCT
aji-7	325	26	article	article	NOUN
aji-7	325	27	no.aji.53258	no.aji.53258	NOUN
aji-7	325	28	43	43	NUM
aji-7	325	29	21	21	NUM
aji-7	325	30	.	.	PUNCT
aji-7	326	1	singh	singh	PROPN
aji-7	326	2	m	m	PROPN
aji-7	326	3	,	,	PUNCT
aji-7	326	4	kumar	kumar	PROPN
aji-7	326	5	v	v	PROPN
aji-7	326	6	,	,	PUNCT
aji-7	326	7	singh	singh	PROPN
aji-7	326	8	i	i	PROPN
aji-7	326	9	,	,	PUNCT
aji-7	326	10	gauttam	gauttam	NOUN
aji-7	326	11	v	v	PROPN
aji-7	326	12	,	,	PUNCT
aji-7	326	13	kalia	kalia	PROPN
aji-7	326	14	a.	a.	NOUN
aji-7	326	15	anti	anti	ADJ
aji-7	326	16	-	-	ADJ
aji-7	326	17	inflammatory	inflammatory	ADJ
aji-7	326	18	activity	activity	NOUN
aji-7	326	19	of	of	ADP
aji-7	326	20	aqueous	aqueous	ADJ
aji-7	326	21	extract	extract	NOUN
aji-7	326	22	of	of	ADP
aji-7	326	23	mirabilis	mirabilis	PROPN
aji-7	326	24	jalapa	jalapa	PROPN
aji-7	326	25	linn	linn	PROPN
aji-7	326	26	.	.	PUNCT
aji-7	327	1	leaves	leaves	PROPN
aji-7	327	2	.	.	PUNCT
aji-7	328	1	pharmacognosy	pharmacognosy	PROPN
aji-7	328	2	research	research	NOUN
aji-7	328	3	,	,	PUNCT
aji-7	329	1	[	[	X
aji-7	329	2	online	online	X
aji-7	329	3	]	]	X
aji-7	329	4	.	.	PUNCT
aji-7	330	1	2010;2(6):364	2010;2(6):364	X
aji-7	330	2	.	.	PUNCT
aji-7	331	1	available	available	ADJ
aji-7	331	2	:	:	PUNCT
aji-7	332	1	http://dx.doi.org/10.4103/09748490.75456	http://dx.doi.org/10.4103/09748490.75456	PROPN
aji-7	332	2	[	[	X
aji-7	332	3	accessed	access	VERB
aji-7	332	4	28	28	NUM
aji-7	332	5	mar	mar	PROPN
aji-7	332	6	.	.	PROPN
aji-7	332	7	2017	2017	NUM
aji-7	332	8	]	]	PUNCT
aji-7	333	1	22	22	NUM
aji-7	333	2	.	.	PUNCT
aji-7	334	1	botz	botz	PROPN
aji-7	334	2	b	b	PROPN
aji-7	334	3	,	,	PUNCT
aji-7	334	4	bölcskei	bölcskei	PROPN
aji-7	334	5	k	k	PROPN
aji-7	334	6	,	,	PUNCT
aji-7	334	7	kemény	kemény	PROPN
aji-7	334	8	á	á	PROPN
aji-7	334	9	,	,	PUNCT
aji-7	334	10	sándor	sándor	PROPN
aji-7	334	11	z	z	PROPN
aji-7	334	12	,	,	PUNCT
aji-7	334	13	tékus	tékus	NOUN
aji-7	334	14	v	v	NOUN
aji-7	334	15	,	,	PUNCT
aji-7	334	16	sétáló	sétáló	NOUN
aji-7	334	17	g	g	NOUN
aji-7	334	18	,	,	PUNCT
aji-7	334	19	csepregi	csepregi	PROPN
aji-7	334	20	j	j	PROPN
aji-7	334	21	,	,	PUNCT
aji-7	334	22	mócsai	mócsai	VERB
aji-7	334	23	a	a	PRON
aji-7	334	24	,	,	PUNCT
aji-7	334	25	pintér	pintér	ADJ
aji-7	334	26	e	e	NOUN
aji-7	334	27	,	,	PUNCT
aji-7	334	28	kollár	kollár	PROPN
aji-7	334	29	l	l	PROPN
aji-7	334	30	,	,	PUNCT
aji-7	334	31	helyes	helyes	PROPN
aji-7	334	32	z.	z.	PROPN
aji-7	334	33	hydrophobic	hydrophobic	PROPN
aji-7	334	34	cyanine	cyanine	PROPN
aji-7	334	35	dye	dye	NOUN
aji-7	334	36	-	-	PUNCT
aji-7	334	37	doped	dope	VERB
aji-7	334	38	micelles	micelle	NOUN
aji-7	334	39	for	for	ADP
aji-7	334	40	optical	optical	ADJ
aji-7	334	41	in	in	ADP
aji-7	334	42	vivo	vivo	ADJ
aji-7	334	43	imaging	imaging	NOUN
aji-7	334	44	of	of	ADP
aji-7	334	45	plasma	plasma	NOUN
aji-7	334	46	leakage	leakage	NOUN
aji-7	334	47	and	and	CCONJ
aji-7	334	48	vascular	vascular	ADJ
aji-7	334	49	disruption	disruption	NOUN
aji-7	334	50	.	.	PUNCT
aji-7	335	1	journal	journal	PROPN
aji-7	335	2	of	of	ADP
aji-7	335	3	biomedical	biomedical	ADJ
aji-7	335	4	optics	optic	NOUN
aji-7	335	5	.	.	PUNCT
aji-7	336	1	2015;20(1):016022	2015;20(1):016022	PROPN
aji-7	336	2	.	.	PUNCT
aji-7	337	1	23	23	NUM
aji-7	337	2	.	.	PUNCT
aji-7	338	1	lin	lin	PROPN
aji-7	338	2	y	y	PROPN
aji-7	338	3	,	,	PUNCT
aji-7	338	4	lin	lin	PROPN
aji-7	338	5	s	s	PROPN
aji-7	338	6	,	,	PUNCT
aji-7	338	7	feng	feng	PROPN
aji-7	338	8	c	c	PROPN
aji-7	338	9	,	,	PUNCT
aji-7	338	10	chen	chen	PROPN
aji-7	338	11	p	p	PROPN
aji-7	338	12	,	,	PUNCT
aji-7	338	13	su	su	PROPN
aji-7	338	14	y	y	PROPN
aji-7	338	15	,	,	PUNCT
aji-7	338	16	li	li	PROPN
aji-7	338	17	c	c	PROPN
aji-7	338	18	,	,	PUNCT
aji-7	338	19	yang	yang	PROPN
aji-7	338	20	s	s	PROPN
aji-7	338	21	,	,	PUNCT
aji-7	338	22	jean	jean	PROPN
aji-7	338	23	y	y	PROPN
aji-7	338	24	,	,	PUNCT
aji-7	338	25	sung	sing	VERB
aji-7	338	26	p	p	SYM
aji-7	338	27	,	,	PUNCT
aji-7	338	28	duh	duh	INTJ
aji-7	338	29	c	c	NOUN
aji-7	338	30	,	,	PUNCT
aji-7	338	31	wen	wen	PROPN
aji-7	338	32	z.	z.	PROPN
aji-7	338	33	anti	anti	ADJ
aji-7	338	34	-	-	ADJ
aji-7	338	35	inflammatory	inflammatory	ADJ
aji-7	338	36	and	and	CCONJ
aji-7	338	37	analgesic	analgesic	ADJ
aji-7	338	38	effects	effect	NOUN
aji-7	338	39	of	of	ADP
aji-7	338	40	the	the	DET
aji-7	338	41	marine	marine	ADJ
aji-7	338	42	-	-	PUNCT
aji-7	338	43	derived	derive	VERB
aji-7	338	44	compound	compound	NOUN
aji-7	338	45	excavatolide	excavatolide	PROPN
aji-7	339	1	b	b	PROPN
aji-7	339	2	isolated	isolate	VERB
aji-7	339	3	from	from	ADP
aji-7	339	4	the	the	DET
aji-7	339	5	culturetype	culturetype	PROPN
aji-7	339	6	formosan	formosan	PROPN
aji-7	339	7	gorgonian	gorgonian	PROPN
aji-7	339	8	briareum	briareum	NOUN
aji-7	339	9	excavatum	excavatum	NOUN
aji-7	339	10	.	.	PUNCT
aji-7	340	1	marine	marine	ADJ
aji-7	340	2	drugs	drug	NOUN
aji-7	340	3	.	.	PUNCT
aji-7	341	1	2015;13(5):2559	2015;13(5):2559	NUM
aji-7	341	2	-	-	SYM
aji-7	341	3	2579	2579	NUM
aji-7	341	4	.	.	PUNCT
aji-7	342	1	24	24	NUM
aji-7	342	2	.	.	PUNCT
aji-7	342	3	sakat	sakat	PROPN
aji-7	342	4	s	s	PROPN
aji-7	342	5	,	,	PUNCT
aji-7	342	6	mani	mani	PROPN
aji-7	342	7	k	k	PROPN
aji-7	342	8	,	,	PUNCT
aji-7	342	9	demidchenko	demidchenko	PROPN
aji-7	342	10	y	y	PROPN
aji-7	342	11	,	,	PUNCT
aji-7	342	12	gorbunov	gorbunov	NOUN
aji-7	342	13	e	e	NOUN
aji-7	342	14	,	,	PUNCT
aji-7	342	15	tarasov	tarasov	PROPN
aji-7	342	16	s	s	PROPN
aji-7	342	17	,	,	PUNCT
aji-7	342	18	mathur	mathur	PROPN
aji-7	342	19	a	a	PROPN
aji-7	342	20	,	,	PUNCT
aji-7	342	21	epstein	epstein	PROPN
aji-7	342	22	o.	o.	PROPN
aji-7	342	23	release	release	VERB
aji-7	342	24	-	-	PUNCT
aji-7	342	25	active	active	ADJ
aji-7	342	26	dilutions	dilution	NOUN
aji-7	342	27	of	of	ADP
aji-7	342	28	diclofenac	diclofenac	NOUN
aji-7	342	29	enhance	enhance	VERB
aji-7	342	30	anti	anti	ADJ
aji-7	342	31	-	-	ADJ
aji-7	342	32	inflammatory	inflammatory	ADJ
aji-7	342	33	effect	effect	NOUN
aji-7	342	34	of	of	ADP
aji-7	342	35	diclofenac	diclofenac	NOUN
aji-7	342	36	in	in	ADP
aji-7	342	37	carrageenan	carrageenan	NOUN
aji-7	342	38	-	-	PUNCT
aji-7	342	39	induced	induce	VERB
aji-7	342	40	rat	rat	NOUN
aji-7	342	41	paw	paw	PROPN
aji-7	342	42	edema	edema	PROPN
aji-7	342	43	model	model	NOUN
aji-7	342	44	.	.	PUNCT
aji-7	343	1	inflammation	inflammation	NOUN
aji-7	343	2	,	,	PUNCT
aji-7	344	1	[	[	X
aji-7	344	2	online	online	X
aji-7	344	3	]	]	X
aji-7	344	4	.	.	PUNCT
aji-7	345	1	2013;37(1):1	2013;37(1):1	NUM
aji-7	345	2	-	-	SYM
aji-7	345	3	9	9	NUM
aji-7	345	4	.	.	PUNCT
aji-7	345	5	available	available	ADJ
aji-7	345	6	:	:	PUNCT
aji-7	345	7	http://dx.doi.org/10.1007	http://dx.doi.org/10.1007	ADJ
aji-7	345	8	/	/	SYM
aji-7	345	9	s10753013	s10753013	NOUN
aji-7	345	10	-	-	PUNCT
aji-7	345	11	9705	9705	NUM
aji-7	345	12	-	-	SYM
aji-7	345	13	0	0	NUM
aji-7	346	1	[	[	X
aji-7	346	2	accessed	access	VERB
aji-7	346	3	20	20	NUM
aji-7	346	4	mar	mar	PROPN
aji-7	346	5	.	.	PROPN
aji-7	346	6	2017	2017	NUM
aji-7	346	7	]	]	PUNCT
aji-7	347	1	25	25	NUM
aji-7	347	2	.	.	PUNCT
aji-7	348	1	wise	wise	ADJ
aji-7	348	2	j.	j.	PROPN
aji-7	348	3	diclofenac	diclofenac	PROPN
aji-7	348	4	should	should	AUX
aji-7	348	5	n't	not	PART
aji-7	348	6	be	be	AUX
aji-7	348	7	prescribed	prescribe	VERB
aji-7	348	8	to	to	ADP
aji-7	348	9	people	people	NOUN
aji-7	348	10	with	with	ADP
aji-7	348	11	heart	heart	NOUN
aji-7	348	12	problems	problem	NOUN
aji-7	348	13	,	,	PUNCT
aji-7	348	14	drug	drug	NOUN
aji-7	348	15	agency	agency	NOUN
aji-7	348	16	says	say	VERB
aji-7	348	17	.	.	PUNCT
aji-7	349	1	bmj	bmj	PROPN
aji-7	349	2	.	.	PUNCT
aji-7	350	1	2013;347(jul02	2013;347(jul02	NUM
aji-7	350	2	1):f4285	1):f4285	NUM
aji-7	350	3	-	-	SYM
aji-7	350	4	f4285	f4285	PROPN
aji-7	350	5	.	.	PUNCT
aji-7	351	1	26	26	NUM
aji-7	351	2	.	.	PUNCT
aji-7	352	1	wallace	wallace	PROPN
aji-7	352	2	j.	j.	PROPN
aji-7	353	1	how	how	SCONJ
aji-7	353	2	do	do	AUX
aji-7	353	3	nsaids	nsaid	NOUN
aji-7	353	4	cause	cause	VERB
aji-7	353	5	ulcer	ulcer	NOUN
aji-7	353	6	disease	disease	NOUN
aji-7	353	7	?	?	PUNCT
aji-7	354	1	best	good	ADJ
aji-7	354	2	practice	practice	NOUN
aji-7	354	3	&	&	CCONJ
aji-7	354	4	research	research	NOUN
aji-7	354	5	clinical	clinical	ADJ
aji-7	354	6	gastroenterology	gastroenterology	NOUN
aji-7	354	7	,	,	PUNCT
aji-7	355	1	[	[	X
aji-7	355	2	online	online	X
aji-7	355	3	]	]	X
aji-7	355	4	.	.	PUNCT
aji-7	356	1	2000;14(1):147	2000;14(1):147	NUM
aji-7	356	2	-	-	SYM
aji-7	356	3	159	159	NUM
aji-7	356	4	.	.	PUNCT
aji-7	357	1	available	available	ADJ
aji-7	357	2	:	:	PUNCT
aji-7	358	1	http://dx.doi.org/10.1053	http://dx.doi.org/10.1053	NOUN
aji-7	358	2	/	/	SYM
aji-7	358	3	bega.19	bega.19	NOUN
aji-7	358	4	99.0065	99.0065	NUM
aji-7	359	1	[	[	X
aji-7	359	2	accessed	access	VERB
aji-7	359	3	20	20	NUM
aji-7	359	4	mar	mar	PROPN
aji-7	359	5	.	.	PROPN
aji-7	359	6	2017	2017	NUM
aji-7	359	7	]	]	PUNCT
aji-7	359	8	27	27	NUM
aji-7	359	9	.	.	PUNCT
aji-7	360	1	maheshwari	maheshwari	PROPN
aji-7	360	2	r	r	PROPN
aji-7	360	3	,	,	PUNCT
aji-7	360	4	balaraman	balaraman	NOUN
aji-7	360	5	r	r	NOUN
aji-7	360	6	,	,	PUNCT
aji-7	360	7	sailor	sailor	NOUN
aji-7	360	8	g	g	NOUN
aji-7	360	9	,	,	PUNCT
aji-7	360	10	parmar	parmar	PROPN
aji-7	360	11	g	g	PROPN
aji-7	360	12	,	,	PUNCT
aji-7	360	13	patel	patel	PROPN
aji-7	360	14	a	a	PRON
aji-7	360	15	,	,	PUNCT
aji-7	360	16	seth	seth	PROPN
aji-7	360	17	a.	a.	PROPN
aji-7	360	18	antiulcer	antiulcer	PROPN
aji-7	360	19	and	and	CCONJ
aji-7	360	20	antioxidant	antioxidant	ADJ
aji-7	360	21	effects	effect	NOUN
aji-7	360	22	of	of	ADP
aji-7	360	23	normacid	normacid	NOUN
aji-7	360	24	syrup	syrup	NOUN
aji-7	360	25	(	(	PUNCT
aji-7	360	26	a	a	DET
aji-7	360	27	polyherbal	polyherbal	ADJ
aji-7	360	28	formulation	formulation	NOUN
aji-7	360	29	)	)	PUNCT
aji-7	360	30	on	on	ADP
aji-7	360	31	experimentallyinduced	experimentallyinduce	VERB
aji-7	360	32	gastric	gastric	ADJ
aji-7	360	33	ulcers	ulcer	NOUN
aji-7	360	34	.	.	PUNCT
aji-7	361	1	oriental	oriental	ADJ
aji-7	361	2	pharmacy	pharmacy	NOUN
aji-7	361	3	and	and	CCONJ
aji-7	361	4	experimental	experimental	ADJ
aji-7	361	5	medicine	medicine	NOUN
aji-7	361	6	.	.	PUNCT
aji-7	362	1	2013;14(2):145	2013;14(2):145	NUM
aji-7	362	2	-	-	SYM
aji-7	362	3	155	155	NUM
aji-7	362	4	.	.	PUNCT
aji-7	363	1	28	28	NUM
aji-7	363	2	.	.	PUNCT
aji-7	364	1	drugbank.ca	drugbank.ca	PROPN
aji-7	364	2	.	.	PUNCT
aji-7	365	1	aleglitazar	aleglitazar	PROPN
aji-7	365	2	drugbank	drugbank	PROPN
aji-7	365	3	.	.	PUNCT
aji-7	366	1	[	[	X
aji-7	366	2	online	online	X
aji-7	366	3	]	]	X
aji-7	366	4	;	;	PUNCT
aji-7	366	5	2017	2017	NUM
aji-7	366	6	.	.	PUNCT
aji-7	367	1	available	available	ADJ
aji-7	367	2	:	:	PUNCT
aji-7	367	3	https://www.drugbank.ca	https://www.drugbank.ca	ADJ
aji-7	367	4	/	/	SYM
aji-7	367	5	drugs	drug	NOUN
aji-7	367	6	/	/	SYM
aji-7	367	7	d	d	NOUN
aji-7	367	8	b08915#pharmacology	b08915#pharmacology	NOUN
aji-7	367	9	[	[	X
aji-7	367	10	accessed	access	VERB
aji-7	367	11	26	26	NUM
aji-7	367	12	feb	feb	NOUN
aji-7	367	13	.	.	PROPN
aji-7	367	14	2017	2017	NUM
aji-7	367	15	]	]	PUNCT
aji-7	367	16	29	29	NUM
aji-7	367	17	.	.	PUNCT
aji-7	368	1	herz	herz	PROPN
aji-7	368	2	m	m	PROPN
aji-7	368	3	,	,	PUNCT
aji-7	368	4	gaspari	gaspari	PROPN
aji-7	368	5	f	f	PROPN
aji-7	368	6	,	,	PUNCT
aji-7	368	7	perico	perico	PROPN
aji-7	368	8	n	n	CCONJ
aji-7	368	9	,	,	PUNCT
aji-7	368	10	viberti	viberti	NOUN
aji-7	368	11	g	g	PROPN
aji-7	368	12	,	,	PUNCT
aji-7	368	13	urbanowska	urbanowska	PROPN
aji-7	368	14	t	t	PROPN
aji-7	368	15	,	,	PUNCT
aji-7	368	16	rabbia	rabbia	PROPN
aji-7	368	17	m	m	PROPN
aji-7	368	18	,	,	PUNCT
aji-7	368	19	kirk	kirk	PROPN
aji-7	368	20	d.	d.	PROPN
aji-7	368	21	effects	effect	NOUN
aji-7	368	22	of	of	ADP
aji-7	368	23	high	high	ADJ
aji-7	368	24	dose	dose	NOUN
aji-7	368	25	aleglitazar	aleglitazar	NOUN
aji-7	368	26	on	on	ADP
aji-7	368	27	renal	renal	ADJ
aji-7	368	28	function	function	NOUN
aji-7	368	29	in	in	ADP
aji-7	368	30	patients	patient	NOUN
aji-7	368	31	with	with	ADP
aji-7	368	32	type	type	NOUN
aji-7	368	33	2	2	NUM
aji-7	368	34	diabetes	diabetes	NOUN
aji-7	368	35	.	.	PUNCT
aji-7	369	1	international	international	ADJ
aji-7	369	2	journal	journal	NOUN
aji-7	369	3	of	of	ADP
aji-7	369	4	cardiology	cardiology	NOUN
aji-7	369	5	.	.	PUNCT
aji-7	370	1	[	[	X
aji-7	370	2	online	online	X
aji-7	370	3	]	]	X
aji-7	370	4	.	.	PUNCT
aji-7	371	1	2011;151(2):136	2011;151(2):136	NUM
aji-7	371	2	-	-	SYM
aji-7	371	3	142	142	NUM
aji-7	371	4	.	.	PUNCT
aji-7	372	1	available	available	ADJ
aji-7	372	2	:	:	PUNCT
aji-7	373	1	http://dx.doi.org/10.1016	http://dx.doi.org/10.1016	PROPN
aji-7	373	2	/	/	SYM
aji-7	373	3	j.ijcard.2	j.ijcard.2	PROPN
aji-7	373	4	010.08.037	010.08.037	PUNCT
aji-7	374	1	[	[	X
aji-7	374	2	accessed	access	VERB
aji-7	374	3	20	20	NUM
aji-7	374	4	mar	mar	PROPN
aji-7	374	5	.	.	PROPN
aji-7	374	6	2017	2017	NUM
aji-7	374	7	]	]	PUNCT
aji-7	374	8	30	30	NUM
aji-7	374	9	.	.	PUNCT
aji-7	375	1	qiu	qiu	PROPN
aji-7	375	2	b	b	PROPN
aji-7	375	3	,	,	PUNCT
aji-7	375	4	cho	cho	PROPN
aji-7	375	5	c	c	NOUN
aji-7	375	6	,	,	PUNCT
aji-7	375	7	ogle	ogle	VERB
aji-7	375	8	c.	c.	PROPN
aji-7	375	9	chronic	chronic	PROPN
aji-7	375	10	nicotine	nicotine	VERB
aji-7	375	11	treatment	treatment	NOUN
aji-7	375	12	intensifies	intensifie	NOUN
aji-7	375	13	gastric	gastric	ADJ
aji-7	375	14	ulceration	ulceration	NOUN
aji-7	375	15	by	by	ADP
aji-7	375	16	cold	cold	ADJ
aji-7	375	17	-	-	PUNCT
aji-7	375	18	restraint	restraint	NOUN
aji-7	375	19	stress	stress	NOUN
aji-7	375	20	in	in	ADP
aji-7	375	21	rats	rat	NOUN
aji-7	375	22	.	.	PUNCT
aji-7	376	1	agents	agent	NOUN
aji-7	376	2	and	and	CCONJ
aji-7	376	3	actions	action	NOUN
aji-7	376	4	.	.	PUNCT
aji-7	377	1	[	[	X
aji-7	377	2	online	online	X
aji-7	377	3	]	]	X
aji-7	377	4	.	.	PUNCT
aji-7	378	1	1991;33(3	1991;33(3	NUM
aji-7	378	2	-	-	SYM
aji-7	378	3	4):367	4):367	NUM
aji-7	378	4	-	-	PUNCT
aji-7	378	5	370	370	NUM
aji-7	378	6	.	.	PUNCT
aji-7	379	1	available	available	ADJ
aji-7	379	2	:	:	PUNCT
aji-7	379	3	http://dx.doi.org/10.1007	http://dx.doi.org/10.1007	ADJ
aji-7	379	4	/	/	SYM
aji-7	379	5	bf01986	bf01986	ADJ
aji-7	379	6	587	587	NUM
aji-7	380	1	[	[	X
aji-7	380	2	accessed	access	VERB
aji-7	380	3	15	15	NUM
aji-7	380	4	mar	mar	PROPN
aji-7	380	5	.	.	PROPN
aji-7	380	6	2017	2017	NUM
aji-7	380	7	]	]	PUNCT
aji-7	380	8	31	31	NUM
aji-7	380	9	.	.	PUNCT
aji-7	381	1	sanwald	sanwald	ADJ
aji-7	381	2	-	-	PUNCT
aji-7	381	3	ducray	ducray	NOUN
aji-7	381	4	p	p	NOUN
aji-7	381	5	,	,	PUNCT
aji-7	381	6	jamois	jamois	PROPN
aji-7	381	7	c	c	PROPN
aji-7	381	8	,	,	PUNCT
aji-7	381	9	banken	banken	PROPN
aji-7	381	10	l.	l.	PROPN
aji-7	381	11	the	the	DET
aji-7	381	12	effect	effect	NOUN
aji-7	381	13	of	of	ADP
aji-7	381	14	aleglitazar	aleglitazar	NOUN
aji-7	381	15	on	on	ADP
aji-7	381	16	the	the	DET
aji-7	381	17	pharmacokinetics	pharmacokinetic	NOUN
aji-7	381	18	and	and	CCONJ
aji-7	381	19	pharmacodynamics	pharmacodynamic	NOUN
aji-7	381	20	of	of	ADP
aji-7	381	21	sand	sand	NOUN
aji-7	381	22	r	r	NOUN
aji-7	381	23	-	-	NOUN
aji-7	381	24	warfarin	warfarin	NOUN
aji-7	381	25	in	in	ADP
aji-7	381	26	healthy	healthy	ADJ
aji-7	381	27	male	male	ADJ
aji-7	381	28	subjects	subject	NOUN
aji-7	381	29	.	.	PUNCT
aji-7	382	1	journal	journal	NOUN
aji-7	382	2	of	of	ADP
aji-7	382	3	cardiovascular	cardiovascular	ADJ
aji-7	382	4	pharmacology	pharmacology	NOUN
aji-7	382	5	.	.	PUNCT
aji-7	383	1	[	[	X
aji-7	383	2	online	online	X
aji-7	383	3	]	]	X
aji-7	383	4	.	.	PUNCT
aji-7	384	1	2014;63(2):152157	2014;63(2):152157	NUM
aji-7	384	2	.	.	PUNCT
aji-7	385	1	available	available	ADJ
aji-7	385	2	:	:	PUNCT
aji-7	385	3	http://dx.doi.org/10.1097	http://dx.doi.org/10.1097	NOUN
aji-7	385	4	/	/	SYM
aji-7	385	5	fjc.0000	fjc.0000	NUM
aji-7	385	6	000000000033	000000000033	NUM
aji-7	386	1	[	[	X
aji-7	386	2	accessed	access	VERB
aji-7	386	3	20	20	NUM
aji-7	386	4	mar	mar	PROPN
aji-7	386	5	.	.	PROPN
aji-7	386	6	2017	2017	NUM
aji-7	386	7	]	]	PUNCT
aji-7	386	8	32	32	NUM
aji-7	386	9	.	.	PUNCT
aji-7	387	1	henry	henry	PROPN
aji-7	387	2	r	r	PROPN
aji-7	387	3	,	,	PUNCT
aji-7	387	4	buse	buse	PROPN
aji-7	387	5	j	j	PROPN
aji-7	387	6	,	,	PUNCT
aji-7	387	7	wu	wu	PROPN
aji-7	387	8	h	h	PROPN
aji-7	387	9	,	,	PUNCT
aji-7	387	10	durrwell	durrwell	PROPN
aji-7	387	11	l	l	NOUN
aji-7	387	12	,	,	PUNCT
aji-7	387	13	mingrino	mingrino	NOUN
aji-7	387	14	r	r	PROPN
aji-7	387	15	,	,	PUNCT
aji-7	387	16	jaekel	jaekel	PROPN
aji-7	387	17	k	k	PROPN
aji-7	387	18	,	,	PUNCT
aji-7	387	19	el	el	PROPN
aji-7	387	20	azzouzi	azzouzi	PROPN
aji-7	387	21	b	b	PROPN
aji-7	387	22	,	,	PUNCT
aji-7	387	23	andjelkovic	andjelkovic	PROPN
aji-7	387	24	m	m	PROPN
aji-7	387	25	,	,	PUNCT
aji-7	387	26	herz	herz	PROPN
aji-7	387	27	m.	m.	PROPN
aji-7	387	28	efficacy	efficacy	PROPN
aji-7	387	29	,	,	PUNCT
aji-7	387	30	safety	safety	NOUN
aji-7	387	31	and	and	CCONJ
aji-7	387	32	tolerability	tolerability	NOUN
aji-7	387	33	of	of	ADP
aji-7	387	34	aleglitazar	aleglitazar	NOUN
aji-7	387	35	in	in	ADP
aji-7	387	36	patients	patient	NOUN
aji-7	387	37	with	with	ADP
aji-7	387	38	type	type	NOUN
aji-7	387	39	2	2	NUM
aji-7	387	40	diabetes	diabetes	NOUN
aji-7	387	41	:	:	PUNCT
aji-7	387	42	pooled	pool	VERB
aji-7	387	43	findings	finding	NOUN
aji-7	387	44	from	from	ADP
aji-7	387	45	three	three	NUM
aji-7	387	46	randomized	randomized	ADJ
aji-7	387	47	phase	phase	NOUN
aji-7	387	48	iii	iii	NUM
aji-7	387	49	trials	trial	NOUN
aji-7	387	50	.	.	PUNCT
aji-7	388	1	diabetes	diabetes	NOUN
aji-7	388	2	,	,	PUNCT
aji-7	388	3	obesity	obesity	NOUN
aji-7	388	4	and	and	CCONJ
aji-7	388	5	metabolism	metabolism	NOUN
aji-7	388	6	.	.	PUNCT
aji-7	389	1	2015;17(6):560565	2015;17(6):560565	X
aji-7	389	2	.	.	PUNCT
aji-7	390	1	33	33	NUM
aji-7	390	2	.	.	PUNCT
aji-7	391	1	keppler	keppler	PROPN
aji-7	391	2	a	a	PROPN
aji-7	391	3	,	,	PUNCT
aji-7	391	4	gretz	gretz	ADJ
aji-7	391	5	n	n	CCONJ
aji-7	391	6	,	,	PUNCT
aji-7	391	7	schmidt	schmidt	PROPN
aji-7	391	8	r	r	PROPN
aji-7	391	9	,	,	PUNCT
aji-7	391	10	kloetzer	kloetzer	PROPN
aji-7	391	11	h	h	PROPN
aji-7	391	12	,	,	PUNCT
aji-7	391	13	groene	groene	PROPN
aji-7	391	14	h	h	PROPN
aji-7	391	15	,	,	PUNCT
aji-7	391	16	lelongt	lelongt	PROPN
aji-7	391	17	b	b	PROPN
aji-7	391	18	,	,	PUNCT
aji-7	391	19	meyer	meyer	PROPN
aji-7	391	20	m	m	PROPN
aji-7	391	21	,	,	PUNCT
aji-7	391	22	sadick	sadick	NOUN
aji-7	391	23	m	m	PROPN
aji-7	391	24	,	,	PUNCT
aji-7	391	25	pill	pill	NOUN
aji-7	391	26	j.	j.	PROPN
aji-7	391	27	plasma	plasma	PROPN
aji-7	391	28	creatinine	creatinine	NOUN
aji-7	391	29	determination	determination	NOUN
aji-7	391	30	in	in	ADP
aji-7	391	31	mice	mouse	NOUN
aji-7	391	32	and	and	CCONJ
aji-7	391	33	rats	rat	NOUN
aji-7	391	34	:	:	PUNCT
aji-7	391	35	an	an	DET
aji-7	391	36	enzymatic	enzymatic	ADJ
aji-7	391	37	method	method	NOUN
aji-7	391	38	compares	compare	VERB
aji-7	391	39	favorably	favorably	ADV
aji-7	391	40	with	with	ADP
aji-7	391	41	a	a	DET
aji-7	391	42	highperformance	highperformance	NOUN
aji-7	391	43	liquid	liquid	NOUN
aji-7	391	44	chromatography	chromatography	NOUN
aji-7	391	45	assay	assay	NOUN
aji-7	391	46	.	.	PUNCT
aji-7	392	1	kidney	kidney	PROPN
aji-7	392	2	international	international	PROPN
aji-7	392	3	.	.	PUNCT
aji-7	393	1	[	[	X
aji-7	393	2	online	online	X
aji-7	393	3	]	]	X
aji-7	393	4	.	.	PUNCT
aji-7	394	1	2007;71(1):74	2007;71(1):74	NUM
aji-7	394	2	-	-	SYM
aji-7	394	3	78	78	NUM
aji-7	394	4	.	.	PUNCT
aji-7	395	1	available	available	ADJ
aji-7	395	2	:	:	PUNCT
aji-7	395	3	http://dx.doi.org/10.1038	http://dx.doi.org/10.1038	NOUN
aji-7	395	4	/	/	SYM
aji-7	395	5	sj.ki.500	sj.ki.500	PROPN
aji-7	395	6	1988	1988	NUM
aji-7	395	7	[	[	X
aji-7	395	8	accessed	access	VERB
aji-7	395	9	20	20	NUM
aji-7	395	10	mar	mar	PROPN
aji-7	395	11	.	.	PROPN
aji-7	395	12	2017	2017	NUM
aji-7	395	13	]	]	PUNCT
aji-7	396	1	34	34	NUM
aji-7	396	2	.	.	PUNCT
aji-7	397	1	gu	gu	PROPN
aji-7	397	2	y	y	PROPN
aji-7	397	3	,	,	PUNCT
aji-7	397	4	yang	yang	PROPN
aji-7	397	5	y	y	PROPN
aji-7	397	6	,	,	PUNCT
aji-7	397	7	zhang	zhang	PROPN
aji-7	397	8	j	j	PROPN
aji-7	397	9	,	,	PUNCT
aji-7	397	10	ge	ge	PROPN
aji-7	397	11	s	s	PROPN
aji-7	397	12	,	,	PUNCT
aji-7	397	13	tang	tang	PROPN
aji-7	397	14	z	z	PROPN
aji-7	397	15	,	,	PUNCT
aji-7	397	16	qiu	qiu	PROPN
aji-7	397	17	x.	x.	NOUN
aji-7	397	18	point	point	PROPN
aji-7	397	19	-	-	PUNCT
aji-7	397	20	of	of	ADP
aji-7	397	21	-	-	PUNCT
aji-7	397	22	care	care	NOUN
aji-7	397	23	test	test	NOUN
aji-7	397	24	for	for	ADP
aji-7	397	25	c	c	NOUN
aji-7	397	26	-	-	PUNCT
aji-7	397	27	reactive	reactive	ADJ
aji-7	397	28	protein	protein	NOUN
aji-7	397	29	by	by	ADP
aji-7	397	30	a	a	DET
aji-7	397	31	fluorescence	fluorescence	NOUN
aji-7	397	32	-	-	PUNCT
aji-7	397	33	based	base	VERB
aji-7	397	34	lateral	lateral	ADJ
aji-7	397	35	flow	flow	NOUN
aji-7	397	36	immunoassay	immunoassay	PROPN
aji-7	397	37	.	.	PUNCT
aji-7	398	1	instrumentation	instrumentation	PROPN
aji-7	398	2	science	science	PROPN
aji-7	398	3	&	&	CCONJ
aji-7	398	4	technology	technology	PROPN
aji-7	398	5	,	,	PUNCT
aji-7	399	1	[	[	X
aji-7	399	2	online	online	X
aji-7	399	3	]	]	X
aji-7	399	4	.	.	PUNCT
aji-7	400	1	2014;42(6):635	2014;42(6):635	NUM
aji-7	400	2	-	-	SYM
aji-7	400	3	645	645	NUM
aji-7	400	4	.	.	PUNCT
aji-7	401	1	available	available	ADJ
aji-7	401	2	:	:	PUNCT
aji-7	401	3	http://dx.doi.org/10.1080/107391	http://dx.doi.org/10.1080/107391	NOUN
aji-7	401	4	49.2014.930877	49.2014.930877	NUM
aji-7	402	1	[	[	X
aji-7	402	2	accessed	access	VERB
aji-7	402	3	20	20	NUM
aji-7	402	4	mar	mar	PROPN
aji-7	402	5	.	.	PROPN
aji-7	402	6	2017	2017	NUM
aji-7	402	7	]	]	PUNCT
aji-7	402	8	35	35	NUM
aji-7	402	9	.	.	PUNCT
aji-7	403	1	herz	herz	PROPN
aji-7	403	2	m	m	PROPN
aji-7	403	3	,	,	PUNCT
aji-7	403	4	malmberg	malmberg	PROPN
aji-7	403	5	k	k	PROPN
aji-7	403	6	,	,	PUNCT
aji-7	403	7	hanefeld	hanefeld	PROPN
aji-7	403	8	m	m	PROPN
aji-7	403	9	,	,	PUNCT
aji-7	403	10	michael	michael	PROPN
aji-7	403	11	lincoff	lincoff	PROPN
aji-7	403	12	a	a	PRON
aji-7	403	13	,	,	PUNCT
aji-7	403	14	mudie	mudie	PROPN
aji-7	403	15	n	n	CCONJ
aji-7	403	16	,	,	PUNCT
aji-7	403	17	nicholls	nicholls	PROPN
aji-7	403	18	s.	s.	PROPN
aji-7	403	19	gw24e3085â€	gw24e3085â€	PROPN
aji-7	403	20	…	…	PUNCT
aji-7	403	21	the	the	DET
aji-7	403	22	dual	dual	ADJ
aji-7	403	23	ppar	ppar	NOUN
aji-7	403	24	alpha	alpha	PROPN
aji-7	403	25	/	/	SYM
aji-7	403	26	gamma	gamma	PROPN
aji-7	403	27	agonist	agonist	NOUN
aji-7	403	28	aleglitazar	aleglitazar	NOUN
aji-7	403	29	has	have	VERB
aji-7	403	30	a	a	DET
aji-7	403	31	beneficial	beneficial	ADJ
aji-7	403	32	effect	effect	NOUN
aji-7	403	33	elsawy	elsawy	NOUN
aji-7	403	34	;	;	PUNCT
aji-7	403	35	aji	aji	NOUN
aji-7	403	36	,	,	PUNCT
aji-7	403	37	2(1	2(1	NUM
aji-7	403	38	):	):	PUNCT
aji-7	403	39	34	34	NUM
aji-7	403	40	-	-	SYM
aji-7	403	41	44	44	NUM
aji-7	403	42	,	,	PUNCT
aji-7	403	43	2019	2019	NUM
aji-7	403	44	;	;	PUNCT
aji-7	403	45	article	article	NOUN
aji-7	403	46	no.aji.53258	no.aji.53258	NOUN
aji-7	403	47	44	44	NUM
aji-7	403	48	on	on	ADP
aji-7	403	49	atherogenic	atherogenic	ADJ
aji-7	403	50	dyslipidemia	dyslipidemia	NOUN
aji-7	403	51	in	in	ADP
aji-7	403	52	patients	patient	NOUN
aji-7	403	53	with	with	ADP
aji-7	403	54	type	type	NOUN
aji-7	403	55	2	2	NUM
aji-7	403	56	diabetes	diabetes	NOUN
aji-7	403	57	.	.	PUNCT
aji-7	404	1	heart	heart	NOUN
aji-7	404	2	,	,	PUNCT
aji-7	405	1	[	[	X
aji-7	405	2	online	online	X
aji-7	405	3	]	]	X
aji-7	405	4	.	.	PUNCT
aji-7	406	1	2013;99(suppl	2013;99(suppl	NOUN
aji-7	406	2	3):a248.1	3):a248.1	PROPN
aji-7	406	3	-	-	PUNCT
aji-7	406	4	a248	a248	PROPN
aji-7	406	5	.	.	PUNCT
aji-7	407	1	available	available	ADJ
aji-7	407	2	:	:	PUNCT
aji-7	408	1	http://dx.doi.org/10.1136	http://dx.doi.org/10.1136	NOUN
aji-7	408	2	/	/	SYM
aji-7	408	3	heartjnl2013	heartjnl2013	PROPN
aji-7	408	4	-	-	PUNCT
aji-7	408	5	304613.699	304613.699	PROPN
aji-7	408	6	[	[	X
aji-7	408	7	accessed	access	VERB
aji-7	408	8	20	20	NUM
aji-7	408	9	mar	mar	PROPN
aji-7	408	10	.	.	PROPN
aji-7	408	11	2017	2017	NUM
aji-7	408	12	]	]	PUNCT
aji-7	409	1	36	36	NUM
aji-7	409	2	.	.	PUNCT
aji-7	410	1	van	van	PROPN
aji-7	410	2	bilsen	bilsen	PROPN
aji-7	410	3	m	m	PROPN
aji-7	410	4	,	,	PUNCT
aji-7	410	5	van	van	PROPN
aji-7	410	6	nieuwenhoven	nieuwenhoven	PROPN
aji-7	410	7	f.	f.	PROPN
aji-7	410	8	ppars	ppars	PROPN
aji-7	410	9	as	as	ADP
aji-7	410	10	therapeutic	therapeutic	ADJ
aji-7	410	11	targets	target	NOUN
aji-7	410	12	in	in	ADP
aji-7	410	13	cardiovascular	cardiovascular	ADJ
aji-7	410	14	disease	disease	NOUN
aji-7	410	15	.	.	PUNCT
aji-7	411	1	expert	expert	ADJ
aji-7	411	2	opinion	opinion	NOUN
aji-7	411	3	on	on	ADP
aji-7	411	4	therapeutic	therapeutic	ADJ
aji-7	411	5	targets	target	NOUN
aji-7	411	6	.	.	PUNCT
aji-7	412	1	2010;14(10):10291045	2010;14(10):10291045	NUM
aji-7	412	2	.	.	NOUN
aji-7	412	3	37	37	NUM
aji-7	412	4	.	.	PUNCT
aji-7	413	1	salvi	salvi	PROPN
aji-7	413	2	g	g	PROPN
aji-7	413	3	,	,	PUNCT
aji-7	413	4	yalda	yalda	NOUN
aji-7	413	5	b	b	NOUN
aji-7	413	6	,	,	PUNCT
aji-7	413	7	collins	collins	PROPN
aji-7	413	8	j	j	PROPN
aji-7	413	9	,	,	PUNCT
aji-7	413	10	jones	jones	PROPN
aji-7	413	11	b	b	PROPN
aji-7	413	12	,	,	PUNCT
aji-7	413	13	smith	smith	PROPN
aji-7	413	14	f	f	PROPN
aji-7	413	15	,	,	PUNCT
aji-7	413	16	arnold	arnold	PROPN
aji-7	413	17	r	r	PROPN
aji-7	413	18	,	,	PUNCT
aji-7	413	19	offenbacher	offenbacher	NOUN
aji-7	413	20	s.	s.	PROPN
aji-7	413	21	inflammatory	inflammatory	ADJ
aji-7	413	22	mediator	mediator	NOUN
aji-7	413	23	response	response	NOUN
aji-7	413	24	as	as	ADP
aji-7	413	25	a	a	DET
aji-7	413	26	potential	potential	ADJ
aji-7	413	27	risk	risk	NOUN
aji-7	413	28	marker	marker	NOUN
aji-7	413	29	for	for	ADP
aji-7	413	30	periodontal	periodontal	ADJ
aji-7	413	31	diseases	disease	NOUN
aji-7	413	32	in	in	ADP
aji-7	413	33	insulindependent	insulindependent	NOUN
aji-7	413	34	diabetes	diabetes	NOUN
aji-7	413	35	mellitus	mellitus	NOUN
aji-7	413	36	patients	patient	NOUN
aji-7	413	37	.	.	PUNCT
aji-7	414	1	journal	journal	PROPN
aji-7	414	2	of	of	ADP
aji-7	414	3	periodontology	periodontology	NOUN
aji-7	414	4	.	.	PUNCT
aji-7	415	1	[	[	X
aji-7	415	2	online	online	X
aji-7	415	3	]	]	X
aji-7	415	4	.	.	PUNCT
aji-7	416	1	1997;68(2):127	1997;68(2):127	NUM
aji-7	416	2	-	-	SYM
aji-7	416	3	135	135	NUM
aji-7	416	4	.	.	PUNCT
aji-7	417	1	available	available	ADJ
aji-7	417	2	:	:	PUNCT
aji-7	417	3	http://dx.doi.org/10.1902	http://dx.doi.org/10.1902	NOUN
aji-7	417	4	/	/	SYM
aji-7	417	5	jop.199	jop.199	PROPN
aji-7	417	6	7.68.2.127	7.68.2.127	NOUN
aji-7	418	1	[	[	PUNCT
aji-7	418	2	accessed	access	VERB
aji-7	418	3	20	20	NUM
aji-7	418	4	mar	mar	PROPN
aji-7	418	5	.	.	PROPN
aji-7	418	6	2017	2017	NUM
aji-7	418	7	]	]	PUNCT
aji-7	418	8	38	38	NUM
aji-7	418	9	.	.	PUNCT
aji-7	419	1	qi	qi	PROPN
aji-7	419	2	c	c	PROPN
aji-7	419	3	,	,	PUNCT
aji-7	419	4	pekala	pekala	PROPN
aji-7	419	5	p.	p.	PROPN
aji-7	419	6	tumor	tumor	NOUN
aji-7	419	7	necrosis	necrosis	NOUN
aji-7	419	8	factoralpha	factoralpha	ADV
aji-7	419	9	-	-	PUNCT
aji-7	419	10	induced	induce	VERB
aji-7	419	11	insulin	insulin	NOUN
aji-7	419	12	resistance	resistance	NOUN
aji-7	419	13	in	in	ADP
aji-7	419	14	adipocytes	adipocyte	NOUN
aji-7	419	15	.	.	PUNCT
aji-7	420	1	proceedings	proceeding	NOUN
aji-7	420	2	of	of	ADP
aji-7	420	3	the	the	DET
aji-7	420	4	society	society	NOUN
aji-7	420	5	for	for	ADP
aji-7	420	6	experimental	experimental	ADJ
aji-7	420	7	biology	biology	NOUN
aji-7	420	8	and	and	CCONJ
aji-7	420	9	medicine	medicine	NOUN
aji-7	420	10	.	.	PUNCT
aji-7	421	1	[	[	X
aji-7	421	2	online	online	X
aji-7	421	3	]	]	X
aji-7	421	4	.	.	PUNCT
aji-7	422	1	2000;223(2):128	2000;223(2):128	NUM
aji-7	422	2	-	-	SYM
aji-7	422	3	135	135	NUM
aji-7	422	4	.	.	PUNCT
aji-7	423	1	available	available	ADJ
aji-7	423	2	:	:	PUNCT
aji-7	423	3	http://dx.doi.org/10.1046	http://dx.doi.org/10.1046	NOUN
aji-7	423	4	/	/	SYM
aji-7	423	5	j.15251373.2000.22318.x	j.15251373.2000.22318.x	PRON
aji-7	424	1	[	[	X
aji-7	424	2	accessed	access	VERB
aji-7	424	3	20	20	NUM
aji-7	424	4	mar	mar	PROPN
aji-7	424	5	.	.	PROPN
aji-7	424	6	2017	2017	NUM
aji-7	424	7	]	]	PUNCT
aji-7	424	8	39	39	NUM
aji-7	424	9	.	.	PUNCT
aji-7	425	1	katsuki	katsuki	PROPN
aji-7	425	2	a	a	PRON
aji-7	425	3	,	,	PUNCT
aji-7	425	4	sumida	sumida	PROPN
aji-7	425	5	y	y	PROPN
aji-7	425	6	,	,	PUNCT
aji-7	425	7	murashima	murashima	NOUN
aji-7	425	8	s	s	PROPN
aji-7	425	9	,	,	PUNCT
aji-7	425	10	murata	murata	PROPN
aji-7	425	11	k	k	PROPN
aji-7	425	12	,	,	PUNCT
aji-7	425	13	takarada	takarada	PROPN
aji-7	425	14	y	y	PROPN
aji-7	425	15	,	,	PUNCT
aji-7	425	16	ito	ito	PROPN
aji-7	425	17	k	k	PROPN
aji-7	425	18	,	,	PUNCT
aji-7	425	19	fujii	fujii	PROPN
aji-7	425	20	m	m	PROPN
aji-7	425	21	,	,	PUNCT
aji-7	425	22	tsuchihashi	tsuchihashi	PROPN
aji-7	425	23	k	k	PROPN
aji-7	425	24	,	,	PUNCT
aji-7	425	25	goto	goto	ADJ
aji-7	425	26	h	h	NOUN
aji-7	425	27	,	,	PUNCT
aji-7	425	28	nakatani	nakatani	PROPN
aji-7	425	29	k	k	PROPN
aji-7	425	30	,	,	PUNCT
aji-7	425	31	yano	yano	PROPN
aji-7	425	32	y.	y.	PROPN
aji-7	425	33	serum	serum	PROPN
aji-7	425	34	levels	level	NOUN
aji-7	425	35	of	of	ADP
aji-7	425	36	tumor	tumor	NOUN
aji-7	425	37	necrosis	necrosis	NOUN
aji-7	425	38	factor	factor	NOUN
aji-7	425	39	-	-	PUNCT
aji-7	425	40	î±	î±	PROPN
aji-7	425	41	are	be	AUX
aji-7	425	42	increased	increase	VERB
aji-7	425	43	in	in	ADP
aji-7	425	44	obese	obese	ADJ
aji-7	425	45	patients	patient	NOUN
aji-7	425	46	with	with	ADP
aji-7	425	47	noninsulin	noninsulin	NOUN
aji-7	425	48	-	-	PUNCT
aji-7	425	49	dependent	dependent	ADJ
aji-7	425	50	diabetes	diabetes	NOUN
aji-7	425	51	mellitus	mellitus	NOUN
aji-7	425	52	1	1	X
aji-7	425	53	.	.	PUNCT
aji-7	426	1	the	the	DET
aji-7	426	2	journal	journal	NOUN
aji-7	426	3	of	of	ADP
aji-7	426	4	clinical	clinical	ADJ
aji-7	426	5	endocrinology	endocrinology	NOUN
aji-7	426	6	&	&	CCONJ
aji-7	426	7	metabolism	metabolism	NOUN
aji-7	426	8	.	.	PUNCT
aji-7	427	1	[	[	X
aji-7	427	2	online	online	X
aji-7	427	3	]	]	X
aji-7	427	4	.	.	PUNCT
aji-7	428	1	1998;83(3):859	1998;83(3):859	NUM
aji-7	428	2	-	-	PUNCT
aji-7	428	3	862	862	NUM
aji-7	428	4	.	.	PUNCT
aji-7	429	1	available	available	ADJ
aji-7	429	2	:	:	PUNCT
aji-7	429	3	http://dx.doi.org/10.1210	http://dx.doi.org/10.1210	NOUN
aji-7	429	4	/	/	SYM
aji-7	429	5	jcem.83	jcem.83	PROPN
aji-7	429	6	.3.4618	.3.4618	PUNCT
aji-7	430	1	[	[	X
aji-7	430	2	accessed	access	VERB
aji-7	430	3	20	20	NUM
aji-7	430	4	mar	mar	PROPN
aji-7	430	5	.	.	PROPN
aji-7	430	6	2017	2017	NUM
aji-7	430	7	]	]	PUNCT
aji-7	430	8	40	40	NUM
aji-7	430	9	.	.	PUNCT
aji-7	431	1	mason	mason	PROPN
aji-7	431	2	,	,	PUNCT
aji-7	431	3	robert	robert	PROPN
aji-7	431	4	f.	f.	PROPN
aji-7	431	5	jacob	jacob	PROPN
aji-7	431	6	,	,	PUNCT
aji-7	431	7	corbalan	corbalan	PROPN
aji-7	431	8	jj	jj	PROPN
aji-7	431	9	,	,	PUNCT
aji-7	431	10	lulin	lulin	PROPN
aji-7	431	11	jiang	jiang	PROPN
aji-7	431	12	,	,	PUNCT
aji-7	431	13	tadeusz	tadeusz	PROPN
aji-7	431	14	malinski	malinski	NOUN
aji-7	431	15	.	.	PUNCT
aji-7	432	1	circulation	circulation	NOUN
aji-7	432	2	.	.	PUNCT
aji-7	433	1	2013;128	2013;128	NUM
aji-7	433	2	:	:	PUNCT
aji-7	433	3	a15154	a15154	NOUN
aji-7	433	4	.	.	PUNCT
aji-7	434	1	(	(	PUNCT
aji-7	434	2	originally	originally	ADV
aji-7	434	3	published	publish	VERB
aji-7	434	4	january	january	PROPN
aji-7	434	5	13	13	NUM
aji-7	434	6	,	,	PUNCT
aji-7	434	7	2016	2016	NUM
aji-7	434	8	)	)	PUNCT
aji-7	434	9	41	41	NUM
aji-7	434	10	.	.	PUNCT
aji-7	435	1	miyazaki	miyazaki	PROPN
aji-7	435	2	y	y	PROPN
aji-7	435	3	,	,	PUNCT
aji-7	435	4	pipek	pipek	PROPN
aji-7	435	5	r	r	NOUN
aji-7	435	6	,	,	PUNCT
aji-7	435	7	mandarino	mandarino	NOUN
aji-7	435	8	l	l	NOUN
aji-7	435	9	,	,	PUNCT
aji-7	435	10	defronzo	defronzo	PROPN
aji-7	435	11	r.	r.	PROPN
aji-7	435	12	tumor	tumor	PROPN
aji-7	435	13	necrosis	necrosis	NOUN
aji-7	435	14	factor	factor	NOUN
aji-7	435	15	î±	î±	PROPN
aji-7	435	16	and	and	CCONJ
aji-7	435	17	insulin	insulin	NOUN
aji-7	435	18	resistance	resistance	NOUN
aji-7	435	19	in	in	ADP
aji-7	435	20	obese	obese	ADJ
aji-7	435	21	type	type	NOUN
aji-7	435	22	2	2	NUM
aji-7	435	23	diabetic	diabetic	ADJ
aji-7	435	24	patients	patient	NOUN
aji-7	435	25	.	.	PUNCT
aji-7	436	1	international	international	ADJ
aji-7	436	2	journal	journal	NOUN
aji-7	436	3	of	of	ADP
aji-7	436	4	obesity	obesity	NOUN
aji-7	436	5	.	.	PUNCT
aji-7	437	1	[	[	X
aji-7	437	2	online	online	X
aji-7	437	3	]	]	X
aji-7	437	4	.	.	PUNCT
aji-7	438	1	2003;27(1):88	2003;27(1):88	NUM
aji-7	438	2	-	-	SYM
aji-7	438	3	94	94	NUM
aji-7	438	4	.	.	PUNCT
aji-7	439	1	available	available	ADJ
aji-7	439	2	:	:	PUNCT
aji-7	439	3	http://dx.doi.org/10.1038	http://dx.doi.org/10.1038	NOUN
aji-7	439	4	/	/	SYM
aji-7	439	5	sj.ijo.08	sj.ijo.08	ADJ
aji-7	439	6	02187	02187	NUM
aji-7	440	1	[	[	X
aji-7	440	2	accessed	access	VERB
aji-7	440	3	10	10	NUM
aji-7	440	4	mar	mar	PROPN
aji-7	440	5	.	.	PROPN
aji-7	440	6	2017	2017	NUM
aji-7	440	7	]	]	PUNCT
aji-7	441	1	_	_	PUNCT
aji-7	442	1	_	_	PUNCT
aji-7	443	1	_	_	PUNCT
aji-7	444	1	_	_	PUNCT
aji-7	445	1	_	_	PUNCT
aji-7	446	1	_	_	PUNCT
aji-7	447	1	_	_	PUNCT
aji-7	448	1	_	_	PUNCT
aji-7	449	1	_	_	PUNCT
aji-7	450	1	_	_	PUNCT
aji-7	451	1	_	_	PUNCT
aji-7	452	1	_	_	PUNCT
aji-7	453	1	_	_	PUNCT
aji-7	454	1	_	_	PUNCT
aji-7	455	1	_	_	PUNCT
aji-7	456	1	_	_	PUNCT
aji-7	457	1	_	_	PUNCT
aji-7	458	1	_	_	PUNCT
aji-7	459	1	_	_	PUNCT
aji-7	460	1	_	_	PUNCT
aji-7	461	1	_	_	PUNCT
aji-7	462	1	_	_	PUNCT
aji-7	463	1	_	_	PUNCT
aji-7	464	1	_	_	PUNCT
aji-7	465	1	_	_	PUNCT
aji-7	466	1	_	_	PUNCT
aji-7	467	1	_	_	PUNCT
aji-7	468	1	_	_	PUNCT
aji-7	469	1	_	_	PUNCT
aji-7	470	1	_	_	PUNCT
aji-7	471	1	_	_	PUNCT
aji-7	472	1	_	_	PUNCT
aji-7	473	1	_	_	PUNCT
aji-7	474	1	_	_	PUNCT
aji-7	475	1	_	_	PUNCT
aji-7	476	1	_	_	PUNCT
aji-7	477	1	_	_	PUNCT
aji-7	478	1	_	_	PUNCT
aji-7	479	1	_	_	PUNCT
aji-7	480	1	_	_	PUNCT
aji-7	481	1	_	_	PUNCT
aji-7	482	1	_	_	PUNCT
aji-7	483	1	_	_	PUNCT
aji-7	484	1	_	_	PUNCT
aji-7	485	1	_	_	PUNCT
aji-7	486	1	_	_	PUNCT
aji-7	487	1	_	_	PUNCT
aji-7	488	1	_	_	PUNCT
aji-7	489	1	_	_	PUNCT
aji-7	490	1	_	_	PUNCT
aji-7	491	1	_	_	PUNCT
aji-7	492	1	_	_	PUNCT
aji-7	493	1	_	_	PUNCT
aji-7	494	1	_	_	PUNCT
aji-7	495	1	_	_	PUNCT
aji-7	496	1	_	_	PUNCT
aji-7	497	1	_	_	PUNCT
aji-7	498	1	_	_	PUNCT
aji-7	499	1	_	_	PUNCT
aji-7	500	1	_	_	PUNCT
aji-7	501	1	_	_	PUNCT
aji-7	502	1	_	_	PUNCT
aji-7	503	1	_	_	PUNCT
aji-7	504	1	_	_	PUNCT
aji-7	505	1	_	_	PUNCT
aji-7	506	1	_	_	PUNCT
aji-7	507	1	_	_	PUNCT
aji-7	508	1	_	_	PUNCT
aji-7	509	1	_	_	PUNCT
aji-7	510	1	_	_	PUNCT
aji-7	511	1	_	_	PUNCT
aji-7	512	1	_	_	PUNCT
aji-7	513	1	_	_	PUNCT
aji-7	514	1	_	_	PUNCT
aji-7	515	1	_	_	PUNCT
aji-7	516	1	_	_	PUNCT
aji-7	517	1	_	_	PUNCT
aji-7	518	1	_	_	PUNCT
aji-7	519	1	_	_	PUNCT
aji-7	520	1	_	_	PUNCT
aji-7	521	1	_	_	PUNCT
aji-7	522	1	©	©	ADP
aji-7	522	2	2019	2019	NUM
aji-7	522	3	elsawy	elsawy	NOUN
aji-7	522	4	;	;	PUNCT
aji-7	522	5	this	this	PRON
aji-7	522	6	is	be	AUX
aji-7	522	7	an	an	DET
aji-7	522	8	open	open	ADJ
aji-7	522	9	access	access	NOUN
aji-7	522	10	article	article	NOUN
aji-7	522	11	distributed	distribute	VERB
aji-7	522	12	under	under	ADP
aji-7	522	13	the	the	DET
aji-7	522	14	terms	term	NOUN
aji-7	522	15	of	of	ADP
aji-7	522	16	the	the	DET
aji-7	522	17	creative	creative	ADJ
aji-7	522	18	commons	common	NOUN
aji-7	522	19	attribution	attribution	NOUN
aji-7	522	20	license	license	NOUN
aji-7	522	21	(	(	PUNCT
aji-7	522	22	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-7	522	23	)	)	PUNCT
aji-7	522	24	,	,	PUNCT
aji-7	522	25	which	which	PRON
aji-7	522	26	permits	permit	VERB
aji-7	522	27	unrestricted	unrestricted	ADJ
aji-7	522	28	use	use	NOUN
aji-7	522	29	,	,	PUNCT
aji-7	522	30	distribution	distribution	NOUN
aji-7	522	31	,	,	PUNCT
aji-7	522	32	and	and	CCONJ
aji-7	522	33	reproduction	reproduction	NOUN
aji-7	522	34	in	in	ADP
aji-7	522	35	any	any	DET
aji-7	522	36	medium	medium	NOUN
aji-7	522	37	,	,	PUNCT
aji-7	522	38	provided	provide	VERB
aji-7	522	39	the	the	DET
aji-7	522	40	original	original	ADJ
aji-7	522	41	work	work	NOUN
aji-7	522	42	is	be	AUX
aji-7	522	43	properly	properly	ADV
aji-7	522	44	cited	cite	VERB
aji-7	522	45	.	.	PUNCT
aji-7	523	1	peer	peer	NOUN
aji-7	523	2	-	-	PUNCT
aji-7	523	3	review	review	NOUN
aji-7	523	4	history	history	NOUN
aji-7	523	5	:	:	PUNCT
aji-7	523	6	the	the	DET
aji-7	523	7	peer	peer	NOUN
aji-7	523	8	review	review	NOUN
aji-7	523	9	history	history	NOUN
aji-7	523	10	for	for	ADP
aji-7	523	11	this	this	DET
aji-7	523	12	paper	paper	NOUN
aji-7	523	13	can	can	AUX
aji-7	523	14	be	be	AUX
aji-7	523	15	accessed	access	VERB
aji-7	523	16	here	here	ADV
aji-7	523	17	:	:	PUNCT
aji-7	523	18	http://www.sdiarticle4.com/review-history/53258	http://www.sdiarticle4.com/review-history/53258	PROPN
aji-7	523	19	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	X